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2 INTRODUCTION  
2.1 Bacillus Anthracis Infection Leads to Anthrax  
Bacillus anthracis is a Gram-positive, capsulated, aerobic and non-motile bacillus. It 
is related to the “Bacillus cereus group” of bacteria. To date, 89 strains have been 
identified. With a size of 3-5µm in length and 1-1.5µm in width, it is one of the largest 
bacteria. Under certain conditions B. anthracis forms spores that are extremely 
resistant to environmental insults. Therefore, they can survive for decades in air, 
water, soil and vegetation (saprophyte). Engulfment of the spores by the host leads 
to germination and conversion to the vegetative, actively dividing bacterium. (Figure 
2-1) One of the striking features of the bacterium is its capsule, which protects it from 
the uptake by phagocytic cells. [1] The mechanism behind the conversion from the 
spore to the bacterium is not well understood. However, the change of the 
carbondioxide concentration and temperature between the environment and after 
uptake in the organism is believed to play a role. [2] 
 
             
 
Figure 2-1: Electron microscopy of spores and vegetative form of anthrax. 
A) Spores (Sterne strain) in close proximity to the apical side of in vitro differentiated airway epithelial 
cells. B) Vegetative form of B. anthracis (copied from [3])  
 
The vegetative form of B. anthracis is known to cause anthrax, an acute infectious 
disease that is capable of inducing death to a variety of organisms, including 
humans. Three different forms of anthrax disease are known, depending on the entry 
route of the infectious bacteria. They are known as cutaneous, gastrointestinal and 
inhalational anthrax. The cutaneous form occurs after contact of spores with small 
skin lesions. Skin colonization with B. anthracis leads to the formation of black 
eschars that have given the disease its name (anthrax is the Greek word for coal). 
[4] It is treatable with antibiotics such as penicillin and therefore the least fatal but 
most common form. [5] Both gastrointestinal anthrax, which is caused by ingestion of 
contaminated meat [6], and inhalational anthrax have a much higher mortality rate 
(90-95%) among human cases.  
In the past, certain outbreaks of the inhalational anthrax were reported, mostly 
caused by the exposure to contaminated animal material. [7-9] Improved hygiene 
and handling of those products decreased the number of cases. [10] Recently, 
attention was drawn to spore contaminated letters sent to federal departments in the 
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USA. This caused the infection and deaths of approximately 15 people. [11, 12] 
Interestingly, those spores were found to be genetically modified in their size and 
charge, making them highly aerosolized and even more infectious. Normal spores 
are much bigger. [13] 
2.1.1 The Genetics Behind Bacillus Anthracis  
The virulence factors of Bacillus anthracis are encoded by genes located on two 
plasmids called pXO1 and pXO2.  
 
 
 
Figure 2-2: Plasmids pXO1 and pXO2 of B. anthracis contain genes, which encode virulence 
factors.  
 
pXO1 contains the genes pag, lef and cya that encode protective antigen (PA, pag), 
lethal factor (LF, lef) and edema factor (EF, cya) and genes controlling capsule 
(atxA) production. pXO2 encodes proteins important for the biosynthesis and 
regulation of the polyglutamic acid capsule (cap A, cap B, cap C). [14-16] 
Furthermore, the dep gene is associated with depolymerization of the capsular 
polymer. [17] Bicarbonate is required for the capsule, and therefore genes for 
bicarbonate sensing are encoded on both plasmids. AtaX (anthrax toxin activator) 
mediates CO2-dependent regulation of transcription and expression. [18-21] 
2.1.1.1 Protective Antigen – Structure and Function 
Protective antigen is secreted by the vegetative form of B. anthracis. It needs to bind 
to the two known anthrax receptors (TEM8 and/or CMG2) to facilitate the 
translocation of LF and EF across the membrane to the cytosol. Therefore, PA 
needs to be proteolytically cleaved by a cell surface associated furin protease at the 
sequence RKKR164-167, resulting in the removal of a 20kDa fragment. [22] This 
process is required to form a barrel structure of seven PAs, allowing the attachment 
of lethal or edema factor. (Figure 2-9) 
The crystal structure for PA revealed a 100Å tall, 50Å wide and 30Å deep molecule 
with a size of 83kDa. [23] (Figure 2-3) It contains four domains: Domain 1 (aa 1-258) 
which binds two calcium ions, can be viewed as two subdomains, termed PA20 and 
PA63. [24] PA20 corresponds to the residues 1-167. After its cleavage several 
hydrophobic residues become exposed, which are involved in LF and EF binding. 
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The remaining part (168-258) forms the N-terminus of the PA63. [25] Domain 2 (aa 
259-487) is the longest domain, composed of charged or polar residues and is 
important for pore formation. Deletion mutations lacking F313 and F314 are 
defective in channel formation. [26] Domain 3 (aa 488-595) is the smallest domain 
and seems to be important for the self association of PA63, since mutagenesis of 
residue 510-518 inhibits oligomerization. [27, 28] Domain 4 (aa 596-735) is 
implicated in receptor binding, which was shown by deletion mutations of the C-
terminus (679-693, 704-723, N682S). [29-32] 
The heptameric prepore forms a ring shaped barrel structure. (Figure 2-3, B) The 
outside consists of domain 3 and 4 and inside of domain 1 and 2. [33] The lumen 
has an average diameter of 20Å and contains mainly polar and negatively changed 
residues. A maximum of three lethal and/or edema factor proteins can bind to the 
hydrophobic surface of domain 1. LF and EF unfold upon decrease of the pH and 
translocate through the narrow lumen into the pH-neutral cytosol, where they refold. 
To this end, a study by Melnyk et al. proposed a model in which the interaction of 
positive charged Lys397 loop (outside) and negative charged Asp426 (inside) 
contract the pore and bring the Phe427 of domain 2 closer together, which play a 
major role in the translocation of the protein through the pores. [34] This Phe clamp 
could function as a seal and trap LF at the N-terminus. After decreasing pH levels LF 
and EF unfold, translocate through the narrow lumen and refold in the neutral 
cytosol.  
     
 
 
Figure 2-3: Protective antigen crystal structure and pore formation from [35]. 
A) Crystal structure of protective antigen bound to CMG2. The four domains are shown in different 
colors. B) Shape of the heptameric prepore displayed anchored in a lipid membrane. Abbreviation: Å, 
angstrom; CMG2, capillary morphogenesis gene 2. 
2.1.1.2 Edema Factor / Edema Toxin – Structure and Function 
EF is a calcium and calmodulin dependent adenylate cyclase, which shares 
homology of the catalytic adenylate cyclases domain with Bordatella pertussis and 
Bordatella bronchiseptica. [36]  
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It has been shown that treatment of macrophages with edema toxin leads to a wide 
variety of gene alterations. These genes are known to regulate processes such as 
inflammatory responses, apoptosis, adhesion, immune cell activation and 
transcription. [37] In addition to the altered gene expression profile, elevated 
intracellular cAMP levels are important for the establishment of infection. [38, 39] 
This is due to the dampening effect on the innate immune system by suppressing 
cytokine secretion. Treatment of murine bone-marrow derived macrophages with 
edema toxin inhibits IL-12p70 and TNF-alpha production. [40] Furthermore, 
decreased NADPH oxidase activation in human neutrophils through [cAMP] 
elevation leads to less production of superoxide, impeding effective killing of 
bacteria. [41] Independently of macrophages, neutrophil function is also affected. ET 
lowers the chemotaxic response, phagocytosis and oxidative burst. 
Effects of ET are also seen in the endothelium. Primary human microvascular 
endothelial cells (HMVECs) change their cytoskeleton and chemotaxis upon ET 
treatment by inducing transcription of Epac-related activators of Rap1, Epac2 
(RapGEF4), and MR-GEF/RapGEF5. [42] Furthermore, the increased release of 
inflammatory proteins such as prostanoids and histamine causes enhanced 
endothelial permeability. [43] In addition, ET suppresses platelet aggregation by 
activation of protein kinase A. [44] The endothelial cell and platelet alterations could 
be the reason for inefficient wound closure causing bleeding in the interstitium.   
Besides the inflammatory response, ET has been shown to increase hypertension 
caused by significant reduction of the left ventricular volumes and cardiac output. 
[45, 46] 
2.1.1.3 Lethal Factor / Lethal Toxin – Structure and Function  
The gene for lethal factor, called lef, was found on the pXO1 plasmid and generates 
a secreted protein of 90.2kDa. [47, 48] Lethal factor consists of four domains. (Figure 
2-4) 
 
 
Figure 2-4: Crystal structure of lethal factor from [49]. 
Displayed are the four domains of lethal factor: protective antigen (I), MAPKK binding function (II) and 
the catalytic centre (IV). Abbreviation: MAPKK-2, mitogen-activated protein kinase kinase; PA, 
protective antigen; VIP2, vegetative insecticidal protein 2; Zn, zinc. 
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Domain 1 (aa 28-263) is homolog to the edema factor and is important for PA 
binding. Mutations in this region (D182, D187, D188, Y223, H229, L235 and Y236) 
inhibit PA recognition or binding. [50, 51] Domains 2-4 are inserted into each other. 
Domain 2 contains an ADP-ribosyltransferase unit, which is similar to the VIP2 
protein, a toxin of Bacillus cereus. It contains mutations in the active site enhancing 
the substrate recognition. Point mutation studies (L293A, K294A, L514A, N516A, 
R491A: 10 to 50-fold reduction; N516A, L514A with either L293A, K294, or R491: 
complete reduction) showed that domain 2 plays an important role in the MAPKK 
cleavage. This indicates its involvement in the association with the MAPKK complex. 
[52] Domain 3 includes tandem repeats of the domain 2 and seems to be connected 
with it. Domain 4 forms the catalytic site, containing a HEFGHAV site (HEXXH, X 
can be any residue, aa 686-692), which is specific for metalloproteases. [49]  
Lethal factor is a zinc dependent metalloprotease. The protease activity was 
identified by protease inhibitors such as bestatin, which prevents the cytolysis of 
J774A.1 cells. Binding studies with zinc (65Zn) proved that LF interacts with one or 
more zinc atoms. Also, mutagenesis of the histidines 686 and 690 to alanines 
(HEFGH, motif of metalloproteases) reduces cytotoxicity and zinc binding. [53, 54] 
However, a point mutation from cysteine to glutamine (E687C), which is still able to 
bind zinc, inhibits the activity of lethal factor to cleave MAPKK. Duesbery et al. and 
Vitale et al. discovered in 1998 the enzymatic substrates of lethal toxin, called 
mitogen-activated protein kinase kinase or MEK family (MKK1/2, MAPKK 1 and 2) 
with two different approaches, mutagenesis and yeast two-hybrid. [55, 56] LF acts 
preferably upon proline-containing peptides. [57] (Figure 2-5) Until recently, it was 
believed, that LT cuts the N-terminus of all MAPKK besides MKK5 [56-58], which is 
required for phosphorylation of their downstream effectors, ERK, p38 and JNK. 
(Figure 2-1) 
 
 
 
Figure 2-5: Alignment for MAPKK cleavage site. 
N-terminus cleavage sites of all affected MAPKK are shown with their amino acid sequence and their 
consensus sequence. Adapted from [59]. Abbreviation: MEK, mitogen activating ERK kinase; MKK, 
mitogen activating kinase kinase.  
 
Not only the N-terminus is important for the cleavage of MAPKK, the C-terminus 
contains a lethal factor interacting region (LFIR), which is required for their 
proteolysis. (Figure 2-6) Some point mutation in the LFIR of MEK1 (F310, E311, 
E319, L313 or a triple mutation in FEE) had no effect on the lethal factor cleavage, 
whereas others (I316, V317, P322, or L324 to alanine) are crucial for the cleavage of 
MEK1. Those residues were shown to be conserved in all MAPKK. [60]  
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Figure 2-6: Lethal factor interacting region. 
The binding site of lethal factor with MAPKK displayed with their respective amino acid sequence. 
Adapted from [60]. Abbreviation: MEK, mitogen activating ERK kinase; MKK, mitogen activating 
kinase kinase.  
 
Lethal factor shares structural similarities with the N-terminus of edema factor. [61] 
These regions are important for PA binding. [62] Compared to lethal toxin, edema 
toxin has a ten times lower mortality rate in rats. However, it was observed that 
edema toxin can sensitize resistant macrophages and mice strains (DBA/2J) to lethal 
toxin lysis. Therefore, edema and lethal toxin act synergistically to enhance the 
fatality. [63] 
Lethal toxin is believed to be the most important key player in the anthrax infection. 
This was indicated by the comparison of B. anthracis infected and lethal toxin 
injected mice since they have similar phenotypes (shock, hypotension, death, and 
dyspnea). Another supporting fact is the 1000 fold reduction in mortality when LF-
deficient strains were analyzed against wild-type strains. [64] Interestingly, lethal 
toxin does not cause cell death in all cells or mice strains. They are categorized into 
more susceptible or resistant types (Table 2-1).  
 
Susceptible Cell Lines  Susceptible Macrophages  Resistant Macrophages 
J774A.1 (BALB/c  
monocyte macrophage), 
RAW 264.7  (BALB/c  
monocyte macrophage) 
129/J, BALB/cJ, C3H/HeJ, 
C57L/J, CBA/J, FVB/NJ,  
LP/J, MRL/MpJ, NZB/BinJ, 
SWR/J, CAST/EiJ, NON/LtJ, 
NZO/HILtJ 
AKR/J, C57BL/6J, I/LnJ, 
PL/J, DBA/2J, SM/J,  
SPRET/Ei, IC-21, A/J, 
NOD/LtJ, SJL/J, 
129S1/SvImJ 
 
Table 2-1: Resistant and susceptible macrophage cell lines or mouse strains. 
 
The death of susceptible macrophages starts with an increase in ion permeability 
(K+, Rb+, Ca2+, Cr2+, Cl-, SO42-) in the first 45 minutes. Conversion of ATP and the 
release of superoxide followed 15 minutes later. Shortly after, morphological 
changes are visual and cell lysis is initiated by loss of membrane integrity. [65]  
LT abolishes also the MAPK pathway, which leads to decrease of inflammatory 
responses, through the reduction of cytokine (IL6), chemoattractant (IL8, RANTES) 
and enzyme (iNOS) expression. Like ET, LT influences the oxidative burst of 
polymorphonuclear cells. In addition, in human dendritic cells, apoptosis will be 
induced and pro-inflammatory cytokines as well as surface activation markers are 
suppressed (TNFa, IL1b, IL6, IL12, IL10, CD40, CD80, CD86). The elimination of 
dendritic cells prevent the initiation of the adaptive immunity. T-cell activation is 
dependent on the MAPK pathway. Therefore, cytokine production/upregulation of 
surface markers and transcription factors are reduced.  
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Not only is the T-cell activation impaired, but also their proliferation. B-cells show the 
same growth inhibition in addition to a lower antibody production (IgM and IgG). [13] 
2.1.2 Anthrax Receptors TEM8 and CMG2 
As mentioned above, two receptors are known to bind PA, the tumor endothelial 
marker 8 (TEM8) and capillary morphogenesis gene 2 (CMG2). 
The physiological function of TEM8 is not well understood. It was shown to be 
upregulated in endothelial cells, in the colorectal tumors and vasculature in mouse 
embryos. The TEM8 receptor is expressed on a wide range of tissues, such as 
lungs, intestines, heart brain, skeletal muscles and pancreas. [66] TEM8 was 
discovered in a genetic approach as an anthrax receptor which binds protective 
antigen. Chinese hamster ovary cells (CHO-K1) were chemically challenged to 
undergo random mutagenesis and the cDNA of resistant cells were isolated to 
identify the PA receptor. [30] 
 
 
 
Figure 2-7: Alternative splice variants of the TEM8 receptor. 
Splice variants ordered by amino acid size and different domains shown with unique color coding. 
(sv1 - GenBank accession no.: NP_115584, sv2 - GenBank accession no.:NP_444262, sv3 - 
GenBank accession no.: NP_060623). Adapted from [67]. Abbreviations: ATR1, Anthrax toxin 
receptor; sv, splice variant; TEM8, tumor endothelial marker 8; VWA/I Willebrand Factor type A 
/integrin inserted domain I. 
 
So far, there are three alternative splice variants described. (Figure 2-7) [68] The first 
2 variants (sv1 and sv2) function as an anthrax receptor. They contain type I 
membrane proteins and share distinct homology in their sequence beside the C-
terminus tail. On the other hand, the sv3 version is predicted to be secreted due to 
the absence of a membrane domain. TEM8 sv1 is the original protein found in 
endothelial cells and with 564 amino acids the longest transcript. Besides the 
predicted signaling peptide, the extracellular region and the transmembrane domain, 
it has a 221 amino acid proline-rich C-terminal tail. TEM8 sv2 was identified by 
Bradley in 2001 as the first known anthrax receptor. [68] It has a length of 368 amino 
acids containing a shorter C-terminal end than sv1.    
The extracellular side between residues 44 and 216 contains a van Willebrand 
Factor type A (VWA) domain. This motif seems to be important for PA binding, since 
the D50A mutation was unable to internalize PA. [69] The VWA domain is a well 
characterized interaction site of the extracellular matrix. It contains a metal ion-
dependent adhesion site (MIDAS motif; DXDXS…T…D, with X being any amino 
acid) for ligand-interactions, which is conserved in both anthrax receptors. The C-
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terminus consists of an acidic cluster (EESEE; sv1 residues 360-368 and sv2 360-
364), which was also found on the cytoplasmic tail of a furin protease. Therefore, it 
might provide an interaction between the receptor and the protease to cleave the 
PA20 subunit required for pore formation. [30] 
CMG2386 was identified in human umbilical vein endothelial cells (HUVECs) 
undergoing capillary formation in vitro. Since its expression is restricted to the 
endoplasmic reticulum it was excluded as an anthrax receptor, which has to be 
expressed on the cell surface. [70] However, an alternative splice variant was 
identified as another anthrax receptor by overexpression with a green fluorescence 
tag in CHO-R1.1 cells followed by a cytotoxic assay. [71] This CMG2 form was also 
expressed in a variety of tissues, for example placenta, heart, lungs, liver, small 
intestine, colon, spleen, kidney, skeletal muscle and peripheral blood leukocytes, but 
not in brain and thymus.  
 
 
 
Figure 2-8: The splice variants of the CMG2 receptor. 
Splice variants ordered by amino acid size and different domains shown with unique color coding.  
(CMG2489- GenBank accession no.: AY233452, CMG2488- GenBank accession no.: BAC03731, 
CMG2386 - GenBank accession no.: AAK77222). Adapted from [67]. Abbreviations: CMG2, capillary 
morphogenesis gene 2; ER, endoplasmic reticulum; VWA/I Willebrand Factor type A /integrin inserted 
domain I.  
 
TEM8 and CMG2 share a 40% overall homology. The VWA/I domain is 60% 
conserved and contains the MIDAS motif. Another similarity is the cluster of acidic 
residues (EEEEE; CMG2488 and 489 residues 362-366, and CMG2386 residues 259-
263). [67] CMG489 and 488 differ in the 12 amino acids at the C-terminus, which match 
those of CMG386. (Figure 2-8) Therefore, it is believed that 488 and 489 bind 
protective antigen. The C-terminus is not important for either binding or 
internalization of PA. 
In 2006 it was shown that both receptors need a coreceptor. [72, 73] However, a 
different group proved that the low density lipoprotein receptor-related proteins 5 and 
6 (LRP5 or LRP6) are not important for the uptake of the toxins. [74] 
2.1.3 Anthrax Toxin Cycle 
Protective antigen, lethal factor and edema factor are non-toxic by themselves since 
pore formation of PA is required to bind and internalize lethal factor and edema 
factor, which results in lethal toxin (PA+LF=LT) and edema toxin (PA+EF=ET). 
(Figure 2-9) The requirement of PA was proven by a study, which introduced LF by 
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osmotic lysis of pinosomes into cells causing no lethal toxin reaction. [75] The 
engulfment of the toxin complex occurs by a clathrin-dependent endocytosis and 
inserts into early endosomes integrated in the membrane of intraluminal vesicles. 
[76] Edema factor and lethal factor translocate inside the vesicles and are 
transported by multivesicular bodies to the late endosomes. The acidification in the 
endosomes leads to a conformational change of the PA pore and unfolds LF and EF. 
This is required for their translocation through the pore in the cytoplasm after the 
fusion of the intramural vesicles with the membrane of the endosomes take place. 
[77, 78]  
 
 
 
Figure 2-9: Anthrax toxin cycle. 
Protective antigen binds to anthrax receptor and forms a prepore after furin cleavage. Bound EF and 
LF is internalized and released in the cytosol upon pH change, where an increase the cAMP levels or 
cleavage of MKK occurs. Abbreviation: ATP, adenosine triphosphate; ATR, anthrax toxin receptor; 
Ca2+, Calcium ion; CMG2, capillary morphogenesis gene 2; cAMP, cyclic adenosine monophosphate; 
H+, hydrogen ion; EF, edema factor; LF, lethal factor; MKK, mitogen-activated protein kinase kinase ; 
PA, protective antigen,  Zn2+, zinc ion.  
 
2.2 Bacteria and Toxin Interaction with the Epithelium 
The epithelial cell barrier is important for protection against external insults. It 
regulates the transport of molecules and defends the body from infection. Many 
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invasion mechanisms of pathogens have been described. In general, bacteria are 
phagocytosed by innate immune cells, such as macrophages or dendritic cells, and 
destroyed. However, many bacteria are able to interact with cells or secrete toxins to 
modulate the immune response and escape. Mostly junction and/or cytoskeletal 
alterations are induced by the bacteria to enter the host. For example, the 
Bacteroides fragilis toxin, which is like LT a zinc- dependent metalloprotease toxin, 
destroys junctions of polarized intestinal epithelial cells in dose dependent manner. 
[79] 
2.2.1 Lethal Toxin Influence on Junctions and Adhesion 
LT was shown to cause endothelial barrier dysfunction in primary human lung 
microvascular endothelial cells. [80] After 24 hours a drop of transepithelial 
resistance (TEER) up to 40% compared to the untreated cells, was measured. The 
resistance increased to 70% after 72 hours. The resistance alteration was 
accompanied by a change of permeability, which increased by 50%. Morphological 
changes of the cytoskeleton and adherens junctions (VE-cadherin) were studied by 
immunofluorescence. Lethal toxin treated cells showed a decrease of F-actin in the 
cell periphery, whereas the cell body displayed increased stress fibers. Also, the 
monolayer changed to a more elongated fibroblast-like shape. Monolayer density 
was slightly lower after 72 hours, but this cannot be the only reason for the TEER 
increase. Cell death disrupts the integrity of the cell layer and can cause increased 
permeability. However, only 2.5% and 7% of cells were apoptotic after 48 hours and 
72 hours, respectively. [80] 
Inhibition of MKK1/2 and JNK decreased the resistance similar to LT, whereas p38 
increased the resistance. This showed that the MAPK pathways are partially 
involved in resistance and permeability alterations. When Warfel et al. used a 
combination of all three inhibitors, no permeability alteration was seen and the cells 
did not display the same morphological changes in IF compared to LT treatment. [80]   
2.2.2 General Knowledge about Junctions and Adhesions 
Epithelial cells have to be polarized and form tight bond, in order to become a very 
tight barrier. Cell junctions as well as cell-cell and cell-matrix adhesions provide the 
connections required for layer strength, rigidity, integrity, molecule transport, cell 
communication and defense. 
 
 
 
Figure 2-10: Overview of the junction complex. 
Adapted from [81]. 
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Four major classes of junctions were described: tight junctions, gap junctions, 
adherens junctions and desmosomes. (Figure 2-10) Tight junctions are located 
basolateral right below the apical cell surface. Through their sealing features, they 
separate apical from basolateral fluids, which is important for the epithelial cell 
integrity and transport of ions, nutrition and molecules. It also blocks the diffusion of 
membrane proteins and glycolipids. The major integral membrane proteins present 
in the junction structure are occludin and claudin. However, many proteins are 
known to connect junctions with the cytoskeleton, such as vinculin, cortactin, α-
actinin and WASP. [82] 
Adherens junctions are cell-cell connections to support the cell shape and are 
localized right under the tight junctions. E-cadherin is associated with actin and 
myosin through the adaptor protein α- and β-catenin. They are regulated by 
GTPases, PI3K and the Arp2/3 complex. [82] 
Desmosomes were found in adhesion plaques, which are associated with 
intermediate filaments. Desmoglein and desmocollin are transmembrane linker 
proteins connecting proteins in the plaques, such as plakoglobin. They are important 
for maintaining the tissue homeostasis and strength. [82, 83] Gap junctions are 
intercellular cylindrical channels formed by the transmembrane protein connexin. 
This channel allows the exchange of ions (e.g. Ca2+, cAMP) and small molecules 
between cells. Therefore, they control the metabolic activity of cell-cell interactions.  
[82] 
Epithelial cells are linked basal to extracellular matrix proteins. Integrins are the 
major class of cell-matrix adhesion molecules. They form heterodimers out of α and 
β subunits. Epithelial cells express a wide range of both of them (α1β1, α2β1, α3β1, 
α5β1, α6β1, α9β1, α6β4, αvβ5, αvβ6). [84] Most common ligands are fibronectin, 
laminin and collagen. Talin and α-actinin regulate integrin activation, focal adhesion 
formation, recruitment of proteins to the focal adhesion complex and form a bridge 
between the integrins and the cytoskeleton. [85] 
Focal adhesions are sites connecting the actin cytoskeleton with integrin and matrix 
proteins. They are distinct by location, size and composition. The front of migrating 
cells contains mostly small focal adhesion, which are controlled by Rac and Cdc42, 
followed by elongated attachments regulated by Rho. They are connected to the 
actin cytoskeleton, located on the end of stress fibers. A variety of focal adhesion 
proteins are known, such as Src, FAK, cortactin, paxillin and vinculin. Tyrosine 
phosphorylation is a key event to regulate the dynamics of adhesion molecules. This 
occurs through Src and FAK. FAK is a tyrosine kinase, which is activated by 
autophosphorylation at tyrosine 397 (p-Y397). Src becomes stimulated by binding on 
p-Y397 and causes increased FAK activation and interaction with other proteins 
(Ras-MAPK pathway) by phosphorylating sites such as Y576, Y577, Y861 and Y925. 
The importance of FAK on migration was shown in FAK knockout cells leading to an 
increase of focal adhesion and defect in migration. [85] Active Src is not only 
important for FAK activation but also binds through a proline-rich domain to the 
adhesion adapter protein paxillin and phosphorylates it at Tyr31 and Tyr118. Paxillin 
is connected to the cell membrane, or directly to β1 integrin, and can either enhance 
or decrease motility. [85]       
2.2.3 Lethal Toxin Influence on the Cytoskeleton 
Proteomic analysis of a macrophage cell line (J774A.1) exposed to LT revealed 
alteration of cytoskeletal proteins, stress responses and energy generation. In detail, 
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the expression of tubulin-β2 and γ-actin were decreased, whereas vimentin, a 
protein of the intermediary family, was increased. [86] 
The effect of lethal toxin on the cytoskeleton was shown mainly in neutrophils where 
it paralyzes actin-based motility. LT impaired the fMLP stimulation of chemokinesis 
by more then 60% and enabled chemotaxis induced by chemoattractants. Migration 
requires active dynamics of the cytoskeleton. A lower filamentous actin content after 
lethal toxin treatment was caused by a reduction of Hsp27 phosphorylation. 
Cleavage of MKK3/6 led to a p38 activation defect, which reduced the 
phosphorylation of Hsp27. The reduced activity of Hsp27 results in the release of 
sequestered actin monomers, which altered the assembly of actin filaments. [87, 88] 
This could be the reason for the impaired phagocytosis after LT treatment. [89] 
2.2.4 General Overview of the Cytoskeleton 
The cytoskeleton provides a filamentous network in the cytoplasm shaping the cell 
and facilitates movements. The main structural elements are microtubules, 
microfilaments (actin filaments) and intermediate filaments. (Figure 2-11) 
 
 
 
Figure 2-11: Cytoskeletal polymers. 
Three different types of filaments are described with their structure and function. Adapted from [90] 
and [82].  Abbreviation: G-actin, globular actin; F-actin, filamentous actin; nm, nanometer. 
 
The smallest components of the cytoskeleton are the microfilaments. Monomer G-
actin (G = globular) forms double helical strands, called F-actin (F = filamentous), 
which twist around themselves to construct microfilaments. [90] Filamentous actin 
can shape distinct structures, such as stress fibers. To elongate in the direction of 
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protrusion, thin actin sheets (lamellipodia) and filopodia (finger-like protrusions) are 
developed by migrating cells. [91] The polymerization and depolymerization of actin 
on the leading edge is shown in Figure 2-12. They influence motility, cytoplasmic 
movements, cell shape, muscle contraction and cell division by producing the 
cleavage furrow.  
The actin cytoskeleton can be disrupted by inhibitors, which provide a tool for 
studying actin polymerization/depolymerization. For example, cytochalasin B binds to 
the barbed ends and blocks its assembly. Latrunculin inhibits the formation of F-actin 
by binding G-actin. F-actin is stabilized by phalloidin to abolish depolarization.  
Microtubules contribute to the cell shape, polarity, organelle position, vesicle 
transport, cell division (mitotic spindle), centriole organization and motility. They are 
located throughout the cell and indispensible player for structural components, such 
as cilia, centrioles and mitotic spindle. 
A variety of tubulin inhibitors are known to interfere with cell polarity. High 
concentrations of colchicine lead to depolarization of microtubules. Animal cells 
treated with lower concentration of colchinine block the microtubule rearrangement. 
This leads to the synchronization of cells in the metaphase. Nocodazole is also used 
for metaphase synchronization by promoting microtubule depolymerization. Taxol 
inhibits microtubule dynamics by binding on tubulin sites leading to the stabilization 
of microtubules. [82] Furthermore, post-translational modifications of tubulin can 
influence the motility. Table 2-2 shows the most important alterations and their 
function.  
 
Tubulin 
Modification Comment Function 
Acetylation/ 
deacetylation 
  
Tyrosination/ 
detyrosination 
 
Generation of  
∆2-tubulin 
 
 
Polyglutamylation 
 
 
 
Polyglycylation 
 
 
 
Palmitoylation 
 
 
Phosphorylation 
Only tubulin; marker for stable 
microtubules 
 
Reversible 
 
 
Only tubulin; marker for stable 
microtubules 
 
 
α- and β-tubulin; multiple glutamylation 
sites possible, up to 20 side-chain 
residues 
 
α- and β-tubulin; multiple glutamylation 
sites possible, up to 30-40 side-chain 
residues 
 
Demonstrated for budding yeast α 
tubulin on residues 376 
 
Better established for β-tubulin on 
Ser441/444 
Regulation of cell motility, binding of 
MAPs to microtubule 
 
Crosstalk to intermediate filaments; 
differentiation 
 
Removing tubulin from tyrosination 
cycle; marking microtubule for 
polyglycylation 
 
Centriole maturation and stability; 
flagellar and cilary motility; regulation 
of interaction with MAPs 
 
Cilary motility, cytokinesis 
 
 
 
Positioning of astral microtubules in 
budding yeast 
 
Neuronal differentiation  
 
 
Table 2-2: Posttranslational modification of tubulin.  
Shown are different modifications of tubulin with their function. Adapted from [92]. Abbreviation: MAP, 
Microtubules associated protein; Ser, serine; 
 
Intermediate filaments are, in contrast to the other filaments, a more permanent and 
stable component. Therefore, they fix the position of organelles and cell shapes even 
if high mechanical stress occurs. [90] 
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Cytoskeleton formation and cell polarization (ability to form a front and a back) are 
crucial for cell locomotion. The motility is initiated by the formation of a wide 
protrusion (lamellipodia) at the cell front through microfilament assembly on the 
leading edge. This actin network is cross-linked for stabilization and new focal 
adhesions connect the membrane with the extracellular matrix to anchor the 
protrusions. Afterwards the cytosol flows towards the front and the rear starts to 
contract. Upon disruption of the breakage of focal contacts, the tail moves forward.  
 
 
 
Figure 2-12: Mechanism of actin turnover from [93]. 
Polymerization of actin with important key playes. Abbreviation: ADF, actin depolymerization factor; 
ADP, adenosine diphosphate; Arp2/3, actin related protein 2/3; ATP, adenosine triphosphate; PIP2, 
phosphatidylinositol bisphosphate; Scar, suppressor of cAMP receptor; WASP, Wiscott Aldrich 
syndrome protein. 
   
The directed migration (chemotaxis) towards a chemotactic gradient needs a defined 
mechanism of actin polymerization. (Figure 2-12) After stimulation of cell surface 
receptors (tyrosine kinase receptors) intracellular signaling proteins such as Ras 
family members are activated. This causes the initiation of cytoskeletal 
rearrangement to induce directed motility. Active GTPases stimulate WASP and 
proteins activating the seven protein complex called Arp2/3. This complex initiates 
the actin filament growth from an F-actin branch, by adding profilin bound ATP-G-
actin. CapZ and other capping proteins restrict the barbed ends by preventing the 
addition or exchange of actin subunits through filament growth is stopped. The 
length of actin filaments is also controlled by actin-depolymerization factors, such as 
gelsolin/ADF and cofilin. Actin-binding protein profilin promotes the exchange of 
dissociated ADP-G-actin to ATP and refills the G-actin content used for assembly. 
The microfilament growth process can be increased by the hydrolysis of PIP2 
through phospholipase C (PLC). This increases actin turnover by inducing the 
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release of profilin, cofilin and gelsolin from the membrane. [93] Furthermore, 
cortactin promotes actin polymerization which is important for lamellipodia formation. 
It interacts with the Arp2/3 complex and is a known substrate of Src. [94, 95] These 
mentioned key players for polarization, protrusion and adhesion formation are 
summarized in Figure 2-13.  
 
 
 
Figure 2-13: Cell migration key players.  
Shown are the most important proteins involved in polarization, adhesion, protrusion formation and 
retraction of the tail. Adapted from [94]. Abbreviation: see list in appendix. 
  
2.2.4.1 Rho-Family GTPase Regulation of the Cytoskeleton 
The Rho-family GTPases are one of the most important key regulators of the 
cytoskeleton. They are small monomeric proteins. Activation occurs indirectly by 
receptor tyrosine kinases, which dimerize after ligand binding and autophosphorylate 
their cytosolic tyrosine residues. The exchange of GDP to GTP terminates their 
activity. GTPases are widely distributed in eukaryotic cells. Only few show tissue 
specific expression, such as Rab3b in neuronal and Rab17 in epithelial cells. They 
are localized in the cytosol or at membranes, due to interactions of their post-
translational modification with lipids. [91]  
All members have different functions. The Ras family regulates gene expression, 
whereas the Rab and Sar1/Arf families influence intracellular vesicle trafficking. The 
Ran family changes the nucleo-cytoplasmic transport and arranges the microtubule 
organization during cell cycle progression. The Rho family regulates gene 
expression and cytoskeletal rearrangements. Structural comparison of all families 
reveals a 30-50% homology and shows a specific side for the interaction with GDP 
and GTP. Since the exchange of GDP to GTP is extremely slow, guanine nucleotide 
exchange factors (GEF) are used to support this process. GTPase-activating 
proteins (GAP) regulate the hydrolysis of GTP.  
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The role of Rho, Rac and Cdc42 was identified by injection of their active forms in 
fibroblasts. Rho causes stress fiber formation. Rac induces lamellipodia and Cdc42 
promotes filopodia. [96] Furthermore, Rho/Rac/Cdc42 are involved in cell growth, 
development, membrane trafficking, axon guidance and extension. Figure 2-14 shows 
the downstream effectors of Rho, Rac and Cdc42 and their involvement in the 
cytoskeleton reorganization.   
 
 
 
Figure 2-14: Signaling cascade of Rho, Rac and Cdc42 and their influence on the cytoskeleton. 
Cytoskeletal rearrangements caused by GTPases and their downstream effectors. Picture adapted 
from [91, 97]. Abbreviation: see appendix.  
 
Wound closure of epithelial cells requires normal levels of Rac and Rho expression 
in addition to intact microtubules. Activation and inhibition of RhoA or the expression 
of dominant active Rac1 abolished wound closure. Furthermore, expression of 
Rac1wt leads to RhoA upregulation, junction disruption and wound closure defects. 
The inhibition of ROCK (Rho-kinase) stimulates wound closure by increasing Rac1 
activity, reducing actin stress fibers and focal contacts. [98]    
Cdc42 is an important key player for migration, proliferation, apoptosis and cell 
polarity. Its localization and connection with the cytoskeleton was explored by FRET 
analysis. Cdc42 promotes the growth of fine cell extensions, called filopodia. Inhibitor 
studies with nocodazole and cytochalasin D concluded that Cdc42 interacts with 
microtubules to regulate vesicle trafficking and adhesion complexes formation. [99] 
The loss of Cdc42 leads to defects in wound closure, establishment of polarity, 
migration toward a serum gradient and adhesion to fibronectin. Interestingly, Cdc42 
seems to enable the G1/S transition and plays a role in cell cycle regulation. [100] 
The Rho family is also involved in the activation of the MAPK pathway. Rac and 
Cdc42 regulate the activation of p38 MAPK and Jun NH2-terminal kinase (JNK), 
whereas Ras proteins and Cdc42 control the activation of the ERK pathway 
(p42/p44). [91] 
2.2.4.2 MAPK Pathway Targets the Cytoskeleton 
The only known substrates for LT are MAPKK. They influence inflammation, cell 
growth, differentiation and apoptosis, but also cytoskeletal changes.  
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Figure 2-15: MAPK pathway.  
Cleavage of the N-terminus of MAPKK by LT affects ERK, p38 and JNK signaling, whereas MEK5 is 
not altered. Adapted from [101]. Abbreviation: see appendix. 
 
In general the MAPK pathway is activated by extracellular signals stimulating 
receptor tyrosine kinases or G-protein coupled receptors, which activate MAPKKK 
through the phosphorylation of threonine and/or serine. (Figure 2-15) MAPKKK induce 
phosphorylation of MAPKK followed by the downstream signaling to MAPK (ERK = 
Thr183-Glu-Tyr185 motif, p38 = Thr-Ala-Tyr motif and JNK = Thr-Pro-Tyr motif). 
MAPKs can translocate into the nucleus to induce transcription. For their activation 
dual phosphorylation is required, causing the exposure of threonine and tyrosine. 
This conformational change allows ATP to bind to the catalytic site. It was also 
shown, that the ERK, p38 and JNK pathway alter cell migration through 
rearrangements of the cytoskeleton. 
In detail, the ERK pathway is initiated by growth factors stimulating Ras and Raf. 
(Figure 2-16) Consequently, MEK1 and 2 are activated through phosphorylation of 
Ser217 and Ser221. [102-106] ERK exists in two isoforms, called p44 (ERK1) and 
p42 (ERK2), which are both activated by threonine and tyrosine phosphorylation. 
Studies conducted with dominant negative MEK1 deminished motility, whereas 
active MEK1 promoted migration. The decrease of ERK by specific inhibitors, such 
as U0126 and PD98059 or by a dominant negative ERK mutation, inhibits cell 
migration of various cell types after growth factor stimulation. [107]  
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Figure 2-16: ERK signaling pathway causes motility changes. 
Shown are the MEK1/2 pathway and its upstream and downstream cytoskeletal effectors. Adapted 
from [108]. Abbreviation: see appendix. 
 
Some of the ERK substrates affect actin dynamics, adhesion molecules and cell 
motility. (Figure 2-16) The myosin light chain kinase (MLCK) induces membrane 
protrusion at the front of polarized cells and influences adhesion maturation. [109, 
110] Calpain is phosphorylated at Ser50 by ERK. This is required for cell migration 
by promoting detachment in the end of the cell shown by mutation analysis. [111] 
FAK and paxillin are also involved in the adhesion dynamics. They control the focal 
contacts and connect them to cytoskeletal proteins, respectively. ERK 
phosphorylates FAK at a variety of tyrosine residues, but the phosphorylation at Ser 
910 causes the disruption of the FAK-paxillin interaction. [112] 
 
The proteins involved in activation of p38 and downstream cytoskeletal signaling are 
shown in Figure 2-17. The decrease of p38 avtivity by specific inhibitors or expression 
of a dominant negative mutant causes, in a variety of cells, defects in cell motility. 
[113, 114]  
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Figure 2-17: p38 signaling pathway causes motility changes. 
Proteins of the MKK3/6 cascade influencing cell migration are displayed. Adapted from [108]. 
Abbreviation: see appendix. 
 
p38 regulates adhesion dynamics by phosphorylating the focal adhesion protein 
paxillin at serine 83. [115] Caldesmon does not affect focal connections. It regulates 
the formation of podosomes. It also stabilizes actin filaments by inhibiting the Arp2/3 
complex. When phosphorylation by p38 and cdc2 kinase occurs, these described 
effects are inhibited. [116]   
MAPK-activating protein kinase 2/3 (MAPKAPK2/3) stimulates p16-Arc and the heat 
shock protein 27 (Hsp27) after being activated by p38. Phosphorylated Hsp27 
controls actin polymerization, induces stress fibers and is involved in endothelial cell 
migration. [117-119] p16-Arc, a subunit of the Arp2/3 complex, which influences actin 
rearrangement, might regulate the speed of migration. [120, 121]       
 
The JNK pathway is initiated by growth factors and influences proteins important for 
cell migration and also focal adhesion, such as Rac, FAK and Src. Proteins of the 
cytoskeleton and those involved in migration are contolled through downstream 
phosphorylation, especially of the threonine and tyrosine motif of JNK. [108] The 
importance of the JNK pathway in cell migration and cytoskeletal rearrangement was 
demonstrated with different approaches. (Figure 2-18) The upstream kinase MEKK1 
recognizes microtubule integrity and regulates epithelial cell and fibroblast migration. 
This was observed in MEKK1 (-/-) mice, which are also defective in eyelid closure. 
[122] 
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Activation of JNK and expression of constitutively active MKK4 was associated with 
faster motility in human lung adenocarcinoma cell line A549. [123, 124] The 
reduction of JNK activity through inhibitors on the other hand or expression of the 
constitutive-negative mutant (JNK1AF) impaired this motility increase. [125, 126] 
JNK also needs to be activated to perform proper wound healing in fibroblasts. [125] 
 
 
 
Figure 2-18: JNK signaling pathway causes motility changes. 
Actin, adhesion and microtubule dynamics changed by proteins of the MKK4/7 pathway are shown. 
Adapted from [108].  Abbreviation: see appendix. 
 
Figure 2-18 demonstrates JNK interacting/activating proteins and their possible 
influence on the cytoskeleton and migration. Jun is a component of the activator 
protein 1 (AP-1) transcription factor. The phosphorylation at Ser63 and Ser73 of Jun 
is crucial for cell migration. [125] JNK phosphorylates paxillin at Ser178. Point 
mutation S178A cannot be phosphorylated anymore and causes migration defect. 
Overexpression of S178A leads to focal adhesion and stress fiber formation in rat 
bladder carcinoma cells. Spir is a WASP family member which regulates actin 
rearrangement causing F-actin clustering. [127]  
DCX is associated with neuronal migration, which is inhibited, when JNK mediated 
phosphorylation of Thr331 and Ser334 does not occur. This microtubule associated 
protein regulates stabilization of microtubules through phosphorylation. [128] 
Furthermore, MAP1B and MAP2 are hyperphosphorylated in JNK -/- mice causing 
defects in microtubule assembly and binding. [129] 
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2.3 Lethal Toxin Induced Cell Death in Murine Cells 
Interactions between LT and murine cells generally lead to cell death. The uptake of 
Bacillus anthracis spores in the lungs occurs through alveolar macrophages [130], 
dendritic cells [131] and epithelial cells [132]. Engulfment of the spores causes 
germination inside the macrophage to the vegetative form, which is released after 
necrosis [133-136] and/or apoptosis [137] of macrophages. Toxin accumulation and 
rapid bacteria multiplication lead to sepsis and shock. Understanding the death 
mechanisms would assist in identifying therapeutic targets.  
Lethal toxin can cause death after intravenous injection in a variety of susceptible 
mice and rats strains, such as BALB/c and Fisher rats. (Table 2-1) Interestingly, there 
are also resistant macrophages which do not lyse after lethal toxin treatment. 
Genetic studies identified an Ltx1 region at chromosome 11 to be responsible. Kif1C, 
a kinesin-like motor protein, is located in this region but was excluded because 
resistant NOD and SJL mice carry the Kif1C allele. Further studies identified Nalp1b 
as the key player. There are 3 different forms of Nalp1 expressed: Nalp1a, Nalp1b 
and Nalp1c. Analysis of 18 mouse strains showed that almost all of them carry all 
three forms. However, 129S1 mice do only express Nalp1b and are susceptible to 
LT. Further sequencing of the Nalp1b cDNA classified five polymorphic alleles. 
Resistant strains carry allele 2, 3 or 4, whereas susceptible strains such as 129S1 
only have allele 1. These findings suggest that the expression of allele 1 of Nalp1b is 
important for the susceptibility. This agrees with most of the strains except one 
strain. The susceptible strain (CAST/EiJ) does not carry the allele 1; instead it 
displays a 13 residue substitution in allele 5. [138, 139]  
Nalp1 is a member of the NOD-like receptor family (NLR) and part of the 
inflammasome, which controls innate immunity and inflammation. [140, 141] In 
susceptible mouse macrophage cell lines, RAW264.7 and J774A.1, it has been 
shown previously that lethal toxin induces the release of IL-1β and IL-18 through 
caspase-1 activation. [142] However, to this date it is unknown how the process is 
possibly initiated by the inflammasome (a multiprotein complex) which is known to be 
a caspase-1 activator. Nalp1b interacts with the ASC domain (apoptosis-associated 
speck-like protein containing a CARD) of pro-caspase-1 leading to oligomerization of 
caspase-1 and autoactivation. [143, 144] How the interaction of lethal toxin and 
Nalp1b occurs and if it is a proteolytic target is also unknown.  
If activation of caspase-1 were solely responsible for the cytotoxicity, caspase-1 
inhibitors should prevent cytolysis. Unfortunately, inhibitors (Ac-YVAD-CMK and Z-
WEHD-FMK) which covalently bind to the active site of the p10/p20 tetrameric form 
of active caspase-1 did not reduce cell death significantly and intermediate levels of 
IL-1β maturation were detected. Also, IL-1β neutralizing antibodies could not protect 
macrophages against LT lysis. Furthermore, caspase activation and therefore IL-1β 
production are late events occuring after 50-75 minutes followed by cell death at 85-
90 minutes. The MKK cleavage takes place at 20-40 minutes. This suggests that the 
late cytokine response is not the reason for cell lysis. [145, 146] 
Table 2-3 lists inhibitors, which prevent or inhibit the lysis of macrophages after LT 
treatment. ROS, mitochondria, proteasome and acidification of late endosomes are 
required for the cytotoxicity of lethal toxin.   
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Inhibitor Effect 
Oxidants: 
Beta-mercaptoethanol, dithiothrietol, 
ethyl alcohol dimethylsulfoxide  
 
Blocks cytolysis by inhibiting oxidative 
burst [147] 
Proteasome inhibitors: 
MG132, lactacystein, ALLN, 
epoxomycin 
 
Inhibition of cytotoxicity [148] 
Protease inhibitor: 
Bestatin, chloromethylketones of 
leucine and phenylalanine 
EDTA, amino acid hydroxamates, zinc 
matelloprotease inhibitor ZINCOV 
 
Prevent lethal toxin induced lysis of 
J774A.1 cells [53] 
Abolishes all in vitro catalytic function [149] 
Vacuolar ATPase pump inhibitor: 
Concanamycin A, bafilomycin A1, B1, 
C1, D 
 
Inhibition of acidification of late 
endosomes, lower cytotoxicity [150] 
Protein Phosphatase 
Calyculin (serine/threonine) 
 
Prevents MEK1 cleavage, by enhanced 
phosphorylation and inhibits cell death by 
78% in J774.1 cells (pretreatment) [151]  
Lethal factor inhibitor: 
EGCG 
N-Oleoyldopamine 
Hydroxamate, (2R)-2-[(4-fluoro-3-
methylphenyl)sulfonylamino]-N-
hydroxy-2-(tetrahydro-2H-pyran-4-
yl)acetamide 
quinoline-containing compounds  
rhodamine derivates 
catechol 
aminoglycosides  
mixed-type inhibitors 
 
anti-oxidant polyphenol of green tea [152] 
[153] 
inhibits LF protease activity [154] 
 
 
 
[155] 
[156] 
[157] 
[158] 
[159-163] 
 
Table 2-3: Inhibitors for lethal toxin induced cytotoxicity.  
 
The proteasome controls the levels of regulatory proteins which are important in 
many cellular processes, such as transcription, cell cycle and apoptosis. The 
proteasome activity was not affected by LT treatment in macrophages after one 
hour. However, the inhibition of the proteasome by specific inhibitors such as 
MG132, ALLN and lactacystin prevented lysis of Raw 264.7 when added at the same 
time with LT. The MAPKK cleavage still occurred, which indicates that the 
downstream events are not responsible for apoptosis, instead an unknown substrate 
might be involved. [148] Another hypothesis suggests that toxin-induced resistant 
macrophages have a decreased proteasome activity. [164] Furthermore, caspase-1 
activation is also controlled by the proteasome. Its activity was diminished after 
addition of proteasome inhibitors. [165] 
Mitochondria dysfunction and membrane perturbation are critical events in induced 
cytolysis. Lethal toxin leads to swelling of mitochondria accompanied with 
mitochondrial impairment, shown by decreased mitochondrial membrane potentials 
and succinate dehydrogenase (SDH) activity in murine J774A.1 macrophages. Two 
mitochondrial proteins, called Bcl-2/adenovirus E1B 19-kDa interacting protein 3 
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(Bnip3) and Bnip3-like (Bnip3L; also known as Nip3-like protein X) were 
downregulated in LT resistant bone marrow-derived macrophages from C57BL6 
mice. In toxin-induced susceptible Raw 264.7 macrophages this might be partially 
mediated through the inhibition of the p38 pathway. [166, 167] 
The involvement of p38 in apoptosis was identified by Michael Karin’s group. 
Reconstitution of non-cleavable MKK6 mutants in murine macrophages protected 
cells from apoptosis induced by lethal toxin treatment. [168] Decreased p38 activity 
affects NF-κB target genes, which have association with cell death regulation, 
causing the activation of apoptosis.  
Not all cell types undergo fast apoptosis or necrosis after LT treatment. However, 
cell proliferation and differentiation were inhibited in B und T lymphocytes [169-171] 
and in melanocytes [172]. Cell cycle arrest in G0-G1 phase was induced via 
downregulation of cyclin D1/D2 and checkpoint kinase 1 (Chk1) in U-937 cells. 
Interestingly, THP1 cells could overcome this cell cycle arrest by activation of PI3-K 
and AKT. [173] 
2.3.1 Cytotoxicity Comparison Between Mouse and Human 
Human cells seem to be more resistant against lethal toxin induced cytotoxicity than 
mouse macrophages, which undergo cell death in as early as 2 hours. Human lung 
epithelial cells and microvascular endothelial cells showed only a very modest 
increase in cell death after 18 hours. [174] Endothelial cells were treated for up to 72 
hours with lethal toxin and evaluated for early and late apoptosis/necrosis. After 24 
hours no indication of cell death was found, but after 48 hours a 2% increase of 
apoptotic cells was detected. This amount increased to 7% at 72 hours and 
correlated with slightly elevated PI stain, which was only increased by 5%. [80] A 
different study of human umbilical vein endothelial cells (HUVEC) showed 25% 
apoptotic nuclei after 18 hours, a 40% decrease in cell viability after 24 hours and 
80% after 48 hours. Similar results were obtained by using an inhibitor of MEK1/2 
(PD98059). [175]  
Innate immune cells, such as human peripheral blood mononuclear cells 
(lymphocytes and monocytes), were resistant to lysis in the presence of LT for 15-24 
hours. However, activated monocytes (IFN-γ for 48 hours) treated with LT showed a 
slight increase of early apoptosis. Nucleosomal fragmentation was also slightly 
higher after treatment. [176] Human monocytic cell lines U-937, HL-60 and THP-1 
were only susceptible to LT induced cell death when differentiated into a 
macrophage-like state. [177] 
In the human T cell line, Jurkat E6.1 lethal toxin did not decrease the cell 
proliferation. [178] Whereas murine CD4+ T cells derived from Balb/c mice showed a 
proliferation inhibition after 24 hours lethal toxin treatment. [179] 
In addition, lethal toxin induced MAPKK cleavage was shown to inhibit tumor growth 
in renal cell carcinoma (RCC). Those tumor cells have a higher expression of MKK1 
and ERK2. Since lethal toxin leads to a reduction of ERK2 activation by MKK1 
cleavage, it inhibits tumor vasculature without affecting cell death and cell cycle 
progression after 72 hours. [180] Similar effects were detected in murine endothelial 
cells expressing a human herpes virus protein-coupled receptor (vGPCR-SVEC) 
causing Kaposi’s sarcoma. Lethal toxin blocked cell proliferation and the release of 
endothelial growth factors. [181] LT causes in human endothelial cells (HUVEC) a 
20% reduction in proliferation. [180] In this case, the use of LT in cancer therapeutics 
would be only possible, if treatments can be directed locally on the tumor without 
damaging normal tissue.  
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2.3.2 Clinical Symptoms and Treatment of Inhalational Anthrax 
Inhalational anthrax symptoms are similar to those of a common flu. For example, 
fever, nonproductive cough and chest discomfort are early symptoms of the 
infection, which often leads to false diagnosis. (Table 2-4)  
 
Symptoms N=10 
Fever, chills  
Fatigue, malaise, lethargy 
Cough 
Nausea or vomiting 
Dyspnea 
Sweats, often drenching 
Chest discomfort or pleuritic pain 
10 
10 
9 
9 
8 
7 
7 
 
Table 2-4: Symptoms of 10 Inhalational anthrax cases between October-November of 2001. 
Adapted from [11]. Abbreviation: N, number of cases.  
 
Chest radiographs illustrate a widened mediastinum, which occurs through internal 
bleeding and an increase of pleura fluid. [182] Furthermore, patients showed 
inflammation, hemorrhage, and lesions in the mediastinum, mediastinal lymph 
nodes, bronchi, lungs and central nervous system. [13, 183] This leads to short 
breath, strident cough, pulmonary edema and skin discoloration, caused by poor 
blood oxygenation. 
As of now, only very few prevention and treatment options are available. The 
protective antigen-based anthrax vaccine is a series of 6 shots in 18 months followed 
by annual boosters. This vaccine is only available for those people being at a higher 
risk of exposure such as soldiers.  
Antibiotics such as ampicillin, amoxicillin, chloramphenicol, ciprofloxacin, 
doxycycline, gatifloxacin, levofloxacin and penicillin are effective against B. 
anthracis. The Centers for Disease Control and Prevention (CDC) recommend 
treatment with 400-500mg ciprofloxacin and 100mg doxycycline in combination with 
one more antibiotics for at least 60 days. It is important to understand that antibiotics 
do not destroy the spores. After the antibiotic treatment is completed, a new infection 
may occur, if spores were able to escape the immune defense system to germinate 
into bacteria. Other studies showed that antibodies against protective antigen were 
effective in preventing death, such as ETI-2004 or AVP-21D9. [184, 185]  
Most treatments are antibiotic treatments for longer periods of time. This still does 
not ensure protection. Only recently, a new vaccine-antitoxin combination was 
discovered, which has not been introduced into clinical trails. This vaccine is based 
on the expression of the von Willebrand A domain of the CMG-2 receptor on the 
surface of an insect virus (flock house virus of the family Nodaviridae) coated with 
protective antigen. Fisher 344 rats were completely protected when immunized 4 
weeks prior to lethal toxin challenge (intravenous), and had no intoxication 
symptoms such as respiratory distress or hypoxia. [186]  
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3 AIM OF THE WORK 
The goal of my work has been understanding mechanisms in the late pathogenesis 
of an inhalational anthrax infection. This knowlegde would assist in generating drug 
targets to cure one of the deadliest forms of anthrax, characterized by a mortality 
rate of 95-99%. After inhalation of the spores, phagocytosis by alveolar 
macrophages and dendritic cells takes place. While migrating to the regional 
lymphnodes, germination occurs and the bacteria are released by cell lysis. Fast 
replication and toxin secretion (lethal toxin and edema toxin) influence the behavior 
of cells and their defense mechanism in the body, ultimately leading to septic shock-
like death.  
As of now, many studies aiming at elucidating inhalational anthrax effects were 
performed in mice or mouse cells/cell lines. However, there seems to be a significant 
difference between the responses of murine cells compared to human cells in 
susceptibility and reactions. Therefore, I am focusing mostly on human derived cells 
in my study.  
The lung is an immediate target affected by anthrax infection. This is the place where 
in the beginning bacterial growth and toxin secretion occurs and from where the 
infection spreads. Later stages of infection are characterized by shortness of breath 
and respiratory distress, all contributing to ultimate body failure.  
Inhalational anthrax is a fast progressing disease. Since the first symptoms are very 
similar to a common flu, the disease is frequently misdiagnosed. Fast detection 
methods and antibiotic treatments have been developed. However, they are only 
effective if given at early times. Therefore, it is crucial to understand cellular signaling 
events triggered by anthrax infection in late progression to develop powerful medical 
approaches for death prevention.  
Currently, only two studies determined the effect of anthrax toxins on lung 
microvascular and epithelial cells. They identified permeability changes and a more 
resistant effect on lethal toxin induced cytotoxicity compaired to murine cells.  
My goal was it to study the effect of one of the anthrax toxins, lethal toxin, on the 
human respiratory epithelium. To define key mechanism, human primary lung 
epithelial cells were grown under normal tissue culture conditions. For more 
physiological significance, a fully differentiated, polarized three-dimensional airway 
system was established. During the process of maturation of the 3D-layer an 
increased formation of junctions and secretion of mucus was observed. This model 
epithelium responds to stimulation and was capable of rapid wound healing after 
injury. Consequently, we wanted to define different mechanisms/behaviors between 
mouse and human cells. In this regard, we determined possible viability, junction and 
motility alterations. 
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4 MATERIAL AND METHODS   
4.1 Chemicals and Reagents 
Ammonium persulfate     Sigma-Aldrich Co, St. Louis, MO 
Aprotinin      Sigma-Aldrich Co, St. Louis, MO 
Bovine serum albumin    Sigma-Aldrich Co, St. Louis, MO 
Bromphenolblue     Sigma-Aldrich Co, St. Louis, MO 
BSA, Fatty acid free, low endotoxin   Sigma-Aldrich Co, St. Louis, MO 
Collagenase D     Roche, Basel, Switzerland 
Collagene (human placenta Type VI)  Sigma-Aldrich Co, St. Louis, MO 
DAPI       Sigma-Aldrich Co, St. Louis, MO 
Dexamethasone     EMD Biosciences, San Diego, CA 
Diethyl pyrocarbonate    Sigma-Aldrich Co, St. Louis, MO 
Dimethyl sulfoxide     Sigma-Aldrich Co, St. Louis, MO 
dNTP       Promega, Madison, WI 
Edema factor     List Biological Laboratories, CA 
Ethanol      Aaper Alcohol Co, Shelbyville, KY 
Ethidiumbromide     Sigma-Aldrich Co, St. Louis, MO 
Ethylenediaminetetraacetic acid   Sigma-Aldrich Co, St. Louis, MO 
Fibronectin (human plasma)   Sigma-Aldrich Co, St. Louis, MO 
FITC-albumin       Sigma-Aldrich Co, St. Louis, MO 
Fluoromount G     Southern Biotech, Birmingham, AL 
Glacial acetic acid     Fisher Scientific, Hampton, NH 
Glycerol      Sigma-Aldrich Co, St. Louis, MO 
Glycine      J.T. Baker, Phillipsburg, NJ 
Goat serum      Gibco Invitrogen, Carlsbad, CA 
Keratinocyte growth factor     Cell Sciences, Canton, MA 
Leupeptin      Sigma-Aldrich Co, St. Louis, MO 
Lipofectamine 2000     Invitrogen, Carlsbad, CA 
Lipofectamine Plus     Invitrogen, Carlsbad, CA 
Lipofectamine Reagent     Invitrogen, Carlsbad, CA 
MAPKKide (o-ABZ/DNP)    List Biological Laboratories, Inc 
Methanol      Fisher Scientific, Hampton, NH 
MTT       Sigma-Aldrich Co, St. Louis, MO 
N,N,N’,N’-tetramethylethylene diamine  Sigma-Aldrich Co, St. Louis, MO 
Na-Cholate      Sigma-Aldrich Co, St. Louis, MO 
Nocodazole      Sigma-Aldrich Co, St. Louis, MO 
Nonidet P-40      EMD Biosciences, San Diego, CA 
Paraformaldehyde     Electron Microscopy Sciences, PA 
Phenylmethylsulphonylfluoride   Sigma-Aldrich Co, St. Louis, MO 
Phosphatidylserine     Millipore, Billerica, MA   
Polybrene/Hexadimethrine bromide   Sigma-Aldrich Co, St. Louis, MO  
Poly-L lysine      Sigma-Aldrich Co, St. Louis, MO  
Polyoxyethylene-sorbitan-monolaurate  Sigma-Aldrich Co, St. Louis, MO 
Ponceau’s S      Fisher Scientific, Hampton, NH 
Propidium iodide     Sigma-Aldrich Co, St. Louis, MO 
Sae Kem LE agarose    Chembrex Bio Science, ME 
Saponin       Sigma-Aldrich Co, St. Louis, MO 
Scintillation fluid: Filter Count    Perkin Elmer Instruments, Wellesley, MA 
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Sodium azide     Sigma-Aldrich Co, St. Louis, MO 
Sodium chloride     Fisher Scientific, Hampton, NH 
Sodium dodecyl sulfate    Sigma-Aldrich Co, St. Louis, MO 
Sodium hydroxide     Sigma-Aldrich Co, St. Louis, MO 
Taq-Polymerase      New England Biolabs, Ipswich, MA 
TO-PRO-3 iodide (642/661)   Invitrogen, Carlsbad, CA 
Trans-Blot, pure nitrocellulose   BioRadLaboratories, Hercules,CA 
Tris base      EMD Biosciences, San Diego, CA 
Triton X-100      Sigma-Aldrich Co, St. Louis, MO 
β-mercaptoethanol     Sigma-Aldrich Co, St. Louis, MO 
4.1.1 Kits 
BCA™ Protein Assay Reagent A + B  Pierce, Rockford, IL 
CytoTox-ONE      Promega, Madison, WI 
Endofree Plasmid Maxi Kit    Qiagen, Valencia, CA 
FluoReporter® Mini-biotin-XX Protein Labeling  Invitrogen, Carlsbad, CA 
In Situ Cell Death Detection Kit, Fluorescein Roche, Basel, Switzerland 
QIAfilter Plasmid Maxi Kit    Qiagen, Valencia, CA 
QIAprep Spin Miniprep Kit    Qiagen, Valencia, CA 
QIAshredder      Qiagen, Valencia, CA 
RNeasy Mini Kit      Qiagen, Valencia, CA 
SuperScript™ II Reverse Transcriptase   Invitrogen, Carlsbad, CA 
4.1.2 Inhibitors 
Inhibitor   Inhibition of       Final Conc.            Company 
Aprotinin   serin protease                 10µM  Sigma-Aldrich Co 
Bafilomycin A1  vacuolar H+-ATPase inhibitor   50nM  Sigma-Aldrich Co 
CCCP    mitochondrial potential  100µM     Sigma-Aldrich Co 
Chloroquine   lysosome     100µM  Sigma-Aldrich Co 
Cytocholasin B  actin polymerization   1µg/ml             Sigma-Aldrich Co 
EGCG    LF inhibitor      10µM  EMD Biosciences 
Epoxomycin   proteasome        1µM  EMD Biosciences 
JNKII    JNK inhibition             2.5-5µM            EMD Biosciences 
Latrunculin A   actin polymerization   2µg/ml             BIOMOL 
Leupeptin   serin/cysteine prot.                10µM   EMD Biosciences 
MG132   proteasome/lysosome     10µM  EMD Biosciences 
Nocodazole    tubulin polymerization     10nM             Sigma-Aldrich Co 
PMSF    serin/cysteine prot.                 1mM  Sigma-Aldrich Co 
Oligomycin   mitochondrial potential         2.5µg/ml   Sigma-Aldrich Co 
SB203580   p38       10µM             EMD Biosciences 
SB202190   p38       10µM  EMD Biosciences 
Sodium orthovanadate   tyrosine protease              100µM  Sigma-Aldrich Co 
Sodiumfluoride   protease                  1mM  Sigma-Aldrich Co 
U0126    MEK1/2        5µM             EMD Biosciences 
4.1.3 Molecular Weight Markers 
100bp DNA Ladder     NEB Biolabs, Beverly, MA 
Benchmarker TM Pre-Stained protein ladder  Invitrogen, Carlsbad, CA 
PageRulerTM Prestained protein   Fermentas, Hanover, MD 
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4.1.4 Radioisotopes  
[3H]-Thymidine (1mCi/ml)     MP Biomedical, Solon, OH   
Trans 35S Label (10mCi/ml)   MP Biomedical, Solon, OH 
4.1.5 Buffers 
Antibody diluents  50ml  10x TBS 
    5g  BSA 
15ml   goat serum 
1ml   Tween-20 
add 500ml  dH2O 
 
Blocking buffer  50ml   10x TBS 
(Western Blot)  15g   BSA 
50ml   goat serum 
50ul   20% NaN3 
add 500ml  dH2O 
 
Blocking buffer  5%  BSA 
(IF)    1%  human serum 
    in  PBS 
 
2.5M CaCl2   36.76g  CaCl2  
    100 ml  dH2O 
 
DEPC – H2O   200ul   DEPC 
    add 100ml  ddH2O 
 
2X HBS   281mM  NaCl  
    100mM  HEPES  
    1.5mM  Na2HPO4    
      Adjust pH to 7.12    
   
FACS staining buffer 5%   FCS 
    in  PBS 
 
4x Laemmli Buffer   40ml  0.5M Tris-HCl, pH6.8 
    20ml  glycerol 
    40ml  10% SDS 
    4ml  beta-mercaptoethanol 
    pinch  bromophenolblue 
 
Ponceau’s S    0.5g  Ponceau S 
    1ml  Acetic acid 
    100ml  H2O     
 
RIPA buffer   150mM NaCl 
    50mM  Tris-HCl, pH7.4 
    0.5%  Sodiumcholate 
    1%   NP-40 
    0.1%  SDS 
    in ddH2O 
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10x SDS running buffer 30 g   Tris base 
140 g   Glycine 
10 g   SDS 
add 1000ml   ddH2O 
 
50x TAE   242g  Tris base 
    57.1ml glacial acetic acids 
100ml  0.5M EDTA, pH8 
add 1000ml  ddH2O 
 
10x TBS   0.2M   Tris Base 
1.4M   NaCl 
in dH2O  
 
10x TBST   0.2M   Tris Base 
1.4M   NaCl 
0.5%   Tween-20 pH7.5 
in dH2O  
 
1xTE    10mM  Tris-HCl pH7.5 
    1mM   EDTA 
      in dH2O, sterile filtered  
 
10x Transfer Buffer  250mM  Tris Base 
    1.92M  Glycine 
in dH2O  
 
1x Transfer Buffer   10%   10x transfer buffer 
20%   Methanol 
70%   dH2O  
 
4.1.6 Antibodies 
Antibody Dilution Isotype Vendor 
Alexa Fluor 488  1:500 Goat Invitrogen 
Alexa Fluor 568 1:500 Rabbit Invitrogen 
Alexa Fluor 594 1:500 Donkey Invitrogen 
Cdc42 Hs (P1) 1:1000 Rabbit Santa Cruz 
Cofilin 1:250 Rabbit Cytoskeleton 
Cofilin (alpha) 1:1000 Mouse Jim Bamberg 
Cortactin (p80/85 clone 4F11) 1:1000 Mouse Millipore 
Cyclin B1 (H-433) 1:2000 Rabbit Santa Cruz 
Cyclin D1 (Ab2) 1:1000 Mouse EMD Biosciences 
DMIA alpha –Tubulin 1:750 Mouse Sigma 
Donkey anti rabbit HRP 1:10000 Donkey Promega 
Donkey anti goat HRP 1:5000 Donkey Santa Cruz 
E-Cadherin 1:1000 Mouse BD Transduction Labs 
E-Cadherin 1:1000 Rabbit Invitrogen 
GDI Ab Rab  1:5000 Rabbit Selfmade 
GEFH1 1:1000 Rabbit Gary Bokoch 
Gelsolin (Clone GS-2C4) 1:1000 Mouse Sigma 
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GFP serum A-6455 lot:71C1-2 1:5000 Rabbit Invitrogen 
GM130 1:1000 Mouse BD Transduction Labs 
Goat anti mouse HRP 1:10000 Goat Southern Biotech 
Goat anti rabbit HRP 1:10000 Goat Southern Biotech 
HA – high Affinity 1:1000 Rat Roche 
HA-probe (Y-11) 1:1000 Rabbit Santa Cruz 
His-Probe (H-15) 1:1000 Rabbit Santa Cruz 
6-His 1:1000 Mouse BAbCO 
IkB-α (C-21) 1:1000 Rabbit Santa Cruz 
LMP2 1:4000 Rabbit Biomol 
LMP7 1:4000 Rabbit Biomol 
MEK-1 (C-18) 1:1000 Rabbit Santa Cruz 
MEK-1 (N-term) 1:1000 Rabbit Millipore 
MEK-2 1:2500 Mouse BD Transduction Labs 
MEK-2 (C-16) 1:1000 Rabbit Santa Cruz 
MEK-3 (C-19) 1:1000 Rabbit Santa Cruz 
MEK4 (C-20) 1:1000 Rabbit Santa Cruz 
MEK4 (K-18) 1:1000 Rabbit Santa Cruz 
MKK6 1:1000 Rabbit Biolegend 
MEK7 (C19) 1:1000 Goat Santa Cruz 
MEK7 (ab18565) 1:1000 Rabbit Abcam 
MUC5AC (Clone 45M1) 1:1000 Mouse Neomarker 
p38 MAPK 1:1000 Mouse Cell Signaling Tech. 
p44/42 MAP kinase  1:2000 Rabbit Cell Signaling Tech. 
P53 (sc-6243) 1:1000 Rabbit Santa Cruz 
PARP (H-250) 1:1000 Rabbit Santa Cruz 
Paxillin 1:10000 Mouse BD transduction lab 
Peroxidase Goat anti mouse Ab 1:5000 Goat EMD Biosciences 
phospho FAK [pY397]  1:1000 Rabbit Biosource 
phospho p38 (Thr180/Thr182) 1:1000 Mouse Cell Signaling Tech. 
phospho p44/42  1:1000 Rabbit Cell Signaling Tech. 
phospho Src 1:1000 Rabbit Cell Signaling Tech. 
phospho cofilin #4317  1:400 Rabbit Jim Bamberg 
phospho paxillin [pY118]  1:600 Rabbit Biosource 
Phosphotidylserine 1:40 Mouse Millipore 
pSAPK/JNK (Thr183/Thr185) 1:1000 Rabbit Cell Signaling Tech. 
Rac1 (#R56220, lot3) 1:1000 Mouse BD Transduction Labs 
RhoA (26C4) 1:1000 Mouse Santa Cruz 
Rhodamine phalloidin  1:200  Invitrogen 
Rock 1 (H85) 1:1000 Rabbit Santa Cruz 
SAPK/JNK (56G8) 1:1000 Rabbit Cell Signaling Tech. 
Streptavidin HRP conjugated 1:10000  Invitrogen 
TIAM-1 (C-16) 1:2000 Rabbit Santa Cruz 
Tubulin, Acetylated #T6793 1:1000 Mouse Sigma 
Tubulin-Alpha (B512)  1:1000 Mouse Sigma 
Vinculin (alpha) 1:1000 Mouse Sigma 
ZO-1 1:1000 Mouse Invitrogen 
ZO-1 1:1000 Rabbit Invitrogen 
 
Table 4-1: Antibody List. 
Used antibodies with concentration, isotype and where it was purchased. 
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4.1.7 Primers 
     Annealing 
Name     Sequence (5’? 3’)    Length  Temperature 
β-actin for    TGACGGGGTCACCCACACTGTGCCCA 661bp  60°C 
β-actin rev    CTAGAAGCATTTGCGGTGGACGATGG           18 cycles 
 
ATR for  CCAGGAGGAGACACTTACATG  302bp  50°C 
ATR rev  TGAGTGGATGATGCCTTGC 
 
BD-1 for    CTCTGTCAGCTCAGCCTC   272bp  66°C 
BD-1 rev    CTTGCAGCACTTGGCCTTCCC   
    
BD-2 for    CCAGCCATCAGCCATGAGGGT  254bp  66°C 
BD-2 rev    GGAGCCCTTTCTGAATCCGCA   
 
Calveolin-1 for    TCAACCGCGACCCTAAACACC  562bp  60°C 
Calveolin-1 rev   TGAAATAGCTCAGAAGAGACAT    
 
CMG2 for  CCTTTGATCTCTACTTCGTCC  810bp  50°C 
CMG2 rev  GCTGTGACAATTAATGATCCT 
 
MUC5AC for     TCCGGCCTCATCTTCTCC   662bp  55°C 
MUC5AC rev    ACTTGGGCACTGGTGCTG   
 
MEK2 for  CGTACCTCCGAGAGAAGCAC   560bp  60°C 
MEK2 rev  GAAGGTGTGGTTTGTGAGCA    
 
MKK3 for  TTGGACAGGTCAGCAGACAG   539bp  53°C 
MKK3 rev  TCCAGAGCACTCACCTCCTT    
 
RhoA for  GCCATCCGGAAGAAACTG   548bp  60°C 
RhoA rev  TTCCCACGTCTAGCTTGC 
 
RhoB for  CATCCGCAAGAAGCTGG   583bp  60°C 
RhoB rev  TCATAGCACCTTGCAGCAG 
 
RhoC for  ATGGCTGCAATCCGAAAG   583bp  60°C 
RhoC rev  TCAGAGAATGGGACAGCC 
 
SP-A for     GAGAGATGGTATCAAAGGAG  499bp  58°C 
SP-A rev     GGTACCAGTTGGTGTAGTT   
 
SP-B for    TTCTGGTGCCAAAGCCTGGA  836bp  58°C 
SP-B rev    CAGGCCTGGTGCATTGCC  
 
Table 4-2: Primer list. 
4.2 Technical Equipment  
1024 confocal microscope    Bio Rad, Hercules, CA 
5810R Eppendorf    Brinkman Instuments Inc., Westbury, NY 
AB104 Scale      Mettler Toledo, Switzerland 
AccuBlock Digital Dry Bath    Labnet International Inc, Edison, NJ 
ACCUMET AB15  pH meter   Fisher Scientific, Hampton, NH 
Alphaimager 2200    Alpha Innotech, San Leandro, CA 
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Autoclave Amsco Scientific Series  STERIS Corporation, Mentor, Ohio 
AXIOSKOP Microscope   Zeiss, Goettingen, Germany 
Beckman GS-6KR    Beckman Coulter, Fullerton, CA 
Beckman J2-HC     Beckman Coulter, Fullerton, CA 
Biological Safety Cabinets    NUAIRE, Plymouth, MN 
BioRad Power Pac 1000   Bio Rad, Hercules, CA 
Bio-Rad (Zeiss) MRC1024 LSCM  Bio Rad, Hercules, CA 
Eppendorf Centrifuge 5810R   Eppendorf AG, Hamburg, Germany 
EVOM       World Precision Instruments, Sarasota, FL 
FACSCalibur     BD Biosciences, San Jose, CA 
Fisher Stirring Hotplate    Fisher Scientific, Hampton, NH 
Fisher Vortex Genie     Fisher Scientific, Hampton, NH 
Incubator, NAPCO CO2    Fisher Scientific, Hampton, NH 
IsoTemp215 waterbath    Fisher Scientific, Hampton, NH 
Leica EM FC6 low temp attachment   Leica, Wetzlar, Germany 
Leica EM KMR2 Glass Knife maker  Leica, Wetzlar, Germany 
Leica EM UC62b Ultramicrotome  Leica, Wetzlar, Germany 
LS55 Chemiluminescence Photometer Perkin Elmer Instruments, Wellesley, MA 
Microfuge 22R Centrifuge    Beckman Coulter, Fullerton, CA 
Microplate Luminometer LB 96 V  EG + G Berthold, Bad Wildbach, Germany 
NanoDrop® ND-1000 Spectrophotometer  NanoDrop Technologies, Wilmington, DE 
Nikon Eclipse TE2000-U   Nikon, Melville, NY 
Olympus IX70 Microscope   Olympus, Center Valley, PA 
Optima Ultracentrifuge    Beckman Coulter, Fullerton, CA 
PB3002 Scale     Mettler Toledo, Switzerland 
PCR Express      ThermoHybaid, Heidelberg, Germanny 
Philips CM100 Electronmicroscope   Philips, New York, NY   
Power Pac 200    Bio Rad, Hercules, CA 
Protein Bio Rad Mini Protein II Cell  Amersham Bioscience, Uppsala, Sweden 
PS 500 XT DC Power Supply  Hoefer Scientific Instruments, CA  
Reichert Ultracut E Ultramicrotome  Reichert, Depew, NY 
Rocker Platform     Bellco Glass, INC Vineland, NJ  
SRX-101A Medical film processor   Konica Minolta, Wayne, NJ  
Steri-Cult200 Incubator    Thermo Forma Scientific, Waltham, MA 
STX2 Electrode    World Precision Instruments, Sarasota, FL  
UV/Visible Spectrometer Ultraspec 3000 Pharmacia Biotech, Cambrige, UK 
VERSAmax Microplatereader   Molecular Devices, Sunnyvale, CA 
Vortex Genie 2    Fisher Scientific, Hampton, NH 
4.2.1 Computer and Internet Programs  
BioRad LaserSharp 2000    Bio Rad, Hercules, CA 
BD CellQuest    BD Biosciences, San Rose, CA 
EndNote     EndNote, Carlsbad, CA 
Flow Jo     Tree Star Inc, Ashland, OR 
Imaris5     Bitplane Inc., Saint Paul, MN 
ImageJ     NIH, Bethesda, MD 
Metamorph7     Molecular Devices Corp., Downingtown, PA 
Spectra Alias     Deltasoft/Biometallics, Princeton, NJ 
pDRAW32     AcaClone software 
Prism 5.0     Cadmus Professional Communication 
VectorNTI     Invitrogen, Carlsbad, CA 
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http://elm.eu.org/ 
http://frodo.wi.mit.edu/cgi-bin/primer3/primer3_www.cgi 
http://prowl.rockefeller.edu/prowl/peptidemap.html 
http://smart.embl-heidelberg.de/ 
http://www.basic.northwestern.edu/biotools/oligocalc.html 
http://www.firstmarket.com/cutter/cut2.html 
http://www.idtDNA.com  
http://www.ncbi.nlm.nih.gov/ 
http://www.ncbi.nlm.nih.gov/BLAST/Blast.cgi 
http://www.umass.edu/microbio/rasmol/ 
 
4.3 Cell Culture 
Normal human bronchial epithelial cells (NHBE) were obtained from Lonza 
(Walkersville, MD) and cultured in small airway basal media (SABM) supplemented 
with 30µg/ml bovine pituitary extract, 0.5µg/ml hydrocortisone, 0.5ng/ml human 
recombinant epidermal growth factor, 0.5µg/ml epinephrine, 10µg/ml transferrin, 
5µg/ml insulin, 0.1ng/ml retinoic acid, 6.5ng/ml triiodothyronine, 50µg/ml gentamicin, 
50ng/ml amphotericin-B and 0.5mg/ml bovine serum albumin-fatty acid free 
(SingleQuots) at 37°C in a 5% CO2 incubator.  
Cell Culture and Splitting: The Reagent Pack (Lonza) provided the solutions required 
for subculturing NHBE. It contained HEPES buffered saline solution (HEPES-BSS), 
Trypsin/EDTA, and trypsin neutralizing solution (TNS). HEPES-BSS neutralized the 
complex proteins in growth medium that may inactivate trypsin during trypsinization. 
Trypsin/EDTA removes cells from culture vessel surfaces and TNS neutralized this 
reaction. The cells were counted with a Neubauer haemocytometer and plated at 50-
60% confluency. 
Seeding for Experiments: Cells of passage 4-6 were grown in supplemented SABM 
medium for 24-48 hours. The LT stimulations took place after a three hour starvation 
in media without supplements (SABM or DMEM/BEGM) and were treated mostly 
with 1µg/ml PA and 1µg/ml LF for 48 hours. 
Freezing and Thawing: Cells were cryopreserved to avoid loss by contamination, to 
minimize genetic changes and to avoid aging. After centrifugation (950rpm, 3min, 
RT) cells were resuspended in the freezing medium, containing 80% SABM, 10% 
DMSO and 10% FBS at a concentration of 8-9x105 cells/ml. The cell suspension was 
transferred to cryovials and placed in a Nalgene freezing container at -80°C 
providing 1°C/min cooling rate. After 24 hours the cryovials were transferred to liquid 
nitrogen (-196°C) for long-term storage. The thawing process was done very quickly. 
The vial was placed in a 37°C water bath for few minutes, complete media was 
added, cells were centrifuged and reseeded in fresh SABM media with supplements. 
Afterward the cells were put into a 37°C incubator with 5% CO2 and 80% humidity 
until assay was performed. 
4.3.1 Polarized Airway System  
The air-liquid interface system (ALI) reflects an in vivo situation and need to be 
obtained in order to generate a mucociliary epithelium, since culturing techniques 
with immersed feeding could not generate this type of airway. [187, 188] Several key 
factors play an important role on proliferation, differentiation and secretion of mucus 
in the polarized airway system. Coating of membrane/tissue culture surfaces with 
collagen or fibronectin enhances the attachment and proliferation of bronchial cells. 
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The presents of transforming growth factor-β (TGF-β) in serum, which inhibits 
proliferation of airway cells, led to the use of serum free media. [189] Therefore, 
culturing the cells in a mixture of hormones and growth factors was developed, 
containing insulin, transferrin, epidermal growth factor (EGF), hydrocortisone and 
bovine pituitary extract (BPE) to stimulate the cell growth. Thyroxine hormone (T3) 
inhibits mucin synthesis. Vitamin A plays an important role in maintaining the 
homeostasis of the epithelium, regulating mucus cell differentiation. [190] Another 
key regulator is calcium, which is not only important for junction formation, but also 
required for mucus cell function. [191]  
For the differentiated lung epithelial model (3D) cells were detached with trypsin and 
seeded onto inserts with semi-permeable support membranes (Costar Transwell-
clear culture insert, polyester, 0.4µm pore, Corning Costar) coated with human 
placenta collagen type VI (15µg/cm2, Sigma). The differentiation media contained 
bronchial epithelial basal medium (50% BEBM, 50% DMEM with 4.5g/L D-glucose) 
supplemented with 200µg/ml bovine pituitary extract, 0.5µg/ml hydrocortisone, 
0.5ng/ml human recombinant epidermal growth factor, 0.5µg/ml epinephrine, 
10µg/ml transferrin, 5µg/ml insulin, 1.5µg/ml bovine serum albumin fraction V, 
6.5ng/ml triiodothyronine, 50µg/ml Gentamicin, 50ng/ml Amphotericin-B and 50nM 
retinoic acid, prepared freshly to induce differentiation. After 2 days in immersed 
culture conditions, cells were switched to an air-liquid interface for 3-4 weeks. (Figure 
4-1) Daily media changes were required. 
 
 
Figure 4-1: Differentiated airway system. 
Normal tissue culture plated cells (2D) were trypsinized and plated on an insert (3D) with a porous 
membrane. After two days in culture the upper liquid phase was removed and the differentiation of an 
air-liquid interface took place in 3-4 weeks. Abbreviation: 2D, 2 dimensional; 3D, 3 dimensional; PET, 
polyester. 
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4.3.2 Culturing of Murine Macrophages 
For some cytotoxicity and MAPKK cleavage assays, we used a lethal toxin 
susceptible murine macrophage cell line Raw 264.7. This leukemic monocytic 
macrophage cell line was derived from the mouse strain BALB/c. The cells were fed 
with DMEM high glucose media containing 10% FBS and 1% HEPES and were 
subcultured by gentle scraping using a cell lifter. The cells were grown to 100% 
confluency at 37°C and 5% carbon dioxide. We plated 4x104 cells in a 96-well plate 
for MTT assays and 1x106 cells in a 6-well plate for protein lysates. 
 
4.4 Gene Expression 
RNA Isolation: Ribonucleic acid (RNA) acts as messenger between DNA and 
proteins. Upon the transcription from DNA to RNA by an enzyme called RNA 
polymerase, the RNA leaves the nucleus and moves to the ribosomes. That is where 
the translation to proteins occurs. Isolation of RNA is one of the steps to look at gene 
expression, next to generating cDNA and amplifying the gene of interest. 
After lysis of cells with β–mercaptoethanal containing RLT buffer (supplied in the kit), 
the solution was applied to the QIAshredder (Qiagen) which reduces viscosity 
caused by cellular components and cell debris. Ethanol was added to provide ideal 
binding conditions. The lysates were loaded onto the columns of the RNeasy Mini 
Kit, washed with wash buffer and eluted in 30-50µl water. 
Quantification of RNA and DNA Concentrations: RNA and DNA concentration were 
determined in a Nonodrop spectrophotometer by measuring the absorbance. The 
concentration was calculated with following formula.  
 
  DNA concentration (µg/µl) = A260 * 50 * dilution factor  
                1000 
 
 
  RNA concentration (µg/µl) = A260 * 30 * dilution factor  
                1000 
 
cDNA Synthesis: Complementary DNA (cDNA) was synthesized from RNA by using 
SuperScript™ II Reverse Transcriptase (Invitrogen). 2µg of total RNA were mixed 
with 1µl Oligo(dT)12-18 primers (500µg/ml) and 1µl dNTPs (10mM each) with water 
in a total volume of 12µl and heated to 65°C for 5 minutes. 4µl 5x first-strand buffer 
and 2µl 0.1M DTT were added and incubated at 42°C for 2 minutes. Afterwards 1µl 
SuperScript™ II RT (200units) was used to start the cDNA synthesis at 42°C for 50 
minutes and inactivated by heating at 70°C for 15 minutes. 1µl RNaseH (2units/µl) 
was added for 20 minutes at 37°C to catalyze the cleavage of RNA. 
4.4.1 Polymerase Chain Reaction (PCR) 
Polymerase chain reaction (PCR) is an in vitro technique for enzymatic replication of 
DNA fragments. Primers determine the DNA fragment that is been amplified and can 
be up to 10kb in lenght. The process was carried out by a thermal cycler. The double 
stained DNA was separated at 95°C, followed by an annealing temperature specific 
for the primers binding. At the elongation temperature from 72°C the DNA 
polymerase synthesized a new DNA strand. This process was repeated for up to 35 
cycles to generate enough DNA to visualize on an agarose gel.  
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The following reaction mix was used in all PCRs, whereas the annealing 
temperatures depended on the primers: (Table 4-2) 
 
Reaction Mix: 
    10X  PCR Buffer [200 mM Tris-HCl (pH 8.4), 500 mM KCl]      5µl  
50mM  MgCl2                  1.5µl  
10mM  dNTP Mix            1µl  
 10µM  Forward primer           1µl  
 10µM  Reverse primer          1µl  
  5U/µl  Taq DNA polymerase        0.4µl  
cDNA from first-strand reaction        2µl  
autoclaved, distilled water               38.1µl  
            50ul 
 
Program:     94ºC   - 2min 
    94ºC   - 1min  
      Annealing Temperature    ºC  - 1min        35x cycles 
    72ºC   - 1min 
    72ºC   - 5min 
        4ºC   - hold 
 
Agarose Gel Electrophoresis: Agarose gel electrophoresis is a method to separate 
RNA and DNA by size. The negatively charged nucleic acids are moving towards the 
cathode. The estimation of the size was determined by running a DNA Ladder with 
known fragment sizes, where smaller fragments migrate faster and vise versa. This 
method was used to asses the quality of RNA and visualize the PCR products. 1µg 
of non-degraded RNA showed on a 1% gel the 28S, 18S and 5S ribosomal subunits. 
When a smear with no defined bands occurred, the RNA was degraded and not 
used. 
5-10µl PCR product were mixed with 0.5-1µl 10x DNA loading dye to apply it on an 
1% agarose gel containing ethidium bromide made in 1x TAE. The separation was 
performed at 100 Volt for approximately 30-60 minutes. Ethidium bromide 
intercalates in the DNA, fluoresces under UV light and allowed visualization of the 
PCR products with an Alphaimager 2200. 
 
4.5 Immunoblot 
The immunoblot (western blot) is a method to detect proteins. SDS-PAGE gel 
electrophoresis is used to separate denatured proteins by mass. After transferring 
the proteins on a membrane (nitrocellulose), detection is possible by incubating the 
membrane with a specific antibody. A luminescence reporter enzyme (horseradish 
peroxidase) bound on the secondary antibody allows visualizing the protein band on 
a photographic film. 
Protein Isolation: A detergent-containing lysis buffer (RIPA) with several protease 
inhibitors (see below) was used to break the lipid barrier surrounding cells by 
solubilizing proteins and disrupting lipid:lipid, protein:protein and lipid:protein 
interactions. Before adding the lysis buffer, cells were washed once with 1x PBS. To 
increase the yield of total protein, the cells in RIPA lysis buffer were incubated at       
-80°C for at least 30 minutes. Cells were scraped off the tissue culture plate, 
transferred in a microcentrifuge tube, vortexed and incubated for 15 minutes on ice 
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to ensure the solubilization of transmembrane proteins. The cell debris was 
separated from the lysates by centrifuging at 14000rpm for 15 minutes at 4°C and 
the supernatant was transferred in a new centrifuge tube. Storage of the samples at  
-80°C minimized protein degradation until the assay was performed. 
 
Protease inhibitor: 10µM  Aprotinin   serine protease 
   10µM Leupteptin   serine and cysteine protease 
    1mM  PMSF    serine protease 
           100µM  Sodium orthovanadate tyrosine protease 
 
Protein Quantification Assay: The BCA (bicinchoninic acid) protein assay is a 
method for colorimetric detection and quantification of total amounts of proteins. In 
the first step, proteins reduce Cu2+ to Cu1+ in an alkaline solution. Afterwards the 
BCA forms a complex with the cupric ion, which is blue/violet and absorbs light at 
562nm. The absorption can be detected by using a spectra microplate reader with 
DeltaSoft3 analysis software. The protein concentration of each sample was 
determined from standard curve of absorbance versus micrograms of protein. 
SDS-PAGE Electrophoresis: Polyacrylamide gel electrophoresis (PAGE) was used 
to separate charged proteins according to physical properties as they are forced 
through a gel by an electric current. Sodium dodecyl sulfate (SDS) is an anionic 
detergent that dissolves hydrophobic molecules and covers the protein with many 
negative charges. Laemmli buffer was added to the lysates. It contains β-
mercaptoethanol that linearizes proteins by preventing the reformation of disulfide 
bonds.  
After assembling the gel chamber, the running gel followed by the stacking gel was 
cast. The percentage of the running gel was between 6 -15% acrylamide, depending 
on the size of the protein. Higher molecular weight proteins were better separated in 
lower percentage gels and vice versa.  
 
Running Gel    Percent Acrylamide Gel 
 6% 10% 12% 15% 
1.5M TRIS•HCl pH 8.8 5ml 5ml 5ml 5ml 
30% Acrylamide/  
0.8% Bisacrylamide 3ml 5ml 6ml 7.5ml 
10% SDS 150µl 150µl 150µl 150µl 
10% APS  150µl 150µl 150µl 150µl 
TEMED 20µl 20µl 20µl 20µl 
in H2O 6.3ml 4.3ml 3.3ml 1.8ml 
 
 
Stacking Gel      
 
0.5M TRIS•HCl pH 6.8 
30% Acrylamide /  
0.8% Bisacrylamide 
10% SDS 
10% APS  
TEMED 
in H2O 
3% Acrylamide Gel 
1.2ml 
500µl 
 
50µl 
50µl 
10µl 
3.2ml 
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Protein Transfer: In order to make the proteins accessible to antibody detection, the 
SDS-PAGE gel was transferred onto a membrane made of nitrocellulose by applying 
a current (1hr, 0.3A).  
Blocking: Blocking of non-specific antibody binding was achieved by placing the 
membrane in a blocking solution containing bovine serum albumin (BSA), goat 
serum and sometimes 3% non-fat dry milk for one hour at room temperature. A wash 
of 5 minutes with TBST followed.  
Protein Detection: During the detection process, the membrane was incubated with 
an antibody for the protein of interest (primary antibody) for 1-3 hours at room 
temperature or overnight at 4°C. The secondary antibody, detecting the Fc region of 
the primary antibody, was linked to a reporter enzyme (HRP), which drives a 
colorimetric or photometric signal.  
Protein Analysis: The horseradish peroxidase (HRP)-linked secondary antibody was 
used in conjunction with an enhanced chemiluminescent agent (ECL). The reaction 
product generates luminescence in proportion to the amount of protein, which was 
detected by a photographic film. The amount of ECL and the exposure time 
depended on the amount of detected protein, usually 1:1 - 1:20 dilutions of the ECL 
to water and times between 5 seconds and 20 minutes were used.  
Membrane Stripping: To gently break the antibody-antigen interaction, stripping 
buffer (Western Re-Probe from G-Biosciences) was used. The nitrocellulose 
membrane was washed once for 10 minutes with water, incubated 30 minutes with 
stripping buffer at room temperature on a shaker and washed 3 times with TBST for 
10 minutes. After blocking a different primary antibody can be used for an additional 
signal on the same membrane.  
 
4.6 Immunocytochemistry and Microscopy  
Immunocytochemistry is a powerful method to detect proteins/antigens with 
fluorescent dyes and visualize their location in the cell with a fluorescence 
microscope. Immunostaining was performed on cells grown on collagen coated glass 
coverslips or in inserts. Fixation with 4% paraformaldehyde, methanol or 
methanol/acetone and permeablization in 0.5% Triton X-100 in PBS took place for 
10 minutes at room temperature. After blocking in 5% BSA and 1% heat-inactivated 
human serum for one hour, primary antibodies diluted in 2% BSA were used to 
detect the proteins of interest. The secondary antibody was conjugated with a 
fluorescence dye, such as FITC, alexa-488 or -568. The nucleus was stained for 10 
minutes with 1µg/ml DAPI in PBS and mounted with Fluoromount-G (Southern 
Biotech) on glass slides. After drying the samples overnight at room temperature, 
they were examined with a fluorescent microscope. The pictures were analyzed with 
either ImageJ or Metamorph.  
Confocal Microscopy: Confocal microscopes obtain extremely high-quality images 
with a maximum resolution. Three-dimensional information of cells grown on inserts 
can be generated. Also, colocalization of signals from different fluorochromes can be 
reliably studied. The laser scanning confocal microscope 1024 from BioRad has a 
krypton / argon mixed gas laser that excites at 488nm, 568nm and 647nm. All cells 
were fixed, mounted and the images were taken with 10x to 100x objective lenses. 
The analysis was performed with ImageJ or Metamorph. 
Live cell Imaging: Live cell imaging had the advantage of capturing processes in real 
time. A Nikon Eclipse TE2000-U was used to generate movies of LT, infected or 
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inhibitor treated cells. The cells were plated on collagen coated glass cover slips, 
grown for two days, starved with SABM media for 3 hours and treated for 24 hours 
prior to imaging. DIC pictures were taken every thirty seconds or one minute for thirty 
minutes up to two hours with a 20x objective lens. Metamorph or ImageJ were used 
to analyze and convert the pictures.  
Transmission Electron Microscopy: Transmission electron microscopy (TEM) is an 
imaging technique whereby a beam of electrons is focused onto a specimen causing 
an enlarged version to appear on a photographic film. The sample preparation was 
performed by the microscope core facility at TSRI. 3D differentiated cells were fixed 
for 60 minutes on ice in 2.5% glutaraldehyde in 0.1M sodium cacodylate buffer 
(pH7.3) and washed in 0.1M cacodylate buffer 3 times. After treatment with 1% 
osmium tetroxide in 0.1M cacodylate buffer for 1 hour at room temperature and 
washing in 0.1M sodium cacodylate buffer, each sample was incubated in 0.5% 
tannic acid in 0.05M cacodylate for 30 minutes. They were rinsed in 1% Na2SO4 in 
0.1M cacodylate for 10 minutes and then washed again with 0.1M cacodylate buffer. 
The cells were dehydrated in graded ethanol 50%, 70%, 90% and 100%. The filter 
was removed from the inserts, cleared with two changes of propylene oxide for 15 
minutes and embedded in Epon/Araldite resin. After polymerization at 60°C for 24 
hours, the resin disc of cells was placed on a cleaned glass slide. Using a scalpel 
blade the specimen was cut into strips and placed in the embedding molds. Thin 
sections were sliced using a diamond knife and mounted on copper slot grids. They 
were stained with uranyl acetate and lead citrate and examined on a Philips CM-100 
electron microscope. Images were taken photographically using a Kodak film.  
 
4.7 Flow Cytometry  
Flow cytometry analysis physical and chemical characteristics of cells in suspension 
when they pass by a laser beam. It has many applications, such as the quantification 
of DNA, detection of proteins on the cell surface or in the cytoplasm and sorting a 
specific cell population.   
4.7.1 Determine Cell Cycle Content by Propidium Iodide (PI) Stain 
Propidium iodide is a fluorescent dye that intercalates in the DNA and excites at 
488nm. PI does not penetrate the cell membrane. Therefore, it was required to 
trypsinize the cells, fix them overnight with 70% ethanol at 4°C and permeabilize 
them with 0.25% Triton X-100 for 15 minutes. The cells were washed in PBS twice 
and resuspended in 25µg/ml PI (Sigma) containing 0.1mg/ml RNAse A for 15 
minutes at 37°C to remove the double-stranded RNA, since this would be also 
stained by PI. Nine times more PBS was added and the DNA amount was measured 
in the FACScalibur. The intensity of the PI signal is directly proportional to DNA 
content. Cells in G1 phase have single DNA content, whereas cells in G2/M state 
have a double DNA content. The area between these peaks described cells within S-
phase. 
4.7.2 Measurement of Mitochondrial Potential 
The mitochondrial potential was measured with a fluorometric method using a 
cationic mitochondrial dye (tetramethyl rhodamine methyl ester - TMRM). [192]  
Hyperpolarized cells shifts to the right compared with healthy cells, whereas in 
hypopolarized cells the peak shifts to the left. NHBE cells were treated for 48 hours 
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with lethal toxin or biotinylated-histidine-tagged lethal toxin (LFhisbio), trypsinized 
and stained for 15 minutes with 50nM TMRM at 37°C. A membrane depolarization 
inhibitor CCCP (carbonyl cyanide 3-chlorophenylhydrazone, 100mM) was used as 
hypopolarization control, whereas incubation with oligomycin (2.5mg/ml) led to 
hyperpolarization. The cells were counted in a FACScan (FSC/SSC, linear scale, 
TMRM, log FL2) and analyzed by Flow Jo.  
 
4.8 Lethal Factor Activity Assay 
4.8.1 MAPKKide Cleavage Assay 
The MAPKKide assay is a FRET (fluorescence resonance energy transfer) based 
assay to determine the cleavage activity of lethal factor. List Biological Inc developed 
a fluorescent substrate similar to MAPKK-2, which contains on the N-terminus a 
fluorophore, o-aminobenzoyl (Abz), that is quenched by the C-terminal attached 
chromophore, 2,4-dinitrophenyl (Dnp). Upon substrate cleavage by the lethal factor, 
the N-terminus portion of MAPKK-2 containing Abz can be followed in a fluorometer 
by excitation with 320nm and an emission wavelength of 420nm. To determine the 
total amount of fluorophore a standard curve containing an unquenched MAPKKIDE 
TM (Abz) was diluted in 20mM HEPES, pH8.2 in a range from 0-1µM. Lethal factor or 
its modified forms (LFhis, LFhisbio, LFbio: 1µg/ml) were added to 1µM MAPKKide 
(oABZ/Dnp) and measured every two minutes for one hour at an excitation 
wavelength of 320/20nm and an emission at 440/40nm (75% sensitivity). Each 
dilution was done in triplicate using 250µl/well. 
 
4.9 Lentivirus Production 
Transient Transfection of HEK293Ts for Virus Production: 2x106 HEK293T 
cells/10ml per poly-L-lysine coated 10cm dish were seeded approximately 24 hours 
prior to transfection in DMEM high glucose with 5% FBS, HEPES, Glutamax. 
Plasmid DNAs were prepared in 5ml FACS tubes as follows:  
 
 Per 10cm dish: 10µg transfer vector plasmid 
    6.5µg GAG/pol plasmid 
    3.5µg VSV.G plasmid 
    2.5µg pRSV-rev plasmid 
    Bring up to a total volume of 450µl with 0.1x TE 
 
50µl 2.5M CaCl2 and 500µl warm 2X HBS were applied dropwise, while vortexing at 
full speed. 1ml of the solution was added immediately to the plate of HEK293T cells 
and swirled to disperse the precipitate. Approximately 16 hours later the media was 
changed and the cells were further incubated at 37ºC and 5% CO2. 
Lentivirus Collection and Concentration: The media was collected after 24 and 48 
hours, sterile filtered through a 0.22µm filter and centrifuged in an ultracentrifuge at 
19400rpm for 2.2 hours at 4ºC. The supernatant was discarded and the pellet 
resuspended in 5% BSA/PBS. The virus suspension was frozen in small aliquots at  
-80°C until further use. Table 4-3 shows all the viruses used in this study. 
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Name Vector Origin Base  Change 
CG-WIZ-EGFP CG-WIZ-EGFP Dr. Torbett B.  
MEK1 (P8A) CG-WIZ-EGFP Dr. Kun-Liang Guan P=CCC ->A=GCC 
MEK2 wt CG-WIZ-EGFP Dr. Kun-Liang Guan  
MEK2 (P10A) CG-WIZ-EGFP Dr. Kun-Liang Guan P=CCG ->A=GCG 
MKK 3 (I27E) CG-WIZ-EGFP Dr. David M. I=ATA ->A=GAA 
MKK 4 (K45Q, L46E, R58Q, F59D) CG-WIZ-EGFP Open Biosystems 
Clone ID 5272439 
K=AAG ->Q=CAG 
R=AGG ->Q=CAG 
L=TTG -> GAG 
F=TTT -> D=GAT 
MKK 6 (I15A) CG-WIZ-EGFP Dr. David M. I=ATT ->A=GCT 
MKK 7 (Q44K, G76A) CG-WIZ-EGFP Dr. Han J. Q=CAG ->K=AAG 
G=GGG ->A=GCG 
 
Table 4-3: Non-cleavable MKK mutants.  
 
4.10 Cell Viability and Cell Death 
4.10.1 MTT Assay for Cell Viablity 
MTT is a yellow water-soluble tetrazolium dye that is reduced by living cells to a 
water-insoluble purple formazan. The amount of formazan can be determined by 
solubilizing it in DMSO and measuring the absorbance at 560nm 
spectrophotometrically. Comparisons between the spectra of treated and untreated 
cells can give a relative estimation of cytotoxicity or proliferation. [193]  
MTT assays were performed in a 96-well plate according to manufacturer’s 
instructions (Sigma). After or during the treatment, MTT was added to each well at a 
final concentration of 200-500µg/ml. 0.5-1 hour later, the media was removed, 
washed twice with PBS and formazan was dissolved in DMSO (Sigma). Absorbance 
at 560nm was determined for each well using a microplate reader (Bio-Rad).  
4.10.2 TUNEL Assay to Determine DNA Strand Breaks 
Degradation of nuclear DNA can be examined by the TUNEL assay, which allows in 
situ detection of nicked DNA and DNA breaks. This method is based on the 
enzymatic labeling within the cell of free 3'-OH groups at the ends of nicked DNA 
and the blunt ends of broken double-stranded DNA with fluorescein-labeled 
deoxyuridine. The TUNEL kit from Roche titled In situ Cell Death Detection Kit, 
Fluorescein was used according to manufacturer’s instructions. [194, 195] 
4.10.3 Phosphatidylserine Exposure 
In the early stages of apoptosis changes occur at the cell surface and plasma 
membrane. One of these plasma membrane alterations is the translocation of 
phosphatidylserine (PS) from the inner side of the plasma membrane to the outer 
layer. Therefore, PS becomes exposed at the cell surface. Cells were plated on 
collagen-coated coverslips and treated for 48 hours with or without lethal toxin. 
Afterwards, they were incubated with a PS antibody for 20 minutes, fixed with 4% 
PFA and rinsed quickly with PBS. PS exposed to the cell surface was visualized with 
the mouse-alexa-488 antibody under a fluorescence microscope. 
MATERIAL AND METHODS 
 
 45
4.10.4 Caspase Activation 
Caspase 3 activation plays a key role in the initiation of cellular events during the 
early apoptotic processes. It cleaves specific substrates at aspartic acid residues. 
PARP, a nuclear protein involved in DNA repair, is cleaved from a 116kDa protein, 
yielding fragments of 85 and 25kDa. Rho-associated coiled-coil protein kinase-1 
(ROCK-1, 160kDa) is also a direct cleavage substrate of activated caspase-3, 
leading to fragments of 130kDa and 30kDa, which can be detected by specific 
antibodies in immunoblots.   
4.10.5 LDH Release Assay 
The LDH release assay is a fluorometric method for estimating the number of 
nonviable cells. LDH is a cytoplasmic enzyme which is measured in a 10-minute 
coupled enzymatic assay that results in the conversion of resazurin to the 
fluorescent product, resorufin.   
The LDH amount was determined after 48 hours treatment in the bottom media 
(500µl) of the inserts. The total amount of cells on top of the inserts was measured 
by the release of LDH through lysis. 100µl lysis buffer was added for 10 minutes. 
50µl media were combined with 50µl assay buffer provided by the CytoTox-ONE™ 
Kit from Promega in a 96-well plate. The plate was shaken for 10 minutes 
and fluorescence was measured with an excitation wavelength of 560nm and an 
emission wavelength of 590nm (Ex. 540/35nm, Em. 590/20nm, 30% sensitivity). 
[196, 197] The percent of cytotoxicity was calculated with following formula:  
 
 
4.10.6 Proteasome Activity 
The proteolytic activity of proteasomes was measured by a fluorogenic method. Suc-
LLVY-AMC (Biomol) is a dye, which fluoresces when chymotryptic activity of the 
proteasomes is effective. Cells were treated for 1-48 hours with LT or LThisbio. 
Proteasome inhibitors MG132 or epoxomycin were added for 4 hours to provide 
positive controls for the reduced activity. The cells were scraped in PBS and 
centrifuged at 1000rpm for 3 minutes. The cell pellet was lysed in 200µl lysis buffer 
(50mM Tris HCl, pH 7.5, 250mM sucrose, 5mM MgCl2, 0.5mM EDTA, freshly added 
2mM ATP, 1mM DTT, 0.025% digitonin) and incubated on ice for 5 minutes, followed 
by a centrifugation at 20000g (19300rpm) for 15 minutes 4°C. After a BCA protein 
assay of the supernatant, 25µg of the protein extract was incubated with 100µM Suc-
LLVY-AMC in 200µl assay buffer (50mM Tris HCl, pH 7.5, 40mM KCl, 5mM MgCl2, 
freshly added 0.5mM ATP, 1mM DTT, 0.5mg/ml BSA). The kinetic of the peptide 
cleavage was measured for 1 hour at 37°C in a spectrofluorimeter at an excitation 
wavelength of 380nm and emission wavelength of 460nm (320/20;440/40, 50% 
sensitivity). 
 
Percent cytotoxicity =  
 
100 x  (Amount of LDH in Experimental Medium - Medium Background) 
     (Amount of LDH of Lysed Cells - Medium Background) 
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4.11 Evaluation of the Polarized Airway System  
4.11.1 Epithelium Transepithelial Electrical Resistance  
Transepithelial electric resistance (TEER) is a convenient method to evaluate and 
monitor the growth of epithelial tissue cultures in vitro. The tightness of the cellular 
monolayer is marked by a sharp increase in TEER. The electrical voltohmmeter 
(EVOM) and the STX2 electrode from World Precision Instruments were used for the 
resistance measurement. (Figure 4-2) The electrode was sterilized in 70% Ethanol for 
15 minutes and equilibrated in SABM media for one minute. The media level inside 
and outside of the inserts needed to be adjusted to the same level (inserts with 
membrane area of 0.33cm2 were added 250µl top and 400µl to the 0.6ml existing 
media in the bottom). The resistance measurements were taken 3 times per sample 
and the average was determined. Afterwards the media was gently removed from 
the top. 
 
 
 
Figure 4-2: Resistance measurement of 3D grown cells with an electrical voltohmmeter. 
To evaluate the differentiation of the layers in the polarized system we used an EVOMX to measure 
the electrical resistance in Ohm/area2. Abbreviation: 3D, three dimensional; EVOMX, electrical 
voltohmmeter X. 
4.11.2 Permeability Measurements 
The alterations of junction were also measured by permeability changes of the 
differentiated cell layer in the inserts. A FITC coupled albumin (100µl of 5mg/ml) was 
applied to the apical side and detected by a fluorometric assay in the basal HBSS 
(450µl) after 2 hours at 37°C with an excitation wavelength of 485/20nm and an 
emission wavelength of 530/25nm (30% sensitivity). The standard curve equation of 
x=y/15.195 calculates the penetration through the cell layer in µg. By division of 2 
hours and surface of the insert (0.33cm2) the amount of FITC-albumin per hour and 
surface area (µg/hr/cm2) was determined. Cells were always treated with 1µg/ml LT 
for 48hr in starving media from the basal side. However, KGF (250ng/ml) and 
dexamethasone (10µM) were preincubated for 1 hour before LT was added. 
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4.12  Cell Adhesion and Migration 
4.12.1 Adhesion Assay 
NHBE were plated in 10cm dishes and grown for 2 days. After 3 hours starvation in 
SABM media, cells were treated with 1µg/ml PA and 1µg/ml LF for 48 hours. 24-well 
plates were coated with human fibronectin (10µg/ml), poly-L-lysine (100µg/ml), 
collagen (5µg/ml) or left untreated. The cells were trypsinized, counted and seeded 
in triplicates on the different coatings. Adherence was allowed to take place for 24 
hours. Metabolicly active adherent cells were stained with 500µg/ml MTT solution for 
30 minutes, washed twice with PBS and dissolved in 120µl DMSO. The absorbance 
of 100µl DMSO solution was measured spectrophotometrically at 560nm. 
4.12.2 Migration Assay in Boyden Chamber 
In order to study in vitro cell migration, a polycarbonate membrane with a pore size 
of 8µm was used. The membrane was coated with human fibronectin on both sides. 
After 3 hours of starvation, cells were LT treated for 48 hours, followed by 
detachment with trysin. Cells were plated on the top of the membrane in SABM 
media without supplements and the migration took place for 21 hours towards SABM 
media with supplements. Migrating cells to the lower side of the membrane were 
visualized with actin (rhodamine phalloidin) and nuclear (DAPI) stains by a 
fluorescence microscope. 
4.12.3 Wound Healing Assay 
The closure of a scratch in the 3D system was performed by wounding the cell layer 
with a 10µl pipett tip (cross). The cells were fixed immediately after the wounding as 
a control or grown for 18-21 hours. After staining of the actin filaments with 
rhodamine phalloidin, confocal images with a 10x objective lens were taken. ImageJ 
was used to analyze the width of the scratch. Two different inserts per condition, six 
to eight images with ten measurements per image were calculated.  
   
4.13  Fractionation 
4.13.1 Fractionation of Membrane, Cytosol and Cytoskeleton 
NHBE cells were washed with 1xPBS and scraped on ice in fractionation buffer 
(25mM Tris, pH7.5, containing 2mM EDTA, pH8, 10mM β-mercaptoethanol, 10% 
Glycerol, 10µg/ml leupeptin, 10µg/ml aprotinin, 1mM phenylmethylsulfonyl fluoride). 
Cells were sonicated two times 15 seconds using a microprobe sonicator (Microson 
XL) and the nuclei were removed by centrifugation at 1000xg for 10 minutes. 
Membranes and cytoskeleton were isolated from the post-nuclear supernatant by 
centrifugation at 100,000xg for 30 minutes in an Optima TLX ultracentrifuge with a 
TLA 100.3 rotor (Beckman Instruments Inc., Palo Alto, CA). The pellet (membranes 
and cytoskeleton) was washed with the fractionation buffer and incubated on ice for 
45 minutes in the same buffer including 1% (v/v) Triton X-100. After centrifugation at 
100,000xg for 15 minutes the supernatant containing the membrane fraction was 
removed and the cytoskeletal pellet was washed and sonicated.      
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4.13.2 Fractionation of Membrane and Cytosol 
After washing the cells with 1xPBS, they were harvested in relaxation buffer (100mM 
KCl, 3mM NaCl, 3.5mM MgCl2, 1mM EGTA, 10mM Hepes, 0.5mM 1,4-piperazine 
diethane sulfonic acid, pH7.4) and disrupted by two times 15 seconds of sonication 
at 4ºC using a microprobe sonicator (Microson XL). Unbroken cells and nuclei were 
pelleted by centrifugation at 1000g for 10 minutes at 4ºC. The supernatant was 
centrifuged at 100,000g for 30 minutes at 4ºC in an Optima TLX ultracentrifuge with 
a TLA 100.3 rotor (Beckman Instruments Inc., Palo Alto, CA). The high-speed 
supernatant represented the soluble cytosolic fraction. The pellet was washed and 
resuspended in relaxation buffer by two times sonication.   
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5 RESULTS 
The lung epithelium represents an indispensable barrier between host and 
environment. Its homeostasis and its role in the gas exchange are indispensable for 
normal airway function. The exchange of carbon dioxide in the blood to oxygen and 
its transport to the tissues is essential for cell performance. The secretion of 
surfactant and mucus lowers the surface tension and traps inhaled small particles, 
which are removed by the ciliated movements. Lung injury and pulmonary diseases 
are often caused by an imbalance of pro- and anti-inflammatory responses of the 
epithelium.  
Many pathogens enter the human body through the lungs. In the case of an 
inhalational anthrax infection, spores were ingested by alveolar macrophages, 
dendritic cells and lung epithelial cells. [130-132] During the migration of 
macrophages to the regional lymphnodes the spores develop into the vegetative 
bacterium. After release of the bacteria in the lymphatic system or blood stream fast 
replication occurs followed by lethal and edema toxin secretion. In the late stage of 
anthrax pathogenesis the lungs is characterized by respiratory distress, edema, 
swelling and extensive bleeding, which leads to septic shock and 
toxemia/bacteremia to the death. The mechanism of the respiratory distress is not 
well understood. Therefore, we were investing the effects of one of the toxins – lethal 
toxin – in primary human lung epithelial cells.  
 
5.1 Characterization of Airway Epithelial Cells 
Electron microscopy pictures of normal tissue culture plated NHBE are shown in 
Figure 5-1 (A). Their cell shape varies from round to oval and because of their mixed 
cell population the cell size can differ. Nevertheless, they are large flat cells with a 
large cytoplasm. Not only morphological phenotype changes in those cells were 
studied, but also a more defined in situ system was used. [198] Therefore, we 
established a fully differentiated, polarized three-dimensional airway model by 
culturing primary lung epithelial cells on a collagen coated porous polyester transwell 
membrane (insert). During the process of maturation of the 3D-layer increasing 
formation of junction complexes and the secretion of mucus and surfactant were 
observed. Signaling responses to bacterial ligands and cytokines can be investigated 
and the model is capable of rapid wound healing after injury. The establishment of 
this airway model system enables us to measure alterations in secretion, 
permeability, signaling pathways and pathogen interaction. It provides a perfect tool 
to understand the effect of lethal toxin in the respiratory epithelium. EM cross 
sections of the three-dimensional polarized lung epithelial system are displayed in 
Figure 5-1, B-E.  
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                            Longitudinal section of NHBE          
 
 
 
 
 
Figure 5-1: Morphology of normal tissue culture treated NHBE and polarized 3D cells in EM.  
A) Longitudinal EM sections of tissue culture plated cells stained with uranyl acetate and lead citrate. 
B) Overview picture shown of a 5 weeks old insert in a cross section. C-E) Higher magnifications 
display (C) cilia, (D) junctions and (E) interdigitations indicated by arrows. 
 
In Figure 5-1, B a 3D layer with several different cell types such as basal, ciliated and 
mucus/goblet cells were formed in two to three layers. Interdigitations between cells 
and complex junctions such as tight junctions and desmosomes led to a very dense 
almost tissue-like structure. (Figure 5-1, C-E) The integrity of the cell connection was 
measured by permeability changes (Figure 5-6), which increases with tight 
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connections and interdigitations. Furthermore, cilia and flagella on the apical side 
were formed to transport and segregate the secreted mucus. (Figure 5-1, C)  The 
beating of the cilia could be observed under a normal light microscope.     
To determine which type of lung cells existed under 2D and 3D culture conditions, 
we decided to test for markers characteristic for each lung cell type. (Table 12-1) 
Therefore, we performed a RT-PCR of calveolin-1, a pneumocyte type 1 marker. 
[199] Human beta defensins 1 and 2 are secreted by lung epithelial cells for 
antimicrobial protection. [200] Pneumocyte type 2 and Clara cells secrete surfactant 
A and B, to lower the respiratory surface tension. To distinguish the surfactant 
secretion between pneumocyte type 2 and Clara cells, we also tested for CC10, a 
distinct Clara cell marker. (data not shown) Unfortunately without a positive control, 
we were unable to detect the mRNA expression, which could be due to incorrect 
PCR conditions or not existing Clara cells.  
 
      
          
Figure 5-2: Pneumocyte characterization. 
A) The mRNA message for calveolin-1, h-BD-1, h-BD-2 of NHBE in normal tissue culture treated cells 
(2D) and in the 3D system were shown in RT-PCR. Actin was used as loading control. B) Surfactant A 
and B detected after differentiation in 3D. Abbreviations: 2D, 2 dimensional; 3D, 3 dimensional; h-BD-
1, human beta defensin-1; h-BD-2, human beta defensin-2; RT-PCR, reverse transcription – 
polymerase chain reaction.  
 
Only in the polarized 3D system, NHBE were able to differentiate into pneumocytes. 
(Figure 5-2, A) The surfactant A and B expression in Figure 5-1, B was also exclusively 
detected in the 3D system. Tissue culture grown cells contained precursors of a 
variety of cell types, which under three dimensional conditions develop to define 
bronchial and lung cells.  
After cell differentiation for 7 to 10 days on inserts, mucus production was observed 
by the secretion of a viscous fluid on the apical side. (Figure 5-3, B) The mucus was 
mainly generated by goblet cells. The expression time course of one of the mucin 
proteins (MUC5AC) showed mRNA upregulation between day 2 and 5 of growing 
cells in the air liquid interface. (Figure 5-3, A) The protein expression was visualized in 
immunofluorescence by staining with a MUC5AC specific antibody. The tight 
junctions were used to distinguish cell borders. (Figure 5-3, B)   
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Figure 5-3: mRNA and protein expression of MUC5AC in the 3D system.  
A) RT-PCR of a mucin, called MUC5AC, in differentiated NHBE and actin expression were shown at 
indicated time points. B) Immunofluorescence stain of tight junction (ZO-1, green) and MUC5AC (red) 
in three weeks old inserts. Abbreviations: MUC5AC, mucin 5AC; RT-PCR, reverse transcription-
polymerase chain reaction; ZO-1, zonula occludin-1. 
5.1.1 A Model to Study Anthrax Infection 
In order to investigate, if NHBE are suitable for this study we looked into the anthrax 
receptors expression, anthrax toxin receptor (ATR) and capillary morphogenesis 
gene-2 (CMG2). These receptors are crucial for the uptake of the lethal factor/toxin 
and edema factor/toxin. Lung epithelial cells were previously described to express 
ATR and CMG2. In the ciliated epithelial cells of the bronchi the ATR seemed to be 
particularly abundant. [71, 201] 
To confirm the receptor expression in NHBE we performed RT-PCRs and detected 
mRNAs of ATR and CMG-2. CMG-2 was slightly increased over the ATR message. 
Actin was used as a housekeeping control gene. Because of the lack of available 
receptor antibodies, we were unable to test for their protein expression.   
 
 
 
Figure 5-4: Anthrax receptor expression. 
NHBE cells expressed both anthrax receptors. Actin was used as loading control. Abbreviations: ATR, 
anthrax receptor; CMG-2, capillary morphogenesis gene 2. 
 
The receptor expression on the surface can be indirectly proven by MAPKK 
cleavage. Without the presence of a functional receptor, PA binding cannot occur, 
lethal factor cannot be internalized and released in the cytoplasm. With the 
exemption of MEK5, LT cleaves all N-terminal parts of MAPKK (Figure 2-5). This 
cleavage was visualized by immunoblotting with antibodies raised against the N-
terminal part. The loss was detected after 48 hours of LT treatment of cells in 2D and 
3D conditions. (Figure 5-5, A, B) Lethal toxin did not influence the mRNA levels of 
MEK2 or MKK3, which was demonstrated in Figure 5-5, C by RT-PCR. The actin 
expression was used as equal loading control. Those findings indicate that normal 
human bronchial epithelial cells have all the requirements to study the LT effects in 
the respiratory system.    
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Figure 5-5: Effect of LT treatment on the protein and mRNA levels of MAPKKs. 
A) Protein expression of all MAPKK besides MKK5. After lethal toxin cleavage antibodies against 
MAPKK are unable to detection the protein in 2D. B) The same MKK3 cleavage was observed in 
three weeks old inserts. C) Gene expression was not affected. The untreated panel did not contain 
any DNA. Abbreviations: -, untreated; 2D, 2 dimensional; 3D, 3 dimensional; LT, lethal toxin, MEK, 
mitogen-activated ERK kinase; MKK, mitogen-activated kinase kinase; MAPKK, mitogen-activated 
protein kinase kinase; PA, protective antigen. 
 
5.2 Junction Changes After LT Treatment  
A polarized epithelium has an apical and basolateral side. The junctional complex 
provides a seal between cells and regulates the diffusion of substances. Cell 
connections play major roles in cell communication (gap junctions), formation of 
tissue boundaries, migration and cell shape rearrangements. [202] Therefore, the 
assembly and turnover of adhesive contacts has to be tightly regulated.  
Human lung endothelial cells are located right underneath the epithelium to support 
the gas exchange. It was shown, that lethal toxin disrupts the barrier function of 
endothelial cells by decreasing the resistance and increasing permeability. [80] 
To compare, if there is a similar effect in lung epithelial cells that could induce 
respiratory distress, we analyzed junctional changes and evaluated the tightness of 
the differentiated lung model. We measured a decrease of resistance in NHBE by 
approximately 75% compared to untreated cells. (Figure 5-6, A) Also, the increase of 
permeability measured by a fluorescent dye penetrating through the layer after toxin 
treatment proved the disruption of the cell barrier. (Figure 5-6, B)  
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Figure 5-6: Resistance and permeability change. 
A) Resistance of NHBE grown for 3 weeks in 3D inserts measured before and after 48 hours of LT 
treatment. Resistance before treatment was set as 100% and change after 48 hours is shown in % of 
change. B) Permeability measurements of insert after 48 hours LT (1µg/ml) treatment. Abbreviation: 
%, percent; -, untreated; cm2, square centimeter; hr, hours; LT, lethal toxin; ug, microgram.  
 
The increase of permeability and decrease of resistance might be due to viability or 
junction changes. The death of cells would lower the cell density and damage the 
integrity of the polarized system. On the other hand, junction disruptions or alteration 
would lead to a leaky layer. 
To test the possibility of cell death occurring during the 48 hours of treatment, we 
measured the LDH release in the basal media. Cells undergoing death will burst or 
leak cytosolic LDH in the surrounding media. The release of LDH was compared to 
the amount of apical cells in the intact layer. In Figure 5-7 we showed, that untreated 
as well as LT treated cells had minimal cell death occurring after 48 hours. However, 
lethal toxin treated cells seemed to have 5% higher LDH levels, compared to the 
untreated cells. Therefore, the increased toxicity can be partially involved in the 
resistance changes, but cannot explain the resistance drop of 75% completely.  
 
Figure 5-7: LDH release after LT treatment in the 3D system.  
The LDH release of apoptotic cells was measured after 48 hours treatment of 3 weeks old inserts. 
Displayed is the percentage of toxicity compared to the total amount of cell in the top of the cell layer. 
Abbreviation: LDH, lactate dehydrogenase; LT, lethal toxin; %, percent. 
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To visualize and understand the leakage of this cell layer through junction 
alterations, we decided to look for changes by immunofluorescence and electron 
microscopy. (Figure 5-8, Figure 5-9) The immunofluorescence stain of tight junctions at 
the apical side in the 3D system suggested the mechanism behind the leaky cell 
layer. Lethal toxin treated cells showed an increased appearance of disruptions of 
multicellular junction sites, indicated by the white arrows in Figure 5-8, B. In the kidney 
epithelial cells (MDCK) these sites were identified as naturally occurring events, 
when apoptotic cells detach from the cell layer. [203] In an intact cell layer, junctions 
will be remodeled to form a tight system. This led us believe that both, a slight 
increase in cell death and a junctional modeling defect play a role in the leakage of 
the 3D layer. 
 
  
 
Figure 5-8: Increase of multicellular junction sites after LT treatment at the apical side. 
A) Untreated and B) LT treated immunofluorescence images of ZO-1 (green) of 3 weeks old inserts. 
LT causes disruption of multicellular junction sites indicated with white arrows. A Z-series was 
performed and the images were afterwards flattened. Scale bar represents 50µm. Abbreviations: -, 
untreated; LT, lethal toxin; ZO-1, zonula occludens -1. 
 
A more dramatic change was observed in electron microscopy cross sections after 
lethal toxin treatment. (Figure 5-9, B) LT led to the separation of basolateral cell 
connections and interdigitations, and increased the height of the layer. The apical 
located tight junctions were mostly intact. Figure 5-9, B shows a very extreme case, 
some other experiments had milder disruptions. The untreated layer displayed a very 
tight tissue-like structure with a minimum of two layers. (Figure 5-9, A)  
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Figure 5-9: Electron microscopy pictures of LT treated, polarized NHBE.  
A) EM cross section of 3 weeks old untreated insert. B) Disruptions (white spaces) of the layer after 
48 hours of LT treated insert in EM. Scale bar represents 10µm. Abbreviation: LT, lethal toxin. 
 
Next to the air liquid culture results, we wanted to compare junction alterations in 
normal tissue culture plated cells. This could provide a better understanding of 
molecular mechanism behind the junction complex alterations. Therefore, we stained 
tight and adherens junctions and evaluated them by immunofluorescence.  
 
 
 
Figure 5-10: Lethal toxin induces tight junction alterations. 
IF of ZO-1, a tight junction marker (green), actin (red) and the merged image (red/green). Increased 
amounts of disturbed ZO-1 seen after LT treatment. Actin was used to define the overall cell structure. 
Scale bar represents 50µm. Abbreviations: -, untreated; LT, lethal toxin; ZO-1, zonula occludens -1. 
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The tight junction displayed a very defuse junction phenotype accompanied with an 
increase in the expression after lethal toxin treatment. (Figure 5-10, ZO-1) This proved 
that an induced expression of junction proteins did not favor a tighter layer seen in 
the permeability and resistance changes. There might be incorrect assembly or 
remodeling of tight junctions occurring. 
A similar phenotype was observed with an adherens junction stain (Figure 5-11, E-
cadherin) after LT exposure. The junctions showed a diffuse distribution pattern with a 
wider range and higher amount of cell connection proteins. This alteration also did 
not lead to an increase in junction tightness, instead a deregulation of the junction 
complex took place. 
 
 
 
Figure 5-11: A diffuse adherens junction stain occured after LT treatment. 
Immunofluorescence of E-cadherin (green), actin (red) and the merge (red/green). The upper panel 
showed untreated NHBE whereas the lower panel was LT treated. Lethal toxin increased disrupted 
adherens junctions. Actin was used to define the overall cell structure. Scale bar represents 50µm. 
Abbreviations: -, untreated; LT, lethal toxin. 
 
The increased levels of protein were also detected by immunoblotting, when cell 
lysates were fractionated in cytosol, membrane and cytoskeleton. (Figure 5-12) E-
cadherin was increased in the membrane and cytoskeleton, whereas ZO-1 showed 
only an increase in the cytoskeletal fraction. Those results agree with the 
immunofluorescence pictures where membrane associated junctions and the 
connection with the cytoskeleton were affected, but no change was observed in the 
cytosol. 
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Figure 5-12: Junctional proteins increase in membrane and cytoskeleton after LT exposure. 
Fractionation of junctional proteins and a cytosolic control (GDI) were displayed. Increased amounts 
of E-cadherin were found in the membrane and cytoskeletal fraction, after 48 hours of LT treatment. 
ZO-1 showed only an increase in the cytoskeletal fraction. Abbreviations: -, untreated; LT, Lethal 
Toxin; E-cad, E-cadherin; ZO-1, zonula occludens -1; GDI, GDP dissociation inhibitor. 
 
5.3 Alteration of the Cytoskeleton After LT Treatment  
The cytoskeleton consists of actin, tubulin and intermediate filaments, which control 
the cell shape and the ability to move. Their rapid assembly and disassembly is 
tightly regulated by diverse proteins, such as Rho GTPases and generates an 
efficient recycling mechanism. They also play an important role in chromosome 
transport during mitosis, cell separation in cytokinesis, organelle location and uptake 
of pathogens by phagocytosis. 
LT disrupts the actin filament assembly leading to impaired polymerization and 
motility inhibition in neutrophils. [87] This might be due to a downregulation of Hsp27 
phosphorylation, which is p38 depended. p38 inhibitor studies showed a similar 
effect. [88] In endothelial cells an increase of stress fibers and a reduction in 
peripheral F-actin was observed, leading to incomplete cell-cell adhesion. [80] 
Furthermore, the actin cytoskeleton is linked to the cytoplasmic domain of E-
cadherin containing interaction proteins such as α- and β-catenin, p120 α-actinin and 
vinculin. [202] Therefore, we investigated the effect of LT on the cytoskeleton to 
determine alterations, which could be involved in the deregulations of the junction 
assembly. 
5.3.1 Actin and Tubulin Changes 
Actin und microtubule alterations were visualized by immunofluorescence. We 
observed, when comparing untreated and LT treated cells, increased stress fiber 
formations and bundle-like tubulin assembly in NHBE cells. Interestingly, lethal toxin 
caused the growth of many large protrusions/lamellipodia, seen in the tubulin stain in 
Figure 5-13.   
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Figure 5-13: Stress fiber and tubulin bundle accumulations after LT treatment.  
Immunofluorescence stain of actin (red) and tubulin (green). LT causes severe stress fiber formation 
and bundle-like tubulin structures. Wide protrusions were observed in the tubulin LT treated cells, 
which were indicated with arrows. Scale bar represents 50µm. Abbreviations: -, untreated; LT, lethal 
toxin 
 
The stress fiber formations could be caused by an increase of actin assembly or 
decrease of actin disassembly. Therefore, we tested actin-specific inhibitors, such as 
latrunculin A, which binds actin subunits and prevents their polymerization. (Figure 
5-14, A, B, E) The actin stain revealed more actin filaments left over in the LT treated 
cells. This is not enough evidence to suggest a slower actin disassembly process, 
since the amount of actin filament was higher from the beginning on.   
The inhibition of actin assembly, using cytochalasin B, caps the plus ends and 
prevents the growth of actin filaments. (Figure 5-14, C, D, F) The immunofluorescence 
stain of actin confirmed a similar phenotype with left over actin filaments in the LT 
exposed cells. Only dotty-like actin structures were displayed in the untreated cells 
after cytochalasin B treatment. 
The quantification of containing actin filaments after latrunculin A treatment was up 
to 60% increased with LT exposure. (Figure 5-14, E) The amount of positive cells, with 
almost 100%, was even more dramatically after cytochalasin B. (Figure 5-14, F) 
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Figure 5-14: Quantification of increased actin filaments after LT treatment and actin 
polymerization inhibition.  
Inhibition of actin polymerization with latrunculin (A, B, E) and cytochalasin B (C, D, F) after LT 
treatment (B, D) compared to untreated cells (A, C). Quantification shown in % of positive cells with 
left over actin filaments (red) of 250 cells. Scale bar represents 50µm. Abbreviations: -, untreated; 
CytoB, cytochalasin B, LatA, latrunculin A; LT, lethal toxin. 
RESULTS 
 
 61
Residual actin filaments were observed after LT treatment and inhibition of 
polymerization. To define if it is a defect of actin filament assembly we used a 
reversible inhibitor to stop polymerization of the actin filaments. A wash-out of the 
inhibitor followed, which allowed the cell to generate new filaments in 35 minutes. 
(Figure 5-15) The actin filaments returned to their stress fiber formation, which 
indicates no defect in the actin growth.  
 
 
 
Figure 5-15: Actin assembly is not inhibited after LT treatment.  
Immunofluorescence stains of actin (red) after 48 hours LT treatment, 1 hour cytochalasin B and 35 
minutes of cytochalasin B wash-out with fresh media, displayed the ability of actin to polymerize. 
Scale bar represents 50µm. Abbreviations: -, untreated; CytoB, cytochalasin B, LatA, latrunculin A; 
LT, lethal toxin. 
 
By fractionation of cell lysates in cytosol, membrane and cytoskeleton, we were able 
to detect an increase of actin in the LT treated cytoskeletal fraction. (Figure 5-16) GDI 
was used as a cytosol marker.  
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Figure 5-16: Increased actin amounts in cytoskeletal fraction after LT treatment.  
Amount of actin and GDI in cytosol, membrane and cytoskeletal fractions after 48 hours LT treatment. 
GDI was used as a cytosol loading control. Abbreviations: -, untreated; GDI, GDP dissociation 
inhibitor; LT, lethal toxin. 
 
After LT treatment microtubules showed bundle-like structures, which were directed 
towards the periphery. (Figure 5-13) Tubulin can be modified by acetylation, 
tyrosination, polyglutamylation, polyglycylation, palmitoylation and phosphorylation. 
(Table 2-2) To test, if LT induced changes, leading to loss or increase in tubulin 
stabilization, we prevented their polymerization with an inhibitor called nacodazole 
after LT treatment. Acetylation occurs only at α-tubulin and is a marker for their 
stability. It regulates cell motility and binds microtubule-associated proteins (MAPs) 
to microtubules.  
 
 
 
Figure 5-17: Increased tubulin stabilization after LT treatment. 
IF stain of tubulin after LT exposure. Polyglutamylated and acetylated tubulin after 48 hours of LT and 
1hour nocodazole treatment. Scale bar represents 50µm. Abbreviations: -, untreated; LT, lethal toxin. 
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Up to 20 side-chain residues of glutamic acid can be added to α- and β-tubulin, 
which is called polyglutamylation. This stabilizes microtubules and regulates the 
interaction with MAPs. Using antibodies detecting acetylation and polyglutamylation 
an increase in microtubule stability was detected in lethal toxin treated cells in IF. 
(Figure 5-17) Therefore, we showed, that lethal toxin changes the cytoskeleton by 
increasing the amount of actin filaments and stabilizing microtubules. 
5.3.2 Motility Defects 
Imbalance in cytoskeletal proteins often causes changes in motility. To migrate, cells 
need to polarize and extend their protrusions on the front side. Those protrusions 
can be wide lamellipodia and fine filopodia. By anchoring the cytoskeleton with 
adhesion molecules to the extracellular matrix, the front will be stabilized, while the 
disassembly of actin at the rear end takes place, allowing the tail to detach and move 
forward.  
The accumulation of actin stress fibers and stable tubulin could influence the cell 
shape and motility. Therefore, we performed a wound healing experiment that is also 
called scratch assay. 21 hours after scratching the cell layer, the ability of wound 
closure was evaluated by an actin immunofluorescence stain. Figure 5-18 showed the 
originally scratch (0hr), whereas the next pictures were taken after 21 hours later. At 
that time, untreated cells and the inactive mutant of LF (E687C) were able to almost 
completely close the wound. Lethal toxin treated cells did not migrate into the wound, 
which indicated a defect in cell motility.  
 
 
 
Figure 5-18: Wound healing defect caused by LT.  
Scratch of 3D polarized cells right after scratching (0hr) and 21 hours after wounding with visualized 
with F-actin stain (red). Untreated (-) and the non-proteolytic active LT (E687C) mutant close the 
wound, whereas LT did not migrate into the scratch. Scale bar represents 100µm. Abbreviations: -, 
untreated; LT, lethal toxin. 
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We determined, if the directed migration towards a chemical stimulus would allow 
cell polarization and enhance the motility. Cells migrating through the pores were 
were attracted by chemoattractants, such as EGF to the other side in 21 hours. 
(Figure 5-19, D-E) To prove similar attachment on the top of the chamber, we stained 
NHBE after one hour with actin and a nuclear marker (Figure 5-19, A-C). The 
attachment of cells with no treatment (Figure 5-19, A), LT (Figure 5-19, B) or the 
inhibition of all downstream MAPK pathways (Figure 5-19, C) showed comparable 
adherence. In contrast, the migration to the other side towards the stimulus was only 
achieved by non-treated cells (Figure 5-19, D). Therefore, a defect in chemotaxis and 
wound healing is caused by lethal toxin treatment.    
 
 
 
Figure 5-19: Chemotaxis defect of LT and MAPK inhibitors treated cells.  
A-C) Similar attachment of different treated cells stained with actin (red) and dapi (blue) after one hour 
adhesion from the top. D-F) Migrated cells were visualized after 21 hours on the bottom side of the 
chamber with actin and dapi. D) Untreated cells migrated through the pores. E, F) LT and MAPK 
inhibited cells could not migrate to the side of stimulation. Scale bar represents 100µm. Abbreviations: 
-, untreated; LT, lethal toxin. 
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The tubulin stain in Figure 5-13 revealed the ability to form protrusions after LT 
exposure. However, cytoskeletal proteins seem to accumulate and defects in 
migration were observed causing defects in motility. To observe the cells after lethal 
toxin treatment under live conditions, we performed live cell imaging with a global 
stimulation of EGF supplemented media. Pictures were taken every minute for up to 
2 hours. (Movie 1, Movie 2) Figure 5-20 displays one frame of the Movie 2 (LT treated), 
showing multiple protrusion sides all over the cell edge. The toxin treated cells are 
unable to polarize in one direction. The Movie 1, untreated showed clearly the smooth 
lamellipodia growth in the untreated cells and their ability to polarize and migrate. LT 
treated cells extended rapidly undirected protrusions. (Movie 2)  
          
 
 
Figure 5-20: Live cell imaging picture. 
A) A typical polarized phenotype of a migrating cells after global EGF stimulation, taken from Movie1. 
B) LT treated cell with many unpolarized protrusion from Movie2. The time frame in minutes of the 
movie is indicated at the upper hand corner. Scale bar represents 50µm. Abbreviation: -, untreated; 
LT, lethal toxin. 
5.3.3 Adhesion Alteration After LT Treatment 
Adhesion of cell surface proteins to the extracellular matrix is a crucial factor for cell 
migration and spreading. Focal adhesions are formed behind the leading edge of 
moving cells. They assemble a stationary plaque from where the focal adhesions 
grow. Vinculin, α-actin, talin and paxillin are proteins of the focal adhesion complex. 
These adhesion molecules are associated also with actin filaments. Immature focal 
contacts are increased, when microtubules are disrupted with inhibitor such as 
nacodazole. [204] 
The motility change after LT treatment might be caused by adhesion defects to the 
extracellular matrix. Vinculin is known to play a major role in connecting the integrins 
or adherens junctions with the cytoskeleton. Therefore, we tested if adhesion 
molecules are altered and responsible for the motility alteration. First, we performed 
an immunofluorescence stain for vinculin (Figure 5-21), which suggested, that LT 
treatment partilly enlarged focal contacts.    
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Figure 5-21: Elongation of focal adhesion. 
Comparison of untreated and 48 hours LT treated NHBE in immunofluorescence of actin (red), 
vinculin (green) and merged image. Actin stress fiber formation and slightly elongated focal adhesions 
were seen after LT treatment. Scale bar represents 50µm. Abbreviations: -, untreated; LT, lethal toxin. 
 
Since the IF stain did not show noticeable differences in vinculin formation, we 
thought that the fractionation of focal adhesion proteins could give a clearer picture 
of occurring changes. (Figure 5-22) Vinculin is mainly localized at the cell periphery 
and interacts with the cytoskeleton and the cytosolic part of E-cadherin to promote 
motility. Paxillin is like vinculin a focal adhesion molecule. It binds to actin and 
modulates effecter molecules such as PAK, PIX and the Rho GTPase family, which 
are involved in cytoskeletal rearrangement and migration. Those focal adhesion 
molecules are regulated by phosphorylation through protein tyrosine kinases such as 
FAK and Src. [205]  
Comparison of vinculin and paxillin in the cytosol, membrane and cytoskeleton 
showed a slight increase in the cytoskeletal fraction. Furthermore, paxillin seem to 
have a reduced expression in the cytosolic fraction. However, FAK expression was 
not significantly altered. To prove no cross contamination in the other fractions, GDI 
was chosen as a cytosolic protein.  
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Figure 5-22: Fractionation of adhesion proteins and their regulatory proteins. 
The adhesion proteins vinculin and paxillin were increased in the cytoskeletal fraction of NHBE with 
LT treatment. Paxillin is decreased in the cytosolic fraction. FAK was not altered. GDI was used as a 
cytosol loading control. Abbreviations: -, untreated; LT, lethal toxin, FAK, focal adhesion kinase, GDI, 
GDP dissociation inhibitor. 
 
Activation of FAK and paxillin occurs by phosphorylation. N-terminal phosphorylation 
of paxillin by FAK and Src regulates the downstream effectors CDK, which mediated 
the gene expression levels of MAPKK. [205] Paxillin has a couple of phosphorylation 
sides, such as Y31, Y118 and Y181. The phosphorylation Y118 regulates cell-cell 
adhesions. FAK can be phosphorylated at 8 tyrosine sites, after integrins interact 
with the extracellular matrix. The FAK phosphorylation site Y397 is a Src binding site 
and important for EGF stimulated motility. [206] 
We tested for phosphorylation of FAK at Y397 and Src at Tyr416 and could not 
detect any changes. (Figure 5-23, A-B) However, the phosphorylation of paxillin at 
Y118 seemed to be decreased after LT treatment, but compared to the protein 
expression not changed. (Figure 5-23, C) The lower expression might be involved in 
motility defects, since there is less paxillin expressed over all. 
 
 
 
Figure 5-23: Phosphorylation of adhesion proteins are not altered after LT treatment. 
A) Expression of total FAK and its Y397 phosphorylation site B) Phosphorylation of Y416 Src are not 
altered. C) Lower expression of total paxillin and its Y118 phosphorylation site after LT treatment. B) 
GM130 was used as a loading control for the phosphorylation of Src. Abbreviations: -, untreated; FAK, 
focal adhesion kinase; LT, lethal toxin; GM130, cis-golgi matrix protein 130kDa. 
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Because of the focal adhesion increase in paxillin and vinculin as well as the slight 
decrease in the cytosolic fraction of paxillin, we determined the effect on the actual 
adhesion process of different coated surfaces. Therefore, we measured only viable, 
attached cells, which were untreated or LT treated after replating by an MTT assay. 
Integrin mediated adhesion to fibronectin and collagen was not significantly changed. 
(Figure 5-24) Instead, cells were unable to adhere to positively charged surfaces such 
as tc-treated and poly-L-lysine.  
 
 
Figure 5-24: Adhesion defect to positive charged surfaces after LT treatment. 
Attachment of viable cells (MTT-assay) after replating untreated or 48 hours LT (1µg/ml) treated 
NHBE at indicated surface coated dishes for 21 hours. Abbreviations: -, untreated; LT, lethal toxin; 
nm, nanometer. 
5.3.4 Effecter Molecules for Cytoskeleton and Motility Changes 
Rho GTPases were shown to induce cytoskeletal rearrangements. The involvement 
in the regulation of many proteins was studied, such as WASP, which by themselves 
activate the Arp2/3 complex. The Arp2/3 complex is needed for the initiation of the 
actin filament formation. 
Stress fibers can be caused by an increase of RhoA activity by inducing actin 
polymerization through mDia signaling and inhibition of actin depolymerization by 
reducing cofilin activity (RhoA ? MLCK ? LIMK ─┤cofilin). Measuring mRNA 
expression did not reveal any changes after LT treatment. (Figure 5-25, A) We were 
unable to detect any RhoA activity or observed differences of expression in the 
lysates. (Figure 5-25, B) In addition, we measured protein expression levels of RhoB 
and C, which were also not altered. (data not shown)  
Higher Rac1 activity increases lamellipodia formation. Since LT treatment causes 
protrusions, it was important to determine, if Rac1 plays a role in this process. The 
amounts of active Rac-1 were very similar between untreated and LT treatment and 
therefore, not responsible for the lamellipodia formation. (Figure 5-25, B) NHBE cells 
did not form filopodia after LT treatment. Cdc42 induces filopodia formation and is 
involved in cell polarization. The activity of Cdc42 was increased after LT treatment, 
which might explains why LT treated cells were unable to polarize.        
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Figure 5-25: RhoGTPase mRNA and protein activity measurements. 
A) RT-PCR of RhoA, B and C of untreated, PA and LT treated NHBE. The first lane did not contain 
any cDNA. Equal loading was defined by actin expression. B) GTPase activity and normal expression 
levels after 48hr or 48+48hr of LT treatment were displayed. GTPγS bound to Cdc42 was used as 
positive and inactive GDP bound Cdc42 was used as negative control. [207] Abbreviations: -, 
untreated; GDP, guanosine diphosphate; GTPγs, guanosine 5'-O-thiotriphosphate; hr, hours; LT, 
lethal toxin; PA, protective antigen. 
 
Furthermore, we tested other proteins involved in actin formation. mDia acts 
downstream of RhoA. It increases actin polymerization and stabilizes microtubules. 
We compared the localization and expression levels in immunofluorescence which 
was similar between treatments. (data not shown) Cofilin is an actin-depolymerizing 
factor, which binds actin and promotes the dissociation of the G-actin. It is regulated 
by phosphorylation. In western blot analysis, we could not detect significant 
differences in the phosphorylation pattern. (data not shown) In addition, the Arp2/3 
complex is a major key regulator of the actin cytoskeleton. Therefore, we examined 
modifications in immunofluorescence without any clear difference seen. (data not 
shown)  
 
5.4 Involvement of the MAPK Pathway 
MAPKKs can influence the cytoskeleton and are the only known substrates of LT. 
Since tested proteins involved in the cytoskeletal rearrangement were not the main 
key player in the motility defect, we decided to compare the inhibition of the MAPK to 
the LT effects on wound healing. Figure 5-26 shows, that the inhibition of only the 
MEK1/2, p38 or JNK pathway by itself induces slight closure of the wound. However, 
with a combination inhibition of all three MAPK pathways, cells were unable to 
migrate into the wound. Therefore, the motility defect could be caused by the loss of 
activation of the downstream effectors by the MAPKK cleavage. The inactive LT 
(E687C) mutant closed the wound in the same way compared to untreated. 
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Figure 5-26: MAPK pathways are important for wound healing. 
Polarized NHBE treated with LT or inhibitors for 48 hour. Scratch in picture one (upper left), displays 
original scratch. All other actin stained (red) cell scratches were imaged 21 hours after original 
scratch. LT and three MAPK inhibitor combinations were defective in wound closure, whereas the 
single inhibitors MEK1/2, p38 and JNKII partially migrated in the wound. Inactive LT (E687C) behaved 
like untreated cells. Abbreviation: -, untreated; JNKII, Jun N-terminal kinase II; LT, lethal toxin; MAPK 
INH, mitogen activated protein kinase inhibitor combination; MEK1/2, mitogen activated ERK kinase.  
 
The quantification of the wound was performed by measuring ten times the wound 
distance of 4 scratches in two different experiments. A wide wound lenght indicates 
the inhibition of migration. (Figure 5-27) The zero time point shows the originally 
scratch. The three inhibitor combinations have similar motility defects, followed by 
the JNK inhibition. 
 
 
Figure 5-27: Quantification of wound healing defects. 
Almost complete closure was shown by untreated and LT (E687C) cells. MEK1/2 and p38 inhibition 
closed the wound for around 50% compared to untreated. LT, JNK and 3 inhibitor combination were 
defective in wound healing. The scatter graph indicates the original scratch at 0hr. Abbreviations: -, 
untreated; JNKII, Jun N-terminal kinase II; 3INH, inhibitor combination of MEK1/2, p38 and JNKII; hr, 
hours; LT, lethal toxin; MEK1/2, mitogen activated ERK kinase. 
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We compared the migration behavior of MAPK inhibited cells with LT treated cells to 
determine if the MAPK pathway is involved in global stimulated motility defects. 
Therefore, we performed live cell imaging. After 24 hours of inhibition pictures were 
taken for around 40 minutes with a frame per 30 seconds.  
In Movie 3 untreated cells were able to migrate with smooth protrusion formation. 
Whereas in Movie 4 lethal toxin treated cells were not motile and had many 
disoriented lamellipodia. Inhibition of all three MAPK pathways with a three inhibitor 
combination confirmed the lethal toxin phenotype shown in Movie 5. To distinguish if 
one of the MAPK pathways, ERK, p38 or JNK had a higher impact in motility 
changes, we also imaged individual MKK1/2, p38 and JNK II inhibitors, which are 
shown in the following movies, Movie 6, Movie 7, Movie 8. All of those inhibitors seem 
to have an increase in protrusion formation. The majority of cells were also unable to 
migrate, but a few cells were capable of moving. This agrees with the wound healing 
assay, which indicated partially motility when only one MAPK inhibitor was used. 
However, we were unable to distinguish which of the three pathways is more 
important for the migration effect. Therefore, we focused on the reintroduction of 
non-cleavable MAPKK mutants by lentivirus infections to rescue the effect of LT. 
(Table 4-3) The EGFP controls showed the same motility phenotype seen in untreated 
and LT treated cells. (Movie 9, Movie 10) Interestingly, we observed no rescue effect, 
when we reintroduced a single MAPKK. (data not shown) In Figure 2-15, it is shown, 
that a MAPKK combination (MEK1+2, MKK3+6 and MKK4+7) lead to the activation 
of one MAPK pathway (ERK, p38 and JNK). Therefore, it is possible that the addition 
of only one upstream MAPKK is not sufficient. A double infection of MEK1+2 and 
MKK3+6 gave us a partially rescue effect in motility and decreased lamellipodia 
extension. (Movie 11, Movie 12 untreated; Movie 13, Movie 14 LT) MKK4+7 did not have 
any positive effects of the LT treated cells. (Movie 15 untreated, Movie 16 LT) The 
results of the movies indicate the involvement of the ERK and partially of the p38 
pathway in motility defects, caused by LT induced MAPKK cleavage. 
5.5 Rescue Effect of the Permeability and Resistance 
Keratinocyte growth factor (KGF) and dexamethasone are used in clinical lung 
diseases to improve injuries. The mechanism behind the healing effect is not 
completely understood. It was shown, that KGF plays a role in repairing and 
protecting against lung injuries by stimulating the growth of alveolar type II cells. 
[208, 209] Dexamethasone is a glucocorticosteroid, which has anti-inflammatory and 
immunosuppressive effects. Conditions of neonatal chronic lung diseases improved 
after 72 hours of dexamethasone treatment, by maturing the surfactant 
phosphatidylcholine. [210] Dexamethasone reduced the expression of the mucin 
protein MUC5AC in lung epithelial cell, decreasing the mucus secretion. [211] This 
change in surfactant and mucus production helped in the protection of lung injuries.  
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Figure 5-28: Rescue of resistance by KGF and dexamethasone. 
Three weeks differentiated NHBE were pretreated with 250ng/ml KGF and 10µM dexamethasone for 
one hour and stimulated with 1µg/ml LT for 48 hours. KGF and dexamethasone led to increased 
resistance. Resistance was determined by usage of an EVOMX. Abbreviations: -, untreated; Dexa, 
dexamethasone; KGF, keratinocyte growth factor; LT, lethal toxin. 
 
We determined if the pretreatment with both substances, would have a rescue effect 
on the epithelial cell disruption in 3D. After one hour pretreatment with KGF or 
dexamethasone and 48 hours of LT treatment a significant improvement of 
resistance and permeability was detected. (Figure 5-29, Figure 5-30) Dexamethasone 
increased the resistance of untreated and LT treated cell, whereas KGF influenced 
only LT damaged cells. Even if KGF and dexamethasone could not rescue the 
permeability and resistance effect completely, it could be considered as a 
prophylactic treatment of patients with anthrax infection to decrease the respiratory 
distress. 
 
Figure 5-29: Rescue of permeability increase by KGF and dexamethasone. 
Three weeks differentiated NHBE were pretreated with 250ng/ml KGF and 10µM dexamethasone for 
1hour and stimulated with 1µg/ml LT for 48 hours. KGF and dexamethasone rescued the permeability 
increase caused by LT. The cell permeability was determined by adding FITC-albumin on top of the 
cells and measuring amount of the dye leaking through the layer into the basal compartment. 
Abbreviations: -, untreated; Dexa, dexamethasone; KGF, keratinocyte growth factor; LT, lethal toxin.   
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To test if KGF and dexamethasone have also a positive effect on cell viability, we 
compared the release of the cytosolic protein LDH in the media. LT induced 12% of 
cytotoxicity, which could be decreased to 8% by dexamethasone and 5% after KGF 
treatment. (Figure 5-30) The reduction of cell death could be the reason for the 
decreased cell layer damage seen by resistance and permeability improvements.  
 
 
Figure 5-30: KGF and dexamethasone increase cell viability. 
Three weeks differentiated NHBE were pretreated with 250ng/ml KGF and 10µM dexamethasone for 
one hour and stimulated with 1µg/ml LT for 48 hours. KGF and dexamethasone increased cell 
viability, which was determined in the basal media by LDH release. Abbreviations: -, untreated; Dexa, 
dexamethasone; KGF, keratinocyte growth factor; LDH, lactate dehydrogenase; LT, lethal toxin.   
 
5.6 Cell Viability After LT Treatment 
Murine macrophages from susceptible mouse strains undergo cell death in less than 
3 hours after lethal toxin treatment. Human cells were proven to be more resistant. 
To determine, if human bronchial epithelial cells have a decreased cell viability, we 
used several different cell death assays. 
First, we determined the membrane integrity by phosphotidylserine exposure. (Figure 
5-31) Apoptotic cells flip phosphatidylserine towards the outer membrane side. Lethal 
toxin treated and untreated cells did not reveal increased membrane damage after 
48 hours. (Figure 5-31, B-C) As control the protein synthesis inhibitor cyclohexamide 
was used and caused in 18% of the cells a membrane breakdown resulting in the 
exposure of phosphotidylserine to the outer membrane. (Figure 5-31, A)  
RESULTS 
 
 74
 
                                 D   
 
Figure 5-31: Lethal toxin does not alter membrane integrity.  
A) Cyclohexamide is an inhibitor of protein synthesis and was used as positive control inducing the 
phosphotidylserine exposure to the outside of the cell. B) untreated and C) LT treated cells did not 
show any significant membrane integrity change. DAPI stained the DNA in the nucleus (blue). D) 
Quantification of 500 cells was shown in % of positive cells. Abbreviation: -, untreated; %, percent; 
CHX, cyclohexamide; DAPI, 4’,6-diamidino-2-phenylindole dihydrochloride; LT, lethal toxin. 
 
Apoptotic cells show fragmentations of nuclear DNA, which can be detected by 
connecting fluorescence dUTPs with a transferase into DNA strain breaks. To detect 
the total amount of cells, we stained the nuclei also. DNase1 nicked the DNA and 
was used as positive control and caused in all cells breakage of the DNA. (Figure 
5-32, A) This was not observed in untreated or LT treated cells, which was shown by 
the quantification of 500 cells. (Figure 5-32, B) Therefore, LT does not affect DNA 
integrity. 
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Figure 5-32: Minimal DNA strand breaks after LT treatment measured in a TUNEL assay.   
A) Immunofluorescence to visualize DNA strand breaks (green). DNase 1 was used as positive 
control to introduce nicks in the DNA. No increase in DNA damage was seen in untreated or LT 
treated cells. DAPI (blue) was used to visualize the nucleus of the cells. B) Quantification of 500 cells 
is shown in the bar graph. Abbreviation: -, untreated; DAPI, 4’,6-diamidino-2-phenylindole 
dihydrochloride; LT, lethal toxin. 
 
Caspases are cysteine proteases involved in apoptosis, cytokine production and 
inflammation. Caspases are synthesized as inactive pro-caspases. This allows rapid 
autoactivation and induction of the caspase cascade leading to cell death. Caspase 
3 activity can be detected by the cleavage of proteins such as PARP and ROCK-1. 
After 48 hours of LT treatment, we did not observe any caspase activity. (Figure 5-33)  
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Figure 5-33: Caspase 3 activation is not induced by LT. 
Western blot of PARP and Rock-1 cleavage after 48 hours of untreated and lethal toxin treated cells. 
Actin was used as loading control. Abbreviation: -, untreated; kDa, kilo Dalton; LT, lethal toxin; PARP, 
Poly ADP-ribosepolymerase; ROCK1, Rho-associated coiled-coil protein kinase 1.   
5.6.1 Proliferation Decrease Due to Cell Cycle Arrest 
Lethal factor did not induce any kind of cytotoxicity in epithelial cells after 48 hours of 
treatment, which was shown above. Also, the proliferation rate was not altered at 
that time point. (Figure 5-34, 48hr) However, when NHBE cells were grown longer then 
48 hours lethal toxin treatment, they were unable to recover normal proliferation 
rates compared to untreated cells. Furthermore, slight losses of metabolic active 
cells were seen after 48+48 hours and 48+96 hours. (Figure 5-34)  
 
 
Figure 5-34: Blocked cell proliferation after LT treatment.  
Proliferation measurements (MTT) were performed after 48 hours of LT treatment and an addition 48 
hours and 96 hours of recovery in non-treated media.  Abbreviation: hrs, hours; LT, lethal toxin; nm, 
nanometer. 
 
Proliferation inhibition might be caused by a defect of cell cycle progression. 
Therefore, we determined the cell amount in the G1 phase versus S/G2/M at 
different time points. (Figure 5-35, C) After 48 hours treatment the levels were 
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comparable between untreated and lethal toxin treated cells. When lethal toxin was 
washed away and cells were grown for an additional 48 or 93 hours, the cell 
numbers in S/G2/M phase were decreased. One example is shown in Figure 5-35, A-B 
to demonstrate the G1 arrest. Looking at expression levels of proteins (cyclin B and 
E2) controlling the cell cycle did not show any changes after 48 hours of treatment. 
(data not shown) However, this G1 arrest was also shown in murine macrophages 
by the downregulation of cyclin D. [173] MAPKKs and the cytoskeleton are very 
important for cell division and might not only affect cytokineses, but also, the 
chromosome assembly and orientation of the MTOC in LT treated cells.  
 
 
 
       
 
Figure 5-35: Increase of cells in G1 phase after LT treatment.  
A,B) FACS histogram of PI stained cells untreated (A) or after 48 hours LT treatment (B) and 93 hours 
additional growth. First peak displays single the DNA content in G1 phase. Second lower peak 
contains double DNA content and include S/G2/M phase. C) The table shows the % of cells in each 
phase at three different time points. The biggest changes were highlighted in red. Abbreviation: -, 
untreated; hr, hours; LT, lethal toxin; M, mitosis phase; PI, propidium iodide; S, synthesis phase. 
5.6.2 Mitochondrial Potential Changes 
Lethal toxin impaired mitochondrial function, causing a decrease in membrane 
potential and succinate dehydrogenase (SDH) activity in murine macrophages 
(J774A.1). This event was predicted to be one of the key players of toxin induced 
cytotoxicity. [166] We determined, if the proliferation inhibition could be caused 
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through a mitochondria dysfunction. Figure 5-36, A displays a significant difference in 
untreated and LT treated cells. It seemed that LT treatment led to two types of cells. 
One peak was similar to the untreated one, whereas a second peak shifts to the right 
towards hyperpolarization. Since the three MAPK inhibitor combinations have a 
comparable LT profile, the MAPK pathway might be involved in the mitochondria 
alteration. (Figure 5-36, A) The single inhibitors had unique pattern. JNK was similar to 
LT treated cells. p38 inhibition showed only one population at the hyperpolarized 
side. The reduction of MEK1/2 caused the opposite effect, a shift towards the 
hypopolarized side.    
 
 
 
Figure 5-36: Mitochondrial potential alteration caused by MAPKK cleavage. 
A) Comparison of untreated, LT and 3 MAPK inhibitor treated cells in their mitochondrial potential. B) 
Comparison of the mitochondrial potential of LT with single MAPKK inhibitor. FACS analysis of TMRM 
stained NHBE after 48 hours treatment in starving media. Abbreviation: 3INH, 3 inhibitor MAPK 
combination; LT, lethal toxin; TMRM, tetramethyl rhodamine methyl ester; %, percent. 
5.6.3 Proteasome Impairment 
The proteasome complex is involved in the cytotoxic effect induced by LT, since 
inhibitors partially prevent cell death. The importance of MAPKK in cell death would 
be implicated, if proteasome inhibitors would rescue MAPKK cleavage. Figure 5-37, A 
shows the recovery of MEK2 expression when the proteasome inhibitor is added 
shortly (90min) after lethal toxin treatment. After longer incubations (48hrs) with LT, 
inhibitors did not have any rescue effect on the cleavage of MAPKK. (Figure 5-37, B) 
Epoxomycin is a specific proteasome inhibitor, whereas MG132 can also reduce 
lysosomal protein degradation. The MEK2 expression could only be resuced by the 
proteasome and not by the lysosomes, since MEK2 expression assays performed 
with chloroquine, a lysosomal inhibitor, did not recover MEK2 expression after short 
toxin incubation. (data not shown) 
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Figure 5-37: MAPKK expression induced by proteasome inhibitors. 
A) MEK2 cleavage rescue after 90 minutes LT treatment followed by 4 hours epoxomycin. B) 4 hours 
MG132 after LT 48 hours treatment was unable to gain MEK2 protein expression. Actin was used as 
loading control. Abbreviation: -, untreated; Epo, epoxomycin; hr, hours; LT, lethal toxin; MEK-2, 
mitogen activated ERK kinase; MG, MG132 inhibitor; MKK-3, mitogen activated kinase kinases. 
 
Analysis of the proteasome activity might give more inside information in the 
mechanism of cell death. Proteasome activity was measured for 60 minutes and 
showed a significant reduction through LT treatment. This reduction could be 
partially due to MAPKK cleavage, since a three inhibitor combination (MEK1/2, ERK, 
JNK) lowered the proteasome activity to around 50% of the LT levels. (data not 
shown) MG132, a proteasome inhibitor, was used as a control for complete inhibition 
of its activity. The reduction of proteasome activity was confirmed by the expression 
levels of LRP2, a protein in the proteasome involved in its activity, which was slightly 
reduced after LT treatment. (data not shown) 
 
Figure 5-38: Reduced proteasome activity after LT treatment. 
The proteasome activity was measured after 48 hours of LT treated NHBE and proteasome inhbititor 
MG132 for 4 hours. Abbreviation: LT, lethal toxin; min, minutes; nm, nanometer; ex, excitation; em, 
emission. 
5.7 Continues MAPKK Cleavage Due to Lethal Toxin Residues  
Recently, it was shown by LF inhibitor studies (LF protease inhibitor III), that lethal 
factor can be stored in the cell after exposure, causing constant MAPKK cleavage. 
[167] In Figure 5-39 we observed, that after 48 hours of lethal toxin exposure, MKKs 
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are completely cleaved. However, when we washed the outside LT away and 
incubated the cells for another 48 hours with media only, we did not regain MKK 
expression.  
 
Figure 5-39: Continuous MAPKK cleavage after 48 hours of LT treatment. 
Western blot of MAPKK cleavage after 48 hours of LT treatment and an additional 96 hours of normal 
growth stimulation. Actin was used as loading control. Abbreviation: -, untreated; hr, hours; LT, lethal 
toxin; MEK-2, mitogen activated ERK kinase; MKK-3, mitogen activated kinase kinases. 
 
Since mRNA levels were not affected and resynthesis of MKKs took place [167] 
lethal factor might be stored in epithelial cells. Therefore, we treated NHBE for 24 
hours, washed all extracellular LT away, infected the cells with a MEK2 wild-type 
lentivirus and determined its cleavage. If lethal toxin would be degraded or loses its 
activity in the cell, it should not be able to cleave the newly introduced MEK2 wt. 
However, if LT is stored somewhere in the cell, the cleavage should be observed. 
We detected cleavage of MEK2, which was shown in Figure 5-40. 
 
 
 
 
Figure 5-40: LT residues stored in cell. 
NHBE were infected with MEK2wt as indicated after 24 hours of LT treatment. Overexpression and 
MEK2 cleavage were compared to uninfected cells. Residual LT caused cleavage of reintroduced 
MEK2wt. Equal infection rates were visualized with the GFP antibody, since the lentivirus construct 
contains EGFP. Actin was used as loading control. Abbreviation: -, untreated; GFP, green 
fluorescence protein; LT, lethal toxin; MEK-2, mitogen activated ERK kinase; wt, wild type. 
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With these findings, we had evidence, that lethal factor accumulates in the cell, 
causing constant MKK cleavage. But its location was not identified. Antibodies 
against lethal factor do not perform well. Therefore, we biotinylated LF (LFbio) to 
determine its storage in the cell. To ensure, that biotinylated LF tagged with histidine 
(LFhisbio) was also able to cleave MAPKK, we performed a MAPPKide assay. This 
assay emits fluorescent light upon MAPPKide cleavage. The similar kinetic cleavage 
curves are shown in Figure 5-41. 
 
 
 
Figure 5-41: Similar MAPKK cleavage activity of different LFs. 
The kinetic of the cleavage from the fluorescent MAPPKide by LF and its modified forms were 
followed over time. PA did not cleave MAPKK, whereas all LF forms had similar activity. Abbreviation: 
PA, protective antigen; LF, lethal factor; LFhis, histidine tagged lethal factor; LFhisbio, histidine tagged 
lethal factor biotinylated; RLU relative light units. 
 
Visualizing the localization of biotinylated LF by immunofluorescence was not 
possible due to high background stain caused by the steptavidin conjugated FITC 
secondary antibody. We were unable to distinguish between unspecific binding and 
real signals. Therefore, we conjugated LF with Alexa-488 to detect a better signal. 
The result showed a very weak IF performance, from which we were also not 
capable of determining any significant location in the cell.  
Another option was to fractionate membrane and cytosol of the LF-biotinylated 
treated cell lysates. Figure 5-42 showed that LF is stored in membrane compartments 
and was probably slowly released in the cytosol, where it cleaved the MAPKK. After 
48 hours treatment and washing away all extracellular toxin, MAPKK cleavage 
continued to locate (48hr+48hr) in the membrane compartments. GDI was used as a 
cytosolic marker. 
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Figure 5-42: LF is localized in membrane compartments. 
Western blot analysis to localize LFbio with a strept-avidin antibody. MEK2 cleavage after LTbio 
treatment was observed in the cytosolic fraction. GDI was used as cytosolic loading control. 
Abbreviation: hr, hours; C, cytosol; M, membrane; LTbio, lethal toxin biotinylated, MEK2, mitogen 
activated ERK kinase; GDI, guanine nucleotide dissociation inhibitor. 
 
The incubation of LFhis with a crude Raw cell lysates would indicate its stability in 
the cytoplasm over time. After coating histidine-tagged LF on nickel beads, washing, 
cell lysates exposure and incubation with HIS antibodies and LF antibodies, LFhis 
could not been detected. This agrees with Leppla and coworkers observation that LT 
is degraded after 30-40 minutes in the cytosol and therefore cannot be stored there. 
(Figure 5-43) 
    
Figure 5-43: LF degradation after exposure to Raw cell lysates. 
IP of LFhis and LFhisbio to nickel columns, washed with tritonX containing buffer or after exposure to 
Raw cell lysates for 2 hours. LFhis and LFhisbio were visualized with a His and LF antibody. 
Abbreviation: HIS, histidine antibody; LF, lethal factor; hrs, hours; LTh, histidine tagged lethal toxin; 
LThb, biotinylated histidine tagged lethal toxin. 
5.8 Modification of Lethal Factor Influences Its Cytotoxic Effect  
Murine macrophages from susceptible mouse strains undergo cell death in less than 
3 hours. This is a fast way to detect the cytotoxicity effects of lethal toxin. We choose 
a macrophage cell line called RAW 264.7 and performed a dose dependent cell 
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viability assay after 3 hours of LT incubation. Lethal factor and protective antigen are 
by themselves non-toxic and were used as negative controls. Lethal toxin caused 
over 60% of cell death when a concentration of 50ng/ml was added, which was also 
showed for histidine tagged LF (LFhis) in combination with PA. Biotinylated LThis did 
not have the any cytotoxic effect. (Figure 5-44)  
 
Figure 5-44: Biotinylated lethal factor did not alter cell viability. 
MTT assay to determine viable cells after dose dependent incubation with LThis, LThisbio and LT 
after 3 hours treatment in Raw cells. Lethal toxin caused a dramatically decrease in cell viability, 
whereas LThisbio did not. Abbreviation: nm, nanometer; ug, microgram; ml, milliliter; ng, nanometer; 
PA, protective antigen; LF, lethal factor; LFhis, histidine tagged lethal factor; LFhisbio, biotinylated 
histidine tagged lethal factor. 
 
To prove, that the decrease in toxicity is not due to the inhibited uptake of 
biotinylated LF, expression levels of MAPKK were determined. LFbio was able to 
enter the cell and cleave MEK2 comparable to LT, which is shown in Figure 5-45.  
 
 
Figure 5-45: MAPKK cleavage time course. 
Time dependent MEK2 cleavage in RAW cells. The uptake of biotinylated LT was shown by a 
streptavidin stain. Actin was used as loading control. Abbreviation: MEK2, mitogen activated ERK 
kinase; LTbio, biotinylated lethal toxin; Strep, streptavidin; min, minutes; LT, lethal toxin. 
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All other MKKs including MKK3 and MKK6, which can decrease toxicity, displayed 
also cleavage. (data not shown) Since there might be a delay in cell death we 
increased the incubation time to 24 hours. Even at such a late time point LThisbio 
did not induce cell death compared to LT. (Figure 5-46) However, a slight decrease in 
metabolic active cells after 24 hours was seem. This might not induced by cell death, 
instead we believe that the proliferation was inhibited. 
 
 
 
Figure 5-46: LFhisbio does not induce cell death within 24 hours treatment. 
MTT assay to determine viable cells after 3 and 24 hours of indicated treatment of RAW cells. Lethal 
toxin caused cell death after 3 hours, whereas LThisbio showed only a slight proliferation inhibition. 
Abbreviation: nm, nanometer; hr, hours; PA, protective antigen; LF, lethal factor; LFhis, histidine 
tagged lethal factor; LFhisbio, biotinylated histidine tagged lethal factor; LT, lethal toxin; LThisbio, 
biotinylated histidine tagged lethal toxin. 
 
These findings predict that through random biotinylation of lysines on lethal factor, 
either an unknown binding protein is blocked or that the localization of LTbio inside 
the cell is altered. To detect the specific LTbio biotinylation sites responsible for 
rescue of Raw cell death, we analyzed the LTbio by mass spectrometry. Trypsin 
digest was performed and mass changes were detected with nano-LC-MS-MS. 
(TSRI Core facility) Figure 5-47 displays all identified biotinylated lysines of two 
experiments, which were detected. With sequence coverage of 80% some 
biotinylation sites were probably undetected.   
It would be very time consuming to analyze every of those lysines by mutagenesis in 
a cytotoxicity assay to identify the specific lysine causing the decrease in cell death. 
We used his-tagged LF in immunoprecipitation studies to identify different binding 
partner between LFhis and LFhisbio. Unfortunately, we were unable to pull any 
binding partner down, since LFhis was degraded after 2 hours when exposed to Raw 
cell lysates. (Figure 5-43)  
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MNIKKEFIKVISMSCLVTAITLSGPVFIPLVQGAGGHGDVGMHVKEKEKNKDENKRK
DEERNKTQEEHLKEIMKHIVKIEVKGEEAVKKEAAEKLLEKVPSDVLEMYKAIGGKI
YIVDGDITKHISLEALSEDKKKIKDIYGKDALLHEHYVYAKEGYEPVLVIQSSEDYVE
NTEKALNVYYEIGKILSRDILSKINQPYQKFLDVLNTIKNASDSDGQDLLFTNQLKEH
PTDFSVEFLEQNSNEVQEVFAKAFAYYIEPQHRDVLQLYAPEAFNYMDKFNEQEINL
SLEELKDQRMLSRYEKWEKIKQHYQHWSDSLSEEGRGLLKKLQIPIEPKKDDIIHSLS
QEEKELLKRIQIDSSDFLSTEEKEFLKKLQIDIRDSLSEEEKELLNRIQVDSSNPLSEKE
KEFLKKLKLDIQPYDINQRLQDTGGLIDSPSINLDVRKQYKRDIQNIDALLHQSIGSTL
YNKIYLYENMNINNLTATLGADLVDSTDNTKINRGIFNEFKKNFKYSISSNYMIVDIN
ERPALDNERLKWRIQLSPDTRAGYLENGKLILQRNIGLEIKDVQIIKQSEKEYIRIDAK
VVPKSKIDTKIQEAQLNINQEWNKALGLPKYTKLITFNVHNRYASNIVESAYLILNEW
KNNIQSDLIKKVTNYLVDGNGRFVFTDITLPNIAEQYTHQDEIYEQVHSKGLYVPESR
SILLHGPSKGVELRNDSEGFIHEFGHAVDDYAGYLLDKNQSDLVTNSKKFIDIFKEEG
SNLTSYGRTNEAEFFAEAFRLMHSTDHAERLKVQKNAPKTFQFINDQIKFIINS  
 
Figure 5-47: Protein sequence of lethal factor with biotinylated lysines (K). 
Single protein code of the LF sequence. Lysine (K) biotinylation of two mass spectrometry 
experiments are displayed with different colors. Sites identified in experiment 1 (yellow), in experiment 
2 (red) and when experiments discovered in both experiments (green). Not all areas were found in 
mass spectrometry, which are marked as non-covered region (blue). 
 
Proteasome changes and mitochondria dysfunction were involved in lethal toxin 
toxicity. We wanted to compare the proteasome activity and mitochondrial potential 
between LT and LThisbio. We showed before (Figure 5-38) that lethal factor 
decreases proteasome activity. This can also be seen in Figure 5-48. Biotinylated LT 
displayed normal proteasome activity and was therefore closer to the untreated 
curve.  
 
Figure 5-48: LThisbio does not reduce the proteasome activity in NHBE. 
The proteasome activity was tested after 48 hours treated NHBE. The kinetic of indicated treatments 
were followed. Histidine tagged biotinylated LT did not decrease the proteasome activity compared to 
LT. MG132 is a proteasome inhibitor, reducing its activity. Abbreviation: LT, lethal toxin; LThisbio, 
histidine tagged lethal toxin; min, minutes; nm, nanometer; ex, excitation; em, emission. 
 
The same observation was made in the mitochondria, where the membrane potential 
of LThisbio was similar to the untreated cell profile. (Figure 5-49) It showed three 
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populations of cells. Most LThisbio treated cells were hypopolarized (shift to left), 
others were similar to untreated cells and the rest showed cells in the hyperpolarized 
site such as LT. (Figure 5-49) Since LThisbio altered the proteasome and 
mitochondria in the opposite way compared to LT, it might be less toxic for cells. 
 
 
 
Figure 5-49: LThisbio causes mainly hypopolarization of the mitochondrial potential in NHBE. 
FACS analysis of TMRM stained NHBE after 48 hours treatment in starving media. Abbreviation: LT, 
lethal toxin; LThisbio, biotinylated histidine tagged lethal toxin; TMRM, tetramethyl rhodamine methyl 
ester; %, percent. 
 
Lethal factor caused a variety of morphological and permeability changes in NHBE. 
Therefore, we investigated the effect of LTbio on junctions, cytoskeleton, motility and 
cytotoxicity. (data not shown) We observed very similar changes in all of these areas 
compared to LT. Junction formations were altered and caused a resistance decrease 
with permeability elevated. (Figure 5-50) The cytotoxicity assay performed in inserts 
displayed almost identically cell death. (Figure 5-50) 
 
 
 
 
Figure 5-50: Cytotoxicity and resistance comparison of LT and LTbio in NHBE 3D. 
A) Comparison of LDH release after 48 hours of LT or LTbio treatment. B) Similar resistance changes 
were observed after incubation of LT or LTbio for 48 hours. 
 
Furthermore, the stress fiber formations were increased, causing a defect in motility. 
Therefore, the cells treated with LTbio were studied in live cell imaging and showed 
exactly the same phenotype compared to LT. (Movie 17)  
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6 DISCUSSION  
6.1 Polarized Lung Epithelial - An Excellent Model to Study LT 
Intoxication  
B. anthracis infection in the lungs causes common flu-like symptoms, internal 
bleeding, respiratory distress and in rare cases meningitis. Most of the anthrax 
studies are performed on mice or in murine macrophages. Those were either 
resistant or susceptible to lethal toxin induced cell death. [212-216] Only a few 
studies have focused on human cells, which seem to be more resistant. Depending 
on the cell type, cell death started to occur as early as 18 hours or as late as 72 
hours. [80, 172, 174, 177] In addition, it is not clear what causes the respiratory 
failure in the late pathogenesis. Therefore, we focused on the effect of the lethal 
toxin on the human respiratory system. To do so, we decided to work with primary 
human bronchial epithelial cells. The establishment of a differentiated, polarized 3D 
system gave us the possibility of studying LT intoxication under more physiological 
conditions. [217] NHBE are lung precursor cells which differentiated into 
pneumocytes, goblet, ciliated, and basal cells. The formation of desmosomes, tight 
and adherens junctions results in a very dense layer of cells, controlling tissue 
homeostasis and strength.  
We observed that defense mechanisms such as cilia movement and the secretion of 
mucus and antimicrobial peptides such as defensins protect the apical side for 
environmental insults.  Surfactants were found to be expressed to decrease surface 
tension. This shows that a differentiated epithelial system can be used to mimic 
human lung responses.  
Furthermore, the expression of both anthrax receptors on the cell surface, which 
mediate the translocation of LT into the cell and in turn, led to MAPKK cleavage, 
makes the system best suitable for studying the effects of anthrax toxins. 
Earlier observations in differentiated polarized T84 (human intestinal) cells proved 
the basolateral location of the anthrax receptors. [218] Protective antigen was only 
detected in the cells when treatment was performed from the basal side. [218] With 
this in mind, and knowing that LT would reach the lung epithelial cells from the 
vascular side, we carried out all our treatments from the basal side. 
Taken together, normal tissue culture grown cells and the 3D model provided an 
excellent tool to understand lethal toxin effects in the human body.  
 
6.2 Lethal Toxin Disrupts Barrier Function in Lungs 
In humans anthrax pathogenesis causes blood vessel leakage and edema in the 
lungs, leading to severe bleeding and respiratory distress. Similar effects were seen 
in animal studies. [219, 220] 
Using immunofluorescence, electron microscopy and protein expression assays, we 
observed alterations of junctions, cytoskeleton and adhesion complexes after lethal 
toxin treatment. In fact, LT disrupted the epithelial barrier by disturbing junction 
formation. Wide diffuse tight as well as adherens junctions indicated an assembly 
and remodeling defect in normal tissue culture plated cells.  
Under more physiologic conditions in the form of a polarized epithelial system, we 
were able to identify phenotypical changes, which resemble diseased lungs. Staining 
of tight junctions revealed an enhanced connection failure at sites, where multiple 
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cells connect in one point. Naturally occurring multicellular junction sites have been 
identified in live cell imaging as the detachment of dead cells by extrusion. [203] 
Surrounding cells maintain those sites by reorganizing the junction complex and 
closing them up. We also encountered a slight increase in cell death in 3D, which 
could have been the cause of these described junction site disruptions.  
We further confirmed those severe alterations in a cross section of the polarized 
system by electron microscopy. The basolateral site showed extremely wide 
intercellular space formations, causing the loss of integrity of that layer and swelling. 
Therefore, the junction defect seen in 2D was potentiated in 3D. This caused an 
increase in permeability and a decrease in resistance after 48 hours of lethal toxin 
treatment. Other investigators observed similar effects on the barrier function in the 
underlying lung endothelial cells. The disordered junctions were found to be 
triggered by a loss of peripheral F-actin, which was not seen in our studies after 
treating NHBE with LT. [80] Furthermore, Warfel et al. excluded cell death as a major 
mechanism responsible for permeability changes, as no significant apoptosis was 
observed in the first 72 hours of LT exposure. The probable cause may partially be 
due to the cleavage of MAPKKs. MKK1/2 and JNK inhibition increased the 
permeability in endothelial cells, whereas a reverse effect was seen by the decrease 
of p38. [80]  
The permeability and resistance changes were rescued by pretreatment with 
dexamethasone and keratinocyte growth factor (KGF). This might be due to the 
induction of cell survival in the polarized epithelium. [221] Dexamethasone is a 
glycocorticoid hormone and known to decrease inflammation, severe edema and 
swelling. Lethal toxin was shown to repress the glycocorticoid receptor 
transactivation in a non-competitive manner. [222] This receptor repression is 
partially due to the inhibition of the p38 pathway, which was also seen to reduce 
glycocorticoid receptor-inducing gene expression. Early receptor activation by 
dexamethasone might prevent LT barrier disruption. 
Pretreatment with KGF also increased the resistance of NHBE treated with LT. In 
animal studies it was shown that KGF prevents lung injury. [209] However, the 
mechanisms behind these effects are not well understood. In intestinal epithelial 
cells and pneumocyte type II cells, it induced cell proliferation, differentiation, 
migration and re-epithelialization. [209, 223] This might be due to the fact that KGF 
promotes ERK1/2 and p38 phosphorylation shown in cornea epithelial cells. [113] 
KGF pretreatment of the polarized system might cause an upregulation of the 
MAPKK pathway before lethal factor inhibits all of the MAPKK activation by 
cleavage.  
  
6.3 Lethal Toxin Alters the Cytoskeleton 
Previously it has been shown that LT induces elongated cell shape in monolayer 
formation of lung endothelilal cells. This phenomenon was found to be due to 
increase in stress fiber formation at the center of the cells, whereas peripheral F-
actin was reduced. [80] Other studies in human neutrophils described that LT inhibits 
the actin assembly. [87] This was explained by a lower F-actin content after LT 
treatment. However, this F-actin content was not altered when neutrophils were only 
incubated for 1 hour with lethal toxin. Longer treatments (2hrs) reduced the F-actin 
assembly when migration was induced by fMLP stimulation and also showed lower 
expression of actin in the triton-insoluble-cytoskeletal fraction. [87] In subsequent  
studies, this group connected the actin assembly defect with the inhibition of the p38 
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pathway in neutrophils, which blocks the phosphorylation of Hsp27. Hsp27 facilitates 
the transport of G-actin to regions of new actin filament growth and is therefore 
important for the assembly process. [88]   
In contrast, we observed in epithelial cells that the accumulation of stress fibers 
(actin) and bundle-like tubulin structures resulted in an extremely ridged 
cytoskeleton. LT treatment caused the buildup of actin and tubulin filaments as seen 
after polymerization inhibition. To explore the possibility of an actin assembly defect 
seen in neutrophils by other investigators, we inhibited actin polymerization with 
reversible inhibitors after LT treatment. The assembly process was determined by IF 
showing the capability of the actin network to polymerize. Interestingly, actin 
polymerization led to the same stress fiber formation and inflexible cytoskeleton seen 
after LT treatment. Therefore, the idea of LT causing polymerization and 
depolymerization defects in lung epithelial cells could be excluded. In addition, we 
found that LT induces the stabilization of tubulin as a result of polyglutamination and 
acetylation modification as shown by inhibitor studies.  
The above mentioned results do not explain why neutrophils showed a decreased 
actin assembly, whereas NHBE contained more filaments and had a normal turnover 
mechanism. However, compared to epithelial cells, neutrophils more motile cells, 
which allows them to migrate towards the site of infection, and might therefore differ 
in their regulation of the cytoskeleton compared to epithelial cells.   
We believed that the lethal toxin induced phenotype of stress fiber and protrusion 
formation was caused by RhoGTPases alterations. Increased RhoA activity leads to 
stress fibers, whereas Rac1 forms lamellipodia. [224] Surprisingly, we did not detect 
any activity changes after 48 hours of LT treatment. Interestingly, an increase in 
activated Cdc42, which induces filopodia extensions, was identified after LT 
exposure. Cdc42 engages actin cytoskeletal reorganization, cell polarization and the 
reorientation of MTOC of migrating cells, which could contribute to the LT phenotype. 
[225]     
Furthermore, MAPK pathways were shown to influence cytoskeletal rearrangements. 
ERK was shown to lower F-actin bundling by the phosphorylation of synapsin I in 
neuronal cells, which would be diminished by the downregulation of ERK activity. 
[102] In addition, p38 activates p16-Arc, a subunit of the Arp2/3 known to be crucial 
for actin rearrangements. [120, 121] In contrast, JNK activity can disrupt stress fiber 
formation. [226] Further investigations are required to prove which MAPK pathway 
has the most impact on cytoskeletal changes in epithelial cells. In summary, we 
showed that lethal toxin induced MAPKK cleavage and Cdc42 activation causes 
accumulation of actin and tubulin filament in bronchial epithelial cells. 
 
6.4 Defective Motility and Wound Healing in the Lungs Caused by 
Lethal Factor Exposure  
Cell migration depends on the coordinated interaction of three mechanisms: the 
polarization of the cells, the rearrangement of the cytoskeleton and the formation of 
adhesions. The previously described actin assembly defect in neutrophils paralyzes 
cell motility and prevents the directed migration towards a stimulus. [87] 
We observed migration deficiencies in wound healing assays, due to the impaired 
cytoskeletal dynamics caused by LT. In fact, treating cells with lethal toxin abolished 
wound closure completely. The directed migration in a Boyden chamber experiment 
also displayed no movement towards the stimulus. In addition, live cell imaging 
experiments showed clearly that NHBE exposed to LT were capable of actin 
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polymerization. They formed multiple protrusions around the cell instead of one 
lamellipodium at the front. Therefore, their regulation and signal sensing were 
impaired.  
Besides their role in the cytoskeleton, adhesion proteins are required to connect cell 
extensions with matrix proteins, resulting in their stabilization. By western blot 
analysis, we detected an increased amount of vinculin, a focal complex protein, in 
the cytoskeletal fraction. Paxillin, also known as a focal adhesion protein, was 
decreased in the cytosol, consequently impairing the assembly of focal complexes.  
Similar effects were seen by different investigators in endothelial cells. LT treatment 
in combination with TNFα enhanced the expression of the adhesion protein called 
vascular cell adhesion molecule 1 (VCAM1). [227]  
Although attachments through integrins were not impaired by LT, LT treated NHBE 
were unable to adhere to positively charged tissue culture plates or poly-L lysine. 
This might be explained by the finding of Popova et al., showing an increase in the 
shedding of syndecan 1 by epithelial membranes. The shedding might affect the 
charge or integrity of the cytoplasmic membrane required for attachment to positive 
surfaces. [228]  
Many proteins are involved in the regulation of cell migration. Especially, GTPases 
were proven to play a major role in cytoskeletal rearrangements and motility. Rac1 
and Cdc42 regulate actin polymerization in the front of the cell, forming lamellipodia 
and filopodia. [229] More interestingly, Cdc42 is required for cell polarity. [230] 
Therefore, an increased activity of Cdc42 could cause enhanced protrusion 
formation.  
Other proteins, such as EB1, were also shown to be involved in polarity by 
positioning cues and regulating the connection between microtubules and cortical 
actin. [225] Lethal toxin treated cells might be disabled in sensing those cues by 
extracellular sensor downregulation/malfunction or intracellular signaling deficiency. 
In addition, MAPK pathways are known to regulate cell motility. It was shown that 
downstream effectors of ERK induced membrane protrusion in polarized cells 
through the activation of myosin light chain kinase (MLCK) [109, 110] p38 controls 
adhesion dynamics by the phosphorylation of paxillin and actin filaments through 
inhibition of the Arp2/3 complex and therefore influences cell motility. [115] The 
downstream effecter Hsp27 was shown to induce stress fibers and regulate actin 
polymerization in endothelial cells and neutrophils impaired in migration. [87, 117-
119] In the JNK pathway many interacting proteins were observed to regulate 
locomotion. [122] Reduction of JNK impaired the motility causing improper wound 
healing. [125, 126] Faster migration was induced in lung carcinoma cell lines by 
activation of JNK and expression of constitutively active MKK4. [123, 124]  
Wound healing and directed migration assays with the three MAPK inhibitor 
combinations proved the incapability of wound closure and chemotaxis. Single 
MAPK inhibitors displayed a partial migration into the wound. In addition, we 
performed live cell imaging experiments with either of these inhibitors and saw 
phenotypes similar to those seen with LT treatments. To prove, that the MAPK 
pathway was responsible for the protrusion formation and motility inhibition, we 
generated lentiviruses containing non-cleavable MKK mutants. The reintroduction of 
single MAPKK did not have any positive effects on the LT induced phenotype. Partial 
motility rescues were observed in live cell imaging, when both of the MKKs upstream 
of p38 and ERK were expressed after lentivirus infection. This implied that single 
infections were not sufficient for the activation of the downstream pathways. 
Confirmation of these results is planned in more controlled settings, since we could 
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not exclude that the partial rescue effect was caused by expression of only MAPKK 
after double infection. Therefore, we will sort immortalized lung epithelial cells after 
single infections of MAPKKs (GFP), followed by a second infection with the MAPKK 
affecting the same downstream pathway. This guaranties a much higher expression 
of both MAPKK in one cell, required for a complete rescue effect in live cell 
experiments.  
 
6.5 Lethal Factor Stored in Membrane Compartments Causing 
Continue MAPKK Cleavage 
We decided to look further into the LT localization in NHBE due to the observation of 
continue MAPKK cleavage, when LT was not present in the extracellular media. A 
recent study showed that the MAPKK synthesis was not impaired by exposure to LT. 
[167] Therefore, our hypothesis was, that LT gets stored in the cell and is slow 
release in the cytosol to cleave MAPKK efficiently. To define the localization of LT 
we were constrained to biotinyled LF (LFbio) due to the unavailability of functional 
antibodies. By fractionation assays we were able to detect LFbio in membrane 
compartments.  
However, to determine the type of membrane compartment, further experiments are 
required. The storage of LT in the membranes of multivesicular bodies in endosomes 
is likely since LT is endocytosed. In addition, cytosolic localization was excluded on 
the basis of rapid LF degradation after exposure to cell lysates.  
Unpublished data from the group of Prof. van der Goot suggested that the release of 
LF might not be required for its action. They had evidence that MAPKKs are located 
close to endosomal compartments, where the cleavage could be performed by LT 
without its translocation. This might allow the storage of LF in endosomes for a 
longer time. Therefore, the uptake of only a minimal amount might be efficient to 
cause the constant cleavage.  
 
6.6 Minimal Cytotoxicity Effect of LF in Human Lung Cells 
Lethal toxin causes rapid cell death of murine macrophages from susceptible mouse 
strains and Fisher rats. [137, 231] Park J.M. et al. described the involvement of the 
p38 pathway, which is inhibited by LT induced MAPKK cleavage. The 
overexpression of a non-cleavable MKK6 mutant in murine macrophages was able 
to rescue the cells for cell death. [168]  
However, it was shown that human cells such as endothelial cells and monocytic cell 
lines are more resistant against LT induced cytotoxicity. [80, 173, 174] Lethal toxin 
did not induce changes in membrane integrity, DNA strand breaks or activation of 
the death pathway by caspase3 cleavage in normal tissue culture treated cells. Even 
without the induction of cell death pathways, cell growth was compromised. We 
observed reduced proliferation when we continued cell growth after 48 hours of LT 
treatment in cells. Untreated cells divided and amplified exponentially, whereas LT 
kept their cell number steady for another 48 hours. Afterwards, slow death occurred, 
as shown by slightly lower levels of metabolically active cells. Further analysis of the 
cell cycle demonstrated arrest in the G1 phase which was also observed in human 
monocytic cell lines by another group. [173] They found the responsible mechanism 
for the cell cycle arrest to be the downregulation of cyclin D1/D2 and checkpoint 
kinase 1 (Chk1) by MEK1 cleavage. MEK1 was recovered when stabilized cyclin D 
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activated the PI3-K/Akt/GSK-3β pathway. The importance of the MEK1/2-ERK, p38 
and cyclin D in the cell cycle progression was also shown in different studies. [232, 
233]  
Moreover, we investigated the involvement of other processes in the inhibition of 
proliferation and induction of cell death, such as the alteration of mitochondrial 
potential and proteasome activity. Untreated and LT treated cells shared one peak 
but differed in the second one. LT led to an increase of hyperpolarized cells, 
whereas untreated cells were hypopolarized. Under normal cell culture conditions 
untreated cells should not display any depolarization effects. All of our treatments 
were performed in starving media resulting in some depolarization effects. The 
inhibition of all three MAPK pathways showed the same profile as LT treatment. This 
suggested an impact of the MAPKK pathway on mitochondrial dysfunction.  
Other investigators detected a drop of SDH and mitochondrial potential after short LT 
incubations of murine macrophages, which indicated the involvement of 
mitochondrial potential changes in early cell death induction. [166] The reduced SDH 
activity was not due to the degradation of succinate dehydrogenase (SDH) or other 
mitochondrial proteins such as cytochrome c, as shown in western blots. [166] We 
did not detect similar changes in SDH activity after 48 hours of LT treatment. 
Furthermore, the mitochondrial proteins, Bnip3 and Bnip3L, are regulated by p38. 
[167] Their protein reduction was shown to cause more resistance to cytotoxicity in 
murine macrophages. 
Susceptible murine macrophages were protected against lethal toxin induced cell 
death by the inhibition of the proteasome. [148] Interestingly, neither of the 
chymotryosin-like, trypsin-like or peptidylglutamyl-like activities of the proteasome 
were increased in RAW macrophages after 1 hour of LT treatment. Also, the 
proteasome did not affect the cleavage of MAPKK, suggesting the involvement of a 
downstream pathway or other unknown substrates in the increase in cell survival. 
[147, 148, 167] In addition, macrophages reduce their levels of ubiquitination, which 
is required for protein degradation in the proteasome after 2 hours and was 
undetectable after 4 hours. [166] 
In contrast, our findings showed rescue effects of MAPKK cleavage after short LT 
exposures (90min) followed by proteasome inhibition (4 hours) in NHBE. However, 
5.5 hours of LT treatment did not change their proteasome activity. After 48 hours of 
LT exposure NHBE, proteasome activity was decreased. This was partially induced 
by MAPKK inhibition which caused 50% reduction of the activity compared to 
untreated cells. LT was shown to deplete ATP by the conversion to ADP and AMP in 
murine cells. [65] The protein degradation is an ATP-dependent process and could 
reduce the proteasome function. 
Why the inhibition of the proteasome activity is beneficial for cell survival might be 
explained by the alteration of cell survival proteins by LT, which would, under normal 
conditions, not be degraded through the proteasome and induce apoptosis. Those 
proteins might be involved in cell cycle regulation or stabilization of membrane 
integrity. [148]  
 
6.7 The Modification of LF on Lysines Abolished Induced Cell 
Death in Murine Macrophages  
Biotinylation of LF (LFbio) was performed to localize LF inside NHBE. Interestingly, 
further cytotoxicity studies in susceptible murine macrophages showed complete 
viability after LTbio exposure. Since the biotinylation took place randomly, we 
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investigated by mass spectrometry the sites of biotin addition and detected 18 
lysines to be modified. The observed MAPKK cleavages proved the internalization of 
LF through binding to protective antigen and its zinc metalloprotease activity. The 
time of cleavage was very similar to unbiotinylated LT, but in some cases a slight 
delay (15-30 minutes) occurred, which might lead to a later cell death. However, 
even after 24 hours of LTbio treatment cell death was not observed, but a slower 
proliferation rate was shown. In all other studies LTbio caused the same junction, 
cytoskeleton, adhesion and motility changes as LT.  
Many inhibitors were shown to reduce LT induced cytotoxicity. (Table 2-3) However, 
this is the first report that a modification of LF by the addition of biotin abolished cell 
death. The biotinylation sites on LF might interfere with the interaction of a yet 
unknown substrate. Another possibility would be that biotin changes localization of 
LF in the cell, disabling signaling cascades important for LT induced cell death.  
Further investigations showed that LTbio changed two major processes in epithelial 
cells compared to LT, the mitochondrial potential and proteasome activity. LTbio 
treated cells did not have the reduction in proteasome activity as seen in LT treated 
cells. The ATP reduction after LT treatment might be a cause for the decrease in 
proteasome activity, which might not have been influenced by LTbio. [65]  
LThisbio treated cells were mainly hypopolarized even more then untreated cells, 
while LT treatment caused hyperpolarization. The combination of three MAPKK 
inhibitors with LT displayed a similar responce. The single inhibition of MEK1/2, 
which reduces the effect of the ERK pathway, showed almost identical effects as LT 
treatment. This pathway is known to be involved in proliferation, which might be 
beneficial for cell survival.  
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7 SUMMARY 
Inhalational anthrax is an acute infectious disease caused by exposure of the lungs 
to B. anthracis spores. Alveolar macrophages engulf spores causing them to 
germinate to the vegetative form of B. anthracis, which secretes edema toxin (ET) 
and lethal toxin (LT). The pathogenesis of inhalational anthrax is characterized by 
flu-like symptoms, respiratory distress, meningitis and shock, which is fatal in almost 
all cases. 
The mechanism behind the respiratory distress is not well understood. Therefore, 
our goal was to determine the effects of lethal toxin in the human lung epithelium. To 
study alterations in a more physiological setting, we developed a differentiated, 
polarized lung epithelial system. Lethal toxin exposure disrupted the lung barrier 
function and wound healing. Assembly defects of junction proteins and additional 
multicellular junction sites resulted in a higher permeability. Pretreatment with 
keratinocyte growth factor (KGF) and dexamethasone increased the viability, 
resulting in the rescue of the permeability changes.  
Upon LT treatment, a more rigid cytoskeleton was observed, evidenced by enhanced 
actin stress fiber formations and tubulin stabilization. Cytoskeleton and adhesion 
alterations prevented the epithelial cells from polarization, directed migration, and 
wound healing. The MAPK pathway and Cdc42 activity might be partially responsible 
for these motility defects. 
Lethal toxin is known to induce rapid cell death in murine macrophages. In contrast, 
human epithelial cells are more resistant to the cytotoxic effect of LT. By following 
the growth of epithelial cells after LT treatment, we observed inhibited cell 
proliferation due to a cell cycle arrest in the G1 phase.  
Surprisingly, biotinylated lethal factor did not induce cytotoxicity in murine 
macrophages. This is not due to an internalization or proteolytic activity defect; 
instead changes in the mitochondrial potential and proteasome activity were 
observed. Biotinylated LT did not reduce proteasome activity as seen in LT treated 
cells and caused hypopolarization of the mitochondria. However, it is possible that 
biotinylation of lethal toxin could prevent interaction of LT with proteins that induce 
cell death. 
The major challenge for anthrax treatment is to find a treatment, which can act 
faster, is easy to use and can bring patient out of the dangerous physiological state 
in late pathogenesis. Our study has implications in saving the viability and barrier 
function of lung epithelial cells. One can devise better dosage and delivery of KGF 
and dexamethasone as treatment modality for post anthrax exposure to reduce 
respiratory distress. Furthermore, overcoming the cell cycle arrest by the 
development of a drug would reduce the damage of lung epithelial cells and induce 
proliferation. The discovery that biotinylated LT is non-toxic to murine macrophages 
could revolutionize treatment of anthrax infection. Exploring the types of post-
translational modifications of LT that decrease toxicity and finding the mechanism 
behind it might, lead to therapies that directly counteract the effects of the lethal toxin 
in vivo. 
 
REFERENCES 
 
 95
8 REFERENCES 
1. Keppie, J., P.W. Harris-Smith, and H. Smith, The Chemical Basis of the 
Virulence of Bacillus Anthracis. Ix. Its Aggressins and Their Mode of Action. 
British Journal of Experimental Pathology, 1963. 44: p. 446-53. 
2. Koehler, T.M., Z. Dai, and M. Kaufman-Yarbray, Regulation of the Bacillus 
anthracis protective antigen gene: CO2 and a trans-acting element activate 
transcription from one of two promoters. Journal of Bacteriology, 1994. 
176(3): p. 586-95. 
3. http://www.wadsworth.org/databank/anthrax.htm.   [cited. 
4. Tse, E., et al., A cutaneous sore with black eschar in a cowhide worker. 
Lancet, 2002. 360(9329): p. 306. 
5. Irmak, H., et al., Cutaneous manifestations of anthrax in Eastern Anatolia: a 
review of 39 cases. Acta Medica Okayama, 2003. 57(5): p. 235-40. 
6. Beatty, M.E., et al., Gastrointestinal anthrax: review of the literature. Archives 
of Internal Medicine, 2003. 163(20): p. 2527-31. 
7. Laforce, F.M., Woolsorters' disease in England. Bulletin of the New York 
Academy of Medicine, 1978. 54(10): p. 956-63. 
8. Meselson, M., et al., The Sverdlovsk anthrax outbreak of 1979. Science, 
1994. 266(5188): p. 1202-8. 
9. Suffin, S.C., W.H. Carnes, and A.F. Kaufmann, Inhalation anthrax in a home 
craftsman. Human Pathology, 1978. 9(5): p. 594-7. 
10. Brachman, P.S., Inhalation anthrax. Annals of the New York Academy of 
Sciences, 1980. 353: p. 83-93. 
11. Jernigan, J.A., et al., Bioterrorism-related inhalational anthrax: the first 10 
cases reported in the United States. Emerging Infectious Diseases, 2001. 
7(6): p. 933-44. 
12. Dewan, P.K., et al., Inhalational anthrax outbreak among postal workers, 
Washington, D.C., 2001. Emerging Infectious Diseases, 2002. 8(10): p. 1066-
72. 
13. Baldari, C.T., et al., Anthrax toxins: A paradigm of bacterial immune 
suppression. Trends in Immunology, 2006. 27(9): p. 434-40. 
14. Turk, B.E., Manipulation of host signalling pathways by anthrax toxins. 
Biochemical Journal, 2007. 402(3): p. 405-17. 
15. Makino, S., et al., Molecular characterization and protein analysis of the cap 
region, which is essential for encapsulation in Bacillus anthracis. Journal of 
Bacteriology, 1989. 171(2): p. 722-30. 
16. Green, B.D., et al., Demonstration of a capsule plasmid in Bacillus anthracis. 
Infection & Immunity, 1985. 49(2): p. 291-7. 
17. Uchida, I., et al., Cloning and characterization of a gene whose product is a 
trans-activator of anthrax toxin synthesis. Journal of Bacteriology, 1993. 
175(17): p. 5329-38. 
18. Koehler, T.M., Bacillus anthracis genetics and virulence gene regulation. 
Current Topics in Microbiology & Immunology, 2002. 271: p. 143-64. 
19. Meynell, E. and G.G. Meynell, The Roles of Serum and Carbon Dioxide in 
Capsule Formation by Bacillus Anthracis. Journal of General Microbiology, 
1964. 34: p. 153-64. 
20. Drysdale, M., et al., atxA controls Bacillus anthracis capsule synthesis via 
acpA and a newly discovered regulator, acpB. Journal of Bacteriology, 2004. 
186(2): p. 307-15. 
REFERENCES 
 
 96
21. Drysdale, M., A. Bourgogne, and T.M. Koehler, Transcriptional analysis of the 
Bacillus anthracis capsule regulators. Journal of Bacteriology, 2005. 187(15): 
p. 5108-14. 
22. Molloy, S.S., et al., Human furin is a calcium-dependent serine endoprotease 
that recognizes the sequence Arg-X-X-Arg and efficiently cleaves anthrax 
toxin protective antigen. Journal of Biological Chemistry, 1992. 267(23): p. 
16396-402. 
23. Welkos, S.L., et al., Sequence and analysis of the DNA encoding protective 
antigen of Bacillus anthracis. Gene, 1988. 69(2): p. 287-300. 
24. Gao-Sheridan, S., S. Zhang, and R.J. Collier, Exchange characteristics of 
calcium ions bound to anthrax protective antigen. Biochemical & Biophysical 
Research Communications, 2003. 300(1): p. 61-4. 
25. Petosa, C., et al., Crystal structure of the anthrax toxin protective antigen. 
Nature, 1997. 385(6619): p. 833-8. 
26. Singh, Y., et al., The chymotrypsin-sensitive site, FFD315, in anthrax toxin 
protective antigen is required for translocation of lethal factor. Journal of 
Biological Chemistry, 1994. 269(46): p. 29039-46. 
27. Lacy, D.B., et al., Structure of heptameric protective antigen bound to an 
anthrax toxin receptor: a role for receptor in pH-dependent pore formation. 
Proceedings of the National Academy of Sciences of the United States of 
America, 2004. 101(36): p. 13147-51. 
28. Mogridge, J., M. Mourez, and R.J. Collier, Involvement of domain 3 in 
oligomerization by the protective antigen moiety of anthrax toxin. Journal of 
Bacteriology, 2001. 183(6): p. 2111-6. 
29. Singh, Y., et al., The carboxyl-terminal end of protective antigen is required for 
receptor binding and anthrax toxin activity. Journal of Biological Chemistry, 
1991. 266(23): p. 15493-7. 
30. Bradley, K.A., et al., Identification of the cellular receptor for anthrax toxin.[see 
comment]. Nature, 2001. 414(6860): p. 225-9. 
31. Brossier, F., et al., Functional analysis of the carboxy-terminal domain of 
Bacillus anthracis protective antigen. Infection & Immunity, 1999. 67(2): p. 
964-7. 
32. Varughese, M., et al., Identification of a receptor-binding region within domain 
4 of the protective antigen component of anthrax toxin. Infection & Immunity, 
1999. 67(4): p. 1860-5. 
33. Krantz, B.A., et al., A phenylalanine clamp catalyzes protein translocation 
through the anthrax toxin pore.[see comment]. Science, 2005. 309(5735): p. 
777-81. 
34. Melnyk, R.A. and R.J. Collier, A loop network within the anthrax toxin pore 
positions the phenylalanine clamp in an active conformation. Proceedings of 
the National Academy of Sciences of the United States of America, 2006. 
103(26): p. 9802-7. 
35. Santelli, E., et al., Crystal structure of a complex between anthrax toxin and its 
host cell receptor.[see comment]. Nature, 2004. 430(7002): p. 905-8. 
36. Betsou, F., et al., Cloning and sequence of the Bordetella bronchiseptica 
adenylate cyclase-hemolysin-encoding gene: comparison with the Bordetella 
pertussis gene. Gene, 1995. 162(1): p. 165-6. 
37. Comer, J.E., et al., Murine macrophage transcriptional and functional 
responses to Bacillus anthracis edema toxin. Microbial Pathogenesis, 2006. 
41(2-3): p. 96-110. 
REFERENCES 
 
 97
38. Mock, M., et al., Cloning and expression of the calmodulin-sensitive Bacillus 
anthracis adenylate cyclase in Escherichia coli. Gene, 1988. 64(2): p. 277-84. 
39. Gordon, V.M., S.H. Leppla, and E.L. Hewlett, Inhibitors of receptor-mediated 
endocytosis block the entry of Bacillus anthracis adenylate cyclase toxin but 
not that of Bordetella pertussis adenylate cyclase toxin. Infection & Immunity, 
1988. 56(5): p. 1066-9. 
40. Tournier, J.N., et al., Anthrax edema toxin cooperates with lethal toxin to 
impair cytokine secretion during infection of dendritic cells. Journal of 
Immunology, 2005. 174(8): p. 4934-41. 
41. Crawford, M.A., et al., Bacillus anthracis toxins inhibit human neutrophil 
NADPH oxidase activity. Journal of Immunology, 2006. 176(12): p. 7557-65. 
42. Hong, J., et al., Anthrax edema toxin inhibits endothelial cell chemotaxis via 
Epac and Rap1. Journal of Biological Chemistry, 2007. 282(27): p. 19781-7. 
43. Tessier, J., et al., Contributions of histamine, prostanoids, and neurokinins to 
edema elicited by edema toxin from Bacillus anthracis. Infection & Immunity, 
2007. 75(4): p. 1895-903. 
44. Alam, S., M. Gupta, and R. Bhatnagar, Inhibition of platelet aggregation by 
anthrax edema toxin. Biochemical & Biophysical Research Communications, 
2006. 339(1): p. 107-14. 
45. Cui, X., et al., Bacillus anthracis edema and lethal toxin have different 
hemodynamic effects but function together to worsen shock and outcome in a 
rat model.[see comment]. Journal of Infectious Diseases, 2007. 195(4): p. 
572-80. 
46. Watson, L.E., et al., Lethal and edema toxins of anthrax induce distinct 
hemodynamic dysfunction. Frontiers in Bioscience, 2007. 12: p. 4670-5. 
47. Bragg, T.S. and D.L. Robertson, Nucleotide sequence and analysis of the 
lethal factor gene (lef) from Bacillus anthracis. Gene, 1989. 81(1): p. 45-54. 
48. Robertson, D.L. and S.H. Leppla, Molecular cloning and expression in 
Escherichia coli of the lethal factor gene of Bacillus anthracis. Gene, 1986. 
44(1): p. 71-8. 
49. Pannifer, A.D., et al., Crystal structure of the anthrax lethal factor.[see 
comment]. Nature, 2001. 414(6860): p. 229-33. 
50. Lacy, D.B., et al., Mapping the anthrax protective antigen binding site on the 
lethal and edema factors. Journal of Biological Chemistry, 2002. 277(4): p. 
3006-10. 
51. Quinn, C.P., et al., Functional mapping of anthrax toxin lethal factor by in-
frame insertion mutagenesis. Journal of Biological Chemistry, 1991. 266(30): 
p. 20124-30. 
52. Liang, X., et al., Involvement of domain II in toxicity of anthrax lethal factor. 
Journal of Biological Chemistry, 2004. 279(50): p. 52473-8. 
53. Klimpel, K.R., N. Arora, and S.H. Leppla, Anthrax toxin lethal factor contains a 
zinc metalloprotease consensus sequence which is required for lethal toxin 
activity. Molecular Microbiology, 1994. 13(6): p. 1093-100. 
54. Kochi, S.K., et al., Zinc content of the Bacillus anthracis lethal factor. FEMS 
Microbiology Letters, 1994. 124(3): p. 343-8. 
55. Duesbery, N.S. and G.F. Vande Woude, Anthrax lethal factor causes 
proteolytic inactivation of mitogen-activated protein kinase kinase. Journal of 
Applied Microbiology, 1999. 87(2): p. 289-93. 
56. Vitale, G., et al., Anthrax lethal factor cleaves the N-terminus of MAPKKs and 
induces tyrosine/threonine phosphorylation of MAPKs in cultured 
REFERENCES 
 
 98
macrophages. Biochemical & Biophysical Research Communications, 1998. 
248(3): p. 706-11. 
57. Duesbery, N.S., et al., Proteolytic inactivation of MAP-kinase-kinase by 
anthrax lethal factor.[see comment]. Science, 1998. 280(5364): p. 734-7. 
58. Pellizzari, R., et al., Anthrax lethal factor cleaves MKK3 in macrophages and 
inhibits the LPS/IFNgamma-induced release of NO and TNFalpha. FEBS 
Letters, 1999. 462(1-2): p. 199-204. 
59. Bardwell, A.J., M. Abdollahi, and L. Bardwell, Anthrax lethal factor-cleavage 
products of MAPK (mitogen-activated protein kinase) kinases exhibit reduced 
binding to their cognate MAPKs. Biochemical Journal, 2004. 378(Pt 2): p. 
569-77. 
60. Chopra, A.P., et al., Anthrax lethal factor proteolysis and inactivation of MAPK 
kinase. Journal of Biological Chemistry, 2003. 278(11): p. 9402-6. 
61. Duesbery, N.S. and G.F. Vande Woude, Anthrax toxins. Cellular & Molecular 
Life Sciences, 1999. 55(12): p. 1599-609. 
62. Arora, N. and S.H. Leppla, Fusions of anthrax toxin lethal factor with shiga 
toxin and diphtheria toxin enzymatic domains are toxic to mammalian cells. 
Infection & Immunity, 1994. 62(11): p. 4955-61. 
63. Firoved, A.M., et al., Anthrax edema toxin sensitizes DBA/2J mice to lethal 
toxin. Infection & Immunity, 2007. 75(5): p. 2120-5. 
64. Pezard, C., P. Berche, and M. Mock, Contribution of individual toxin 
components to virulence of Bacillus anthracis. Infection & Immunity, 1991. 
59(10): p. 3472-7. 
65. Hanna, P.C., S. Kochi, and R.J. Collier, Biochemical and physiological 
changes induced by anthrax lethal toxin in J774 macrophage-like cells. 
Molecular Biology of the Cell, 1992. 3(11): p. 1269-77. 
66. Carson-Walter, E.B., et al., Cell surface tumor endothelial markers are 
conserved in mice and humans. Cancer Research, 2001. 61(18): p. 6649-55. 
67. Collier, R.J. and J.A. Young, Anthrax toxin. Annual Review of Cell & 
Developmental Biology, 2003. 19: p. 45-70. 
68. Liu, S. and S.H. Leppla, Cell surface tumor endothelium marker 8 cytoplasmic 
tail-independent anthrax toxin binding, proteolytic processing, oligomer 
formation, and internalization. Journal of Biological Chemistry, 2003. 278(7): 
p. 5227-34. 
69. Bradley, K.A., et al., Binding of anthrax toxin to its receptor is similar to alpha 
integrin-ligand interactions. Journal of Biological Chemistry, 2003. 278(49): p. 
49342-7. 
70. Bell, S.E., et al., Differential gene expression during capillary morphogenesis 
in 3D collagen matrices: regulated expression of genes involved in basement 
membrane matrix assembly, cell cycle progression, cellular differentiation and 
G-protein signaling. Journal of Cell Science, 2001. 114(Pt 15): p. 2755-73. 
71. Scobie, H.M., et al., Human capillary morphogenesis protein 2 functions as an 
anthrax toxin receptor. Proceedings of the National Academy of Sciences of 
the United States of America, 2003. 100(9): p. 5170-4. 
72. Wei, W., et al., The LDL receptor-related protein LRP6 mediates 
internalization and lethality of anthrax toxin.[see comment]. Cell, 2006. 124(6): 
p. 1141-54. 
73. Bann, J.G., L. Cegelski, and S.J. Hultgren, LRP6 holds the key to the entry of 
anthrax toxin.[comment]. Cell, 2006. 124(6): p. 1119-21. 
REFERENCES 
 
 99
74. Young, J.J., et al., LRP5 and LRP6 are not required for protective antigen-
mediated internalization or lethality of anthrax lethal toxin. PLoS Pathogens, 
2007. 3(3): p. e27. 
75. Singh, Y., V.K. Chaudhary, and S.H. Leppla, A deleted variant of Bacillus 
anthracis protective antigen is non-toxic and blocks anthrax toxin action in 
vivo. Journal of Biological Chemistry, 1989. 264(32): p. 19103-7. 
76. Abrami, L., et al., Anthrax toxin triggers endocytosis of its receptor via a lipid 
raft-mediated clathrin-dependent process.[see comment]. Journal of Cell 
Biology, 2003. 160(3): p. 321-8. 
77. Abrami, L., et al., Membrane insertion of anthrax protective antigen and 
cytoplasmic delivery of lethal factor occur at different stages of the endocytic 
pathway. Journal of Cell Biology, 2004. 166(5): p. 645-51. 
78. Koehler, T.M. and R.J. Collier, Anthrax toxin protective antigen: low-pH-
induced hydrophobicity and channel formation in liposomes. Molecular 
Microbiology, 1991. 5(6): p. 1501-6. 
79. Fasano, A. and J.P. Nataro, Intestinal epithelial tight junctions as targets for 
enteric bacteria-derived toxins. Advanced Drug Delivery Reviews, 2004. 
56(6): p. 795-807. 
80. Warfel, J.M., A.D. Steele, and F. D'Agnillo, Anthrax lethal toxin induces 
endothelial barrier dysfunction. American Journal of Pathology, 2005. 166(6): 
p. 1871-81. 
81. Bruce Alberts, A.J., Julian Lewis, Martin Raff, Keith Roberts, and Peter 
Walter., Molecular Biology of the Cell fourth ed. 2002: Garland Science. 
82. Harvey Lodish, A.B., S. Lawrence Zipursky, Paul Matsudaira, David 
Baltimore, James Darnell Molecular Cell Biology. fourth ed. 1999: W. H. 
Freeman and Company. 
83. Holthofer, B., et al., Structure and Function of Desmosomes, in International 
Review of Cytology. 2007, Academic Press. p. 65-163. 
84. Michael, Z.G., Integrin signaling in epithelial cells. Cancer letters, 2007. 
247(1): p. 1-25. 
85. Wozniak, M.A., et al., Focal adhesion regulation of cell behavior. Biochimica 
et Biophysica Acta, 2004. 1692(2-3): p. 103-19. 
86. Chandra, H., et al., Proteome analysis of mouse macrophages treated with 
anthrax lethal toxin. Biochimica et Biophysica Acta, 2005. 1747(2): p. 151-9. 
87. During, R.L., et al., Anthrax lethal toxin paralyzes neutrophil actin-based 
motility. Journal of Infectious Diseases, 2005. 192(5): p. 837-45. 
88. During, R.L., et al., Anthrax lethal toxin paralyzes actin-based motility by 
blocking Hsp27 phosphorylation. EMBO Journal, 2007. 26(9): p. 2240-50. 
89. O'Brien, J., et al., Effects of anthrax toxin components on human neutrophils. 
Infection & Immunity, 1985. 47(1): p. 306-10. 
90. Campbell, N.A., Biology. fourth ed. 1996: Addison Wesley Publishing 
Company. 
91. Takai, Y., T. Sasaki, and T. Matozaki, Small GTP-binding proteins. 
Physiological Reviews, 2001. 81(1): p. 153-208. 
92. Westermann, S. and K. Weber, Post-translational modifications regulate 
microtubule function. Nat Rev Mol Cell Biol, 2003. 4(12): p. 938-948. 
93. Pollard, T.D., The cytoskeleton, cellular motility and the reductionist 
agenda.[comment]. Nature, 2003. 422(6933): p. 741-5. 
94. Ridley, A.J., et al., Cell migration: integrating signals from front to back. 
Science, 2003. 302(5651): p. 1704-9. 
REFERENCES 
 
 100
95. Martinez-Quiles, N., et al., Erk/Src Phosphorylation of Cortactin Acts as a 
Switch On-Switch Off Mechanism That Controls Its Ability To Activate N-
WASP. Mol. Cell. Biol., 2004. 24(12): p. 5269-5280. 
96. Johndrow, J.E., C.R. Magie, and S.M. Parkhurst, Rho GTPase function in 
flies: insights from a developmental and organismal perspective. Biochemistry 
& Cell Biology, 2004. 82(6): p. 643-57. 
97. Govek, E.E., S.E. Newey, and L. Van Aelst, The role of the Rho GTPases in 
neuronal development. Genes & Development, 2005. 19(1): p. 1-49. 
98. Desai, L.P., et al., RhoA and Rac1 are both required for efficient wound 
closure of airway epithelial cells. American Journal of Physiology - Lung 
Cellular & Molecular Physiology, 2004. 287(6): p. L1134-44. 
99. Nalbant, P., et al., Activation of Endogenous Cdc42 Visualized in Living Cells. 
Science, 2004. 305(5690): p. 1615-1619. 
100. Yang, L., L. Wang, and Y. Zheng, Gene targeting of Cdc42 and Cdc42GAP 
affirms the critical involvement of Cdc42 in filopodia induction, directed 
migration, and proliferation in primary mouse embryonic fibroblasts. Molecular 
Biology of the Cell, 2006. 17(11): p. 4675-85. 
101. http://www.cellsignal.com/reference/pathway/pdfs/MAPK_Cascades.pdf.   
[cited. 
102. Lewis, T.S., P.S. Shapiro, and N.G. Ahn, Signal transduction through MAP 
kinase cascades. Advances in Cancer Research, 1998. 74: p. 49-139. 
103. Crews, C.M., A. Alessandrini, and R.L. Erikson, The primary structure of MEK, 
a protein kinase that phosphorylates the ERK gene product. Science, 1992. 
258(5081): p. 478-480. 
104. Alessi, D.R., et al., Identification of the sites in MAP kinase kinase-1 
phosphorylated by p74raf-1. EMBO Journal, 1994. 13(7): p. 1610-9. 
105. Rosen, L.B., et al., Membrane depolarization and calcium influx stimulate 
MEK and MAP kinase via activation of Ras. Neuron, 1994. 12(6): p. 1207-
1221. 
106. Cowley, S., et al., Activation of MAP kinase kinase is necessary and sufficient 
for PC12 differentiation and for transformation of NIH 3T3 cells. Cell, 1994. 
77(6): p. 841-52. 
107. Webb, D.J., D.H. Nguyen, and S.L. Gonias, Extracellular signal-regulated 
kinase functions in the urokinase receptor-dependent pathway by which 
neutralization of low density lipoprotein receptor-related protein promotes 
fibrosarcoma cell migration and matrigel invasion. Journal of Cell Science, 
2000. 113(Pt 1): p. 123-34. 
108. Huang, C., K. Jacobson, and M.D. Schaller, MAP kinases and cell migration. 
Journal of Cell Science, 2004. 117(Pt 20): p. 4619-28. 
109. Totsukawa, G., et al., Distinct roles of MLCK and ROCK in the regulation of 
membrane protrusions and focal adhesion dynamics during cell migration of 
fibroblasts. J. Cell Biol., 2004. 164(3): p. 427-439. 
110. Webb, D.J., et al., FAK-Src signalling through paxillin, ERK and MLCK 
regulates adhesion disassembly. Nature Cell Biology, 2004. 6(2): p. 154-61. 
111. Glading, A., et al., Epidermal growth factor activates m-calpain (calpain II), at 
least in part, by extracellular signal-regulated kinase-mediated 
phosphorylation. Molecular & Cellular Biology, 2004. 24(6): p. 2499-512. 
112. Hunger-Glaser, I., et al., Bombesin, lysophosphatidic acid, and epidermal 
growth factor rapidly stimulate focal adhesion kinase phosphorylation at Ser-
REFERENCES 
 
 101
910: requirement for ERK activation. Journal of Biological Chemistry, 2003. 
278(25): p. 22631-43. 
113. Sharma, G.D., J. He, and H.E. Bazan, p38 and ERK1/2 coordinate cellular 
migration and proliferation in epithelial wound healing: evidence of cross-talk 
activation between MAP kinase cascades. Journal of Biological Chemistry, 
2003. 278(24): p. 21989-97. 
114. Hedges, J.C., et al., A Role for p38MAPK/HSP27 Pathway in Smooth Muscle 
Cell Migration. J. Biol. Chem., 1999. 274(34): p. 24211-24219. 
115. Huang, C., et al., Phosphorylation of paxillin by p38MAPK is involved in the 
neurite extension of PC-12 cells. J. Cell Biol., 2004. 164(4): p. 593-602. 
116. Tamara Mirzapoiazova, I.A.K.L.R.J.G.N.G.A.D.V., The role of caldesmon in 
the regulation of endothelial cytoskeleton and migration. Journal of Cellular 
Physiology, 2005. 203(3): p. 520-528. 
117. Rousseau, S., et al., p38 MAP kinase activation by vascular endothelial 
growth factor mediates actin reorganization and cell migration in human 
endothelial cells. Oncogene, 1997. 15(18): p. 2169-77. 
118. Benndorf, R., et al., Phosphorylation and supramolecular organization of 
murine small heat shock protein HSP25 abolish its actin polymerization-
inhibiting activity. Journal of Biological Chemistry, 1994. 269(32): p. 20780-4. 
119. Lavoie, J.N., et al., Modulation of actin microfilament dynamics and fluid 
phase pinocytosis by phosphorylation of heat shock protein 27. Journal of 
Biological Chemistry, 1993. 268(32): p. 24210-4. 
120. Singh, S., et al., Identification of the p16-Arc subunit of the Arp 2/3 complex 
as a substrate of MAPK-activated protein kinase 2 by proteomic analysis. 
Journal of Biological Chemistry, 2003. 278(38): p. 36410-7. 
121. Werz, O., et al., 5-lipoxygenase is phosphorylated by p38 kinase-dependent 
MAPKAP kinases. Proceedings of the National Academy of Sciences of the 
United States of America, 2000. 97(10): p. 5261-6. 
122. Yujiri, T., et al., MEK kinase 1 gene disruption alters cell migration and c-Jun 
NH2-terminal kinase regulation but does not cause a measurable defect in 
NF-kappa B activation. Proceedings of the National Academy of Sciences of 
the United States of America, 2000. 97(13): p. 7272-7. 
123. Hauck, C.R., et al., Inhibition of focal adhesion kinase expression or activity 
disrupts epidermal growth factor-stimulated signaling promoting the migration 
of invasive human carcinoma cells. Cancer Research, 2001. 61(19): p. 7079-
90. 
124. Shin, E.Y., S.Y. Kim, and E.G. Kim, c-Jun N-terminal kinase is involved in 
motility of endothelial cell. Experimental & Molecular Medicine, 2001. 33(4): p. 
276-83. 
125. Javelaud, D., et al., Disruption of Basal JNK Activity Differentially Affects Key 
Fibroblast Functions Important for Wound Healing. J. Biol. Chem., 2003. 
278(27): p. 24624-24628. 
126. Huang, C., et al., JNK phosphorylates paxillin and regulates cell migration. 
Nature, 2003. 424(6945): p. 219-223. 
127. Otto, I.M., et al., The p150-Spir protein provides a link between c-Jun N-
terminal kinase function and actin reorganization. Current Biology, 2000. 
10(6): p. 345-8. 
128. Gdalyahu, A., et al., DCX, a new mediator of the JNK pathway. EMBO 
Journal, 2004. 23(4): p. 823-32. 
REFERENCES 
 
 102
129. Chang, L., et al., JNK1 is required for maintenance of neuronal microtubules 
and controls phosphorylation of microtubule-associated proteins. 
Developmental Cell, 2003. 4(4): p. 521-33. 
130. Cote, C.K., N. Van Rooijen, and S.L. Welkos, Roles of macrophages and 
neutrophils in the early host response to Bacillus anthracis spores in a mouse 
model of infection. Infection & Immunity, 2006. 74(1): p. 469-80. 
131. Cleret, A., et al., Lung dendritic cells rapidly mediate anthrax spore entry 
through the pulmonary route. Journal of Immunology, 2007. 178(12): p. 7994-
8001. 
132. Russell, B.H., et al., Potential dissemination of Bacillus anthracis utilizing 
human lung epithelial cells. Cellular Microbiology. 0(0): p.???-??? 
133. Gutting, B.W., et al., Differential susceptibility of macrophage cell lines to 
Bacillus anthracis-Vollum 1B. Toxicology in Vitro, 2005. 19(2): p. 221-9. 
134. Hanna, P., Anthrax pathogenesis and host response. Current Topics in 
Microbiology & Immunology, 1998. 225: p. 13-35. 
135. Hanna, P., Lethal toxin actions and their consequences. Journal of Applied 
Microbiology, 1999. 87(2): p. 285-7. 
136. Kim, S.O., et al., Sensitizing anthrax lethal toxin-resistant macrophages to 
lethal toxin-induced killing by tumor necrosis factor-alpha. Journal of 
Biological Chemistry, 2003. 278(9): p. 7413-21. 
137. Popov, S.G., et al., Lethal toxin of Bacillus anthracis causes apoptosis of 
macrophages. Biochemical & Biophysical Research Communications, 2002. 
293(1): p. 349-55. 
138. Boyden, E.D. and W.F. Dietrich, Nalp1b controls mouse macrophage 
susceptibility to anthrax lethal toxin.[see comment]. Nature Genetics, 2006. 
38(2): p. 240-4. 
139. Bugge, T.H. and S.H. Leppla, Anthrax target in macrophages 
unveiled.[comment]. Nature Genetics, 2006. 38(2): p. 137-8. 
140. Ting, J.P. and B.K. Davis, CATERPILLER: a novel gene family important in 
immunity, cell death, and diseases. Annual Review of Immunology, 2005. 23: 
p. 387-414. 
141. Lamkanfi, M., et al., Caspase-1 inflammasomes in infection and inflammation. 
Journal of Leukocyte Biology, 2007. 82(2): p. 220-5. 
142. Cordoba-Rodriguez, R., et al., Anthrax lethal toxin rapidly activates caspase-
1/ICE and induces extracellular release of interleukin (IL)-1beta and IL-18. 
Journal of Biological Chemistry, 2004. 279(20): p. 20563-6. 
143. Burns, K., F. Martinon, and J. Tschopp, New insights into the mechanism of 
IL-1beta maturation. Current Opinion in Immunology, 2003. 15(1): p. 26-30. 
144. Tschopp, J., F. Martinon, and K. Burns, NALPs: a novel protein family 
involved in inflammation. Nature Reviews Molecular Cell Biology, 2003. 4(2): 
p. 95-104. 
145. Wickliffe, K.E., S.H. Leppla, and M. Moayeri, Anthrax lethal toxin-induced 
inflammasome formation and caspase-1 activation are late events dependent 
on ion fluxes and the proteasome. Cellular Microbiology, 2008. 10(2): p. 332-
343. 
146. Muehlbauer, S.M., et al., Anthrax lethal toxin kills macrophages in a strain-
specific manner by apoptosis or caspase-1-mediated necrosis. Cell Cycle, 
2007. 6(6): p. 758-66. 
147. Hanna, P.C., et al., Role of macrophage oxidative burst in the action of 
anthrax lethal toxin. Molecular Medicine, 1994. 1(1): p. 7-18. 
REFERENCES 
 
 103
148. Tang, G. and S.H. Leppla, Proteasome activity is required for anthrax lethal 
toxin to kill macrophages. Infection & Immunity, 1999. 67(6): p. 3055-60. 
149. Hammond, S.E. and P.C. Hanna, Lethal factor active-site mutations affect 
catalytic activity in vitro. Infection & Immunity, 1998. 66(5): p. 2374-8. 
150. Menard, A., et al., The vacuolar ATPase proton pump is required for the 
cytotoxicity of Bacillus anthracis lethal toxin. FEBS Letters, 1996. 386(2-3): p. 
161-4. 
151. Kau, J.H., et al., Calyculin A sensitive protein phosphatase is required for 
Bacillus anthracis lethal toxin induced cytotoxicity. Current Microbiology, 
2002. 44(2): p. 106-11. 
152. Dell'Aica, I., et al., Potent inhibitors of anthrax lethal factor from green tea. 
EMBO Reports, 2004. 5(4): p. 418-22. 
153. Gaddis, B.D., L.V. Avramova, and J. Chmielewski, Inhibitors of anthrax lethal 
factor. Bioorganic & Medicinal Chemistry Letters, 2007. 17(16): p. 4575-4578. 
154. Shoop, W.L., et al., Anthrax lethal factor inhibition. Proceedings of the 
National Academy of Sciences of the United States of America, 2005. 
102(22): p. 7958-63. 
155. Panchal, R.G., et al., Identification of small molecule inhibitors of anthrax 
lethal factor. Nature Structural & Molecular Biology, 2004. 11(1): p. 67-72. 
156. Johnson, S.L., et al., Anthrax lethal factor protease inhibitors: synthesis, SAR, 
and structure-based 3D QSAR studies. Journal of Medicinal Chemistry, 2006. 
49(1): p. 27-30. 
157. Min, D.H., W.J. Tang, and M. Mrksich, Chemical screening by mass 
spectrometry to identify inhibitors of anthrax lethal factor. Nature 
Biotechnology, 2004. 22(6): p. 717-23. 
158. Lee, L.V., et al., Inhibition of the proteolytic activity of anthrax lethal factor by 
aminoglycosides. Journal of the American Chemical Society, 2004. 126(15): 
p. 4774-5. 
159. Schepetkin, I.A., et al., Novel small-molecule inhibitors of anthrax lethal factor 
identified by high-throughput screening. Journal of Medicinal Chemistry, 2006. 
49(17): p. 5232-44. 
160. Fridman, M., et al., Dual effect of synthetic aminoglycosides: antibacterial 
activity against Bacillus anthracis and inhibition of anthrax lethal factor. 
Angewandte Chemie. International Ed. in English, 2005. 44(3): p. 447-52. 
161. Jiao, G.S., et al., Guanidinylated 2,5-dideoxystreptamine derivatives as 
anthrax lethal factor inhibitors. Bioorganic & Medicinal Chemistry Letters, 
2006. 16(6): p. 1527-31. 
162. Jiao, G.S., et al., Selectively guanidinylated derivatives of neamine. 
Syntheses and inhibition of anthrax lethal factor protease. Bioorganic & 
Medicinal Chemistry Letters, 2006. 16(19): p. 5183-9. 
163. Goldman, M.E., et al., Cationic polyamines inhibit anthrax lethal factor 
protease. BMC Pharmacology, 2006. 6: p. 8. 
164. Salles, II, et al., Toxin-induced resistance in Bacillus anthracis lethal toxin-
treated macrophages. Proceedings of the National Academy of Sciences of 
the United States of America, 2003. 100(21): p. 12426-31. 
165. Squires, R.C., S.M. Muehlbauer, and J. Brojatsch, Proteasomes Control 
Caspase-1 Activation in Anthrax Lethal Toxin-mediated Cell Killing. J. Biol. 
Chem., 2007. 282(47): p. 34260-34267. 
REFERENCES 
 
 104
166. Alileche, A., et al., Mitochondrial impairment is a critical event in anthrax lethal 
toxin-induced cytolysis of murine macrophages. Cell Cycle, 2006. 5(1): p. 
100-6. 
167. Ha, S.-D., et al., Mitochondrial Proteins Bnip3 and Bnip3L Are Involved in 
Anthrax Lethal Toxin-induced Macrophage Cell Death. J. Biol. Chem., 2007. 
282(36): p. 26275-26283. 
168. Park, J.M., et al., Macrophage apoptosis by anthrax lethal factor through p38 
MAP kinase inhibition. Science, 2002. 297(5589): p. 2048-51. 
169. Fang, H., et al., Anthrax lethal toxin has direct and potent inhibitory effects on 
B cell proliferation and immunoglobulin production. Journal of Immunology, 
2006. 176(10): p. 6155-61. 
170. Paccani, S.R., et al., Anthrax toxins suppress T lymphocyte activation by 
disrupting antigen receptor signaling.[see comment]. Journal of Experimental 
Medicine, 2005. 201(3): p. 325-31. 
171. Fang, H., et al., Anthrax lethal toxin blocks MAPK kinase-dependent IL-2 
production in CD4+ T cells. Journal of Immunology, 2005. 174(8): p. 4966-71. 
172. Koo, H.M., et al., Apoptosis and melanogenesis in human melanoma cells 
induced by anthrax lethal factor inactivation of mitogen-activated protein 
kinase kinase. Proceedings of the National Academy of Sciences of the 
United States of America, 2002. 99(5): p. 3052-7. 
173. Ha, S.-D., et al., Critical role of PI3-K/Akt/GSK-3beta signaling pathway in 
recovery from anthrax lethal toxin-induced cell cycle arrest and MEK cleavage 
in macrophages. J. Biol. Chem., 2007: p. M707622200. 
174. Paddle, B.M., V.K. Wong, and B.D. Muller, The cytotoxic effect of anthrax 
lethal toxin on human lung cells in vitro and the protective action of bovine 
antibodies to PA and LF. Journal of Applied Toxicology, 2006. 26(2): p. 162-8. 
175. Kirby, J.E., Anthrax lethal toxin induces human endothelial cell apoptosis. 
Infection & Immunity, 2004. 72(1): p. 430-9. 
176. Kassam, A., S.D. Der, and J. Mogridge, Differentiation of human monocytic 
cell lines confers susceptibility to Bacillus anthracis lethal toxin. Cellular 
Microbiology, 2005. 7(2): p. 281-92. 
177. Popov, S.G., et al., Effect of Bacillus anthracis lethal toxin on human 
peripheral blood mononuclear cells. FEBS Letters, 2002. 527(1-3): p. 211-5. 
178. Guidi-Rontani, C., E. Duflot, and M. Mock, Anthrax lethal toxin-induced 
mitogenic response of human T-cells. FEMS Microbiology Letters, 1997. 
157(2): p. 285-9. 
179. Jason E. Comer, A.K.C., Johnny W. Peterson, and Rolf König, Direct 
Inhibition of T-Lymphocyte Activation by Anthrax Toxins In Vivo Infection and 
Immunity, 2005. 73(12): p. 8275-8281. 
180. Huang, D., et al., Inhibition of MAPK Kinase Signaling Pathways Suppressed 
Renal Cell Carcinoma Growth and Angiogenesis In vivo. Cancer Res, 2008. 
68(1): p. 81-88. 
181. Depeille, P., et al., Anthrax Lethal Toxin Inhibits Growth of and Vascular 
Endothelial Growth Factor Release from Endothelial Cells Expressing the 
Human Herpes Virus 8 Viral G Protein Coupled Receptor. Clin Cancer Res, 
2007. 13(19): p. 5926-5934. 
182. Dixon, T.C., et al., Anthrax.[see comment]. New England Journal of Medicine, 
1999. 341(11): p. 815-26. 
183. Grinberg, L.M., et al., Quantitative pathology of inhalational anthrax I: 
quantitative microscopic findings. Modern Pathology, 2001. 14(5): p. 482-95. 
REFERENCES 
 
 105
184. Mohamed, N., et al., A high-affinity monoclonal antibody to anthrax protective 
antigen passively protects rabbits before and after aerosolized Bacillus 
anthracis spore challenge. Infection & Immunity, 2005. 73(2): p. 795-802. 
185. Peterson, J.W., et al., Human monoclonal anti-protective antigen antibody 
completely protects rabbits and is synergistic with ciprofloxacin in protecting 
mice and guinea pigs against inhalation anthrax. Infection & Immunity, 2006. 
74(2): p. 1016-24. 
186. Darly J. Manayani, D.T., Kelly A. Dryden, Vijay Reddy, Marc E. Siladi, John 
M. Marlett, G. Jonah A. Rainey, Michael E. Pique, Heather M. Scobie, Mark 
Yeager, John A. T. Young, Marianne Manchester, Anette Schneemann, A 
Viral Nanoparticle with Dual Function as an Anthrax Antitoxin and Vaccine. 
PLoS Pathogens, 2007. 3(10). 
187. de Jong, P.M., et al., Ciliogenesis in human bronchial epithelial cells cultured 
at the air-liquid interface. American Journal of Respiratory Cell & Molecular 
Biology, 1994. 10(3): p. 271-7. 
188. Gray, T.E., et al., Mucociliary differentiation of serially passaged normal 
human tracheobronchial epithelial cells. American Journal of Respiratory Cell 
& Molecular Biology, 1996. 14(1): p. 104-12. 
189. Bottenstein, J., et al., The growth of cells in serum-free hormone-
supplemented media. Methods in Enzymology, 1979. 58: p. 94-109. 
190. Wu, R., Y.H. Zhao, and M.M. Chang, Growth and differentiation of conducting 
airway epithelial cells in culture. European Respiratory Journal, 1997. 10(10): 
p. 2398-403. 
191. Martin, W.R., et al., Growth and differentiation of primary tracheal epithelial 
cells in culture: regulation by extracellular calcium. Journal of Cellular 
Physiology, 1991. 147(1): p. 138-48. 
192. Floryk, D. and J. Houštěk, Tetramethyl Rhodamine Methyl Ester (TMRM) is 
Suitable for Cytofluorometric Measurements of Mitochondrial Membrane 
Potential in Cells Treated with Digitonin. Bioscience Reports, 1999. 19(1): p. 
27-34. 
193. Alley, M.C., et al., Feasibility of drug screening with panels of human tumor 
cell lines using a microculture tetrazolium assay. Cancer Research, 1988. 
48(3): p. 589-601. 
194. Gorczyca, W., J. Gong, and Z. Darzynkiewicz, Detection of DNA strand 
breaks in individual apoptotic cells by the in situ terminal deoxynucleotidyl 
transferase and nick translation assays. Cancer Research, 1993. 53(8): p. 
1945-51. 
195. Chapman, R.S., et al., Further characterisation of the in situ terminal 
deoxynucleotidyl transferase (TdT) assay for the flow cytometric analysis of 
apoptosis in drug resistant and drug sensitive leukaemic cells. Cytometry, 
1995. 20(3): p. 245-56. 
196. Korzeniewski, C. and D.M. Callewaert, An enzyme-release assay for natural 
cytotoxicity. Journal of Immunological Methods, 1983. 64(3): p. 313-20. 
197. Decker, T. and M.L. Lohmann-Matthes, A quick and simple method for the 
quantitation of lactate dehydrogenase release in measurements of cellular 
cytotoxicity and tumor necrosis factor (TNF) activity. Journal of Immunological 
Methods, 1988. 115(1): p. 61-9. 
198. Radyuk, S.N., et al., In vitro-generated respiratory mucosa: a new tool to 
study inhalational anthrax. Biochemical & Biophysical Research 
Communications, 2003. 305(3): p. 624-32. 
REFERENCES 
 
 106
199. http://www.antibodybeyond.com/reviews/cell-marker-reviews.htm.   [cited. 
200. Ganz, T. and R.I. Lehrer, Defensins. Current Opinion in Immunology, 1994. 
6(4): p. 584-9. 
201. Bonuccelli, G., et al., ATR/TEM8 is highly expressed in epithelial cells lining 
Bacillus anthracis' three sites of entry: implications for the pathogenesis of 
anthrax infection. American Journal of Physiology - Cell Physiology, 2005. 
288(6): p. C1402-10. 
202. Gumbiner, B.M., Regulation of cadherin-mediated adhesion in 
morphogenesis. Nature Reviews Molecular Cell Biology, 2005. 6(8): p. 622-
34. 
203. Mickey Pentecost, G.O., Julie A Theriot, and Manuel R Amieva, Listeria 
monocytogenes Invades the Epithelial Junctions at Sites of Cell Extrusion. 
PLoS Pathogolgy, 2006. 2(1): p. 29-40. 
204. Burridge, K., et al., Focal adhesions: transmembrane junctions between the 
extracellular matrix and the cytoskeleton. Annual Review of Cell Biology, 
1988. 4: p. 487-525. 
205. Turner, C.E., Paxillin interactions. J Cell Sci, 2000. 113(23): p. 4139-4140. 
206. Sieg, D.J., et al., FAK integrates growth-factor and integrin signals to promote 
cell migration. Nat Cell Biol, 2000. 2(5): p. 249-256. 
207. Stefega, M., C. DerMardirossian, and G.M. Bokoch, Affinity-based assay of 
Rho guanosine triphosphatase activation. Methods of Moleculare Biology, 
2006. 332: p. 269-79. 
208. Sugahara, K., et al., Alveolar epithelial cells: differentiation and lung injury. 
Respirology, 2006. 11(s1): p. S28-S31. 
209. Ulrich, K., et al., Keratinocyte growth factor therapy in murine oleic acid-
induced acute lung injury. Am J Physiol Lung Cell Mol Physiol, 2005. 288(6): 
p. L1179-1192. 
210. Ashton, M.R., et al., Surfactant phosphatidylcholine composition during 
dexamethasone treatment in chronic lung disease. Arch. Dis. Child. Fetal 
Neonatal Ed., 1994. 71(2): p. F114-117. 
211. Chen, Y., et al., Dexamethasone-Mediated Repression of MUC5AC Gene 
Expression in Human Lung Epithelial Cells. Am. J. Respir. Cell Mol. Biol., 
2006. 34(3): p. 338-347. 
212. Roberts, J.E., et al., Ltx1, a mouse locus that influences the susceptibility of 
macrophages to cytolysis caused by intoxication with Bacillus anthracis lethal 
factor, maps to chromosome 11. Molecular Microbiology, 1998. 29(2): p. 581-
91. 
213. Friedlander, A.M., et al., Characterization of macrophage sensitivity and 
resistance to anthrax lethal toxin. Infection & Immunity, 1993. 61(1): p. 245-
52. 
214. Welkos, S.L., et al., Resistance to the Sterne strain of B. anthracis: phagocytic 
cell responses of resistant and susceptible mice. Microbial Pathogenesis, 
1989. 7(1): p. 15-35. 
215. Singh, Y., et al., Internalization and processing of Bacillus anthracis lethal 
toxin by toxin-sensitive and -resistant cells. Journal of Biological Chemistry, 
1989. 264(19): p. 11099-102. 
216. Welkos, S.L., T.J. Keener, and P.H. Gibbs, Differences in susceptibility of 
inbred mice to Bacillus anthracis. Infection & Immunity, 1986. 51(3): p. 795-
800. 
REFERENCES 
 
 107
217. Sachs, L.A., W.E. Finkbeiner, and J.H. Widdicombe, Effects of media on 
differentiation of cultured human tracheal epithelium. In Vitro Cellular & 
Developmental Biology. Animal, 2003. 39(1-2): p. 56-62. 
218. Beauregard, K.E., et al., Anthrax toxin entry into polarized epithelial cells. 
Infection & Immunity, 1999. 67(6): p. 3026-30. 
219. Moayeri, M., et al., Bacillus anthracis lethal toxin induces TNF-alpha-
independent hypoxia-mediated toxicity in mice.[see comment]. Journal of 
Clinical Investigation, 2003. 112(5): p. 670-82. 
220. Cui, X., et al., Lethality during continuous anthrax lethal toxin infusion is 
associated with circulatory shock but not inflammatory cytokine or nitric oxide 
release in rats. American Journal of Physiology - Regulatory Integrative & 
Comparative Physiology, 2004. 286(4): p. R699-709. 
221. http://www.emedicine.com/emerg/topic864.htm.   [cited. 
222. Webster, J.I., et al., Anthrax lethal factor represses glucocorticoid and 
progesterone receptor activity. Proceedings of the National Academy of 
Sciences of the United States of America, 2003. 100(10): p. 5706-11. 
223. Tarnawski, A.S., Cellular and molecular mechanisms of gastrointestinal ulcer 
healing. Digestive Diseases & Sciences, 2005. 50: p. S24-33. 
224. Wennerberg, K. and C.J. Der, Rho-family GTPases: it's not only Rac and Rho 
(and I like it). Journal of Cell Science, 2004. 117(Pt 8): p. 1301-12. 
225. Wehrle-Haller, B. and B.A. Imhof, Actin, microtubules and focal adhesion 
dynamics during cell migration. The International Journal of Biochemistry & 
Cell Biology, 2003. 35(1): p. 39-50. 
226. Rennefahrt, U.E., et al., Constitutive JNK activation in NIH 3T3 fibroblasts 
induces a partially transformed phenotype. Journal of Biological Chemistry, 
2002. 277(33): p. 29510-8. 
227. Steele, A.D., J.M. Warfel, and F. D'Agnillo, Anthrax lethal toxin enhances 
cytokine-induced VCAM-1 expression on human endothelial cells. 
Biochemical & Biophysical Research Communications, 2005. 337(4): p. 1249-
56. 
228. Popova, T.G., et al., Acceleration of epithelial cell syndecan-1 shedding by 
anthrax hemolytic virulence factors. BMC Microbiology, 2006. 6: p. 8. 
229. Raftopoulou, M. and A. Hall, Cell migration: Rho GTPases lead the way. 
Developmental Biology, 2004. 265(1): p. 23-32. 
230. Etienne-Manneville, S. and A. Hall, Cdc42 regulates GSK-3beta and 
adenomatous polyposis coli to control cell polarity. Nature, 2003. 421(6924): 
p. 753-6. 
231. Ivins, B.E., J.D. Ristroph, and G.O. Nelson, Influence of body weight on 
response of Fischer 344 rats to anthrax lethal toxin. Applied & Environmental 
Microbiology, 1989. 55(8): p. 2098-100. 
232. Ussar, S. and T. Voss, MEK1 and MEK2, different regulators of the G1/S 
transition. Journal of Biological Chemistry, 2004. 279(42): p. 43861-9. 
233. Yee, A.S., et al., The HBP1 transcriptional repressor and the p38 MAP kinase: 
unlikely partners in G1 regulation and tumor suppression. Gene, 2004. 336(1): 
p. 1-13. 
 
 
INDEX OF FIGURES 
 
 108
9 INDEX OF FIGURES 
Figure 2-1: Electron microscopy of spores and vegetative form of anthrax. 4 
Figure 2-2: Plasmids pXO1 and pXO2 of B. anthracis contain genes, which encode virulence 
factors. 5 
Figure 2-3: Protective antigen crystal structure and pore formation from [35]. 6 
Figure 2-4: Crystal structure of lethal factor from [49]. 7 
Figure 2-5: Alignment for MAPKK cleavage site. 8 
Figure 2-6: Lethal factor interacting region. 9 
Figure 2-7: Alternative splice variants of the TEM8 receptor. 10 
Figure 2-8: The splice variants of the CMG2 receptor. 11 
Figure 2-9: Anthrax toxin cycle. 12 
Figure 2-10: Overview of the junction complex. 13 
Figure 2-11: Cytoskeletal polymers. 15 
Figure 2-12: Mechanism of actin turnover from [93]. 17 
Figure 2-13: Cell migration key players. 18 
Figure 2-14: Signaling cascade of Rho, Rac and Cdc42 and their influence on the cytoskeleton.
 19 
Figure 2-15: MAPK pathway. 20 
Figure 2-16: ERK signaling pathway causes motility changes. 21 
Figure 2-17: p38 signaling pathway causes motility changes. 22 
Figure 2-18: JNK signaling pathway causes motility changes. 23 
Figure 4-1: Differentiated airway system. 37 
Figure 4-2: Resistance measurement of 3D grown cells with an electrical voltohmmeter. 46 
Figure 5-1: Morphology of normal tissue culture treated NHBE and polarized 3D cells in EM. 50 
Figure 5-2: Pneumocyte characterization. 51 
Figure 5-3: mRNA and protein expression of MUC5AC in the 3D system. 52 
Figure 5-4: Anthrax receptor expression. 52 
Figure 5-5: Effect of LT treatment on the protein and mRNA levels of MAPKKs. 53 
Figure 5-6: Resistance and permeability change. 54 
Figure 5-7: LDH release after LT treatment in the 3D system. 54 
Figure 5-8: Increase of multicellular junction sites after LT treatment at the apical side. 55 
Figure 5-9: Electron microscopy pictures of LT treated, polarized NHBE. 56 
Figure 5-10: Lethal toxin induces tight junction alterations. 56 
Figure 5-11: A diffuse adherens junction stain occured after LT treatment. 57 
Figure 5-12: Junctional proteins increase in membrane and cytoskeleton after LT exposure. 57 
Figure 5-13: Stress fiber and tubulin bundle accumulations after LT treatment. 57 
Figure 5-14: Quantification of increased actin filaments after LT treatment and actin 
polymerization inhibition. 57 
Figure 5-15: Actin assembly is not inhibited after LT treatment. 57 
Figure 5-16: Increased actin amounts in cytoskeletal fraction after LT treatment. 57 
Figure 5-17: Increased tubulin stabilization after LT treatment. 57 
Figure 5-18: Wound healing defect caused by LT. 57 
Figure 5-19: Chemotaxis defect of LT and MAPK inhibitors treated cells. 57 
Figure 5-20: Live cell imaging picture. 57 
Figure 5-21: Elongation of focal adhesion. 57 
Figure 5-22: Fractionation of adhesion proteins and their regulatory proteins. 57 
Figure 5-23: Phosphorylation of adhesion proteins are not altered after LT treatment. 57 
INDEX OF FIGURES 
 
 109
Figure 5-24: Adhesion defect to positive charged surfaces after LT treatment. 57 
Figure 5-25: RhoGTPase mRNA and protein activity measurements. 57 
Figure 5-26: MAPK pathways are important for wound healing. 57 
Figure 5-27: Quantification of wound healing defects. 57 
Figure 5-28: Rescue of resistance by KGF and dexamethasone. 57 
Figure 5-29: Rescue of permeability increase by KGF and dexamethasone. 57 
Figure 5-30: KGF and dexamethasone increase cell viability. 57 
Figure 5-31: Lethal toxin does not alter membrane integrity. 57 
Figure 5-32: Minimal DNA strand breaks after LT treatment measured in a TUNEL assay. 57 
Figure 5-33: Caspase 3 activation is not induced by LT. 57 
Figure 5-34: Blocked cell proliferation after LT treatment. 57 
Figure 5-35: Increase of cells in G1 phase after LT treatment. 57 
Figure 5-36: Mitochondrial potential alteration caused by MAPKK cleavage. 57 
Figure 5-37: MAPKK expression induced by proteasome inhibitors. 57 
Figure 5-38: Reduced proteasome activity after LT treatment. 57 
Figure 5-39: Continuous MAPKK cleavage after 48 hours of LT treatment. 57 
Figure 5-40: LT residues stored in cell. 57 
Figure 5-41: Similar MAPKK cleavage activity of different LFs. 57 
Figure 5-42: LF is localized in membrane compartments. 57 
Figure 5-43: LF degradation after exposure to Raw cell lysates. 57 
Figure 5-44: Biotinylated lethal factor did not alter cell viability. 57 
Figure 5-45: MAPKK cleavage time course. 57 
Figure 5-46: LFhisbio does not induce cell death within 24 hours treatment. 57 
Figure 5-47: Protein sequence of lethal factor with biotinylated lysines (K). 57 
Figure 5-48: LThisbio does not reduce the proteasome activity in NHBE. 57 
Figure 5-49: LThisbio causes mainly hypopolarization of the mitochondrial potential in NHBE.
 57 
Figure 5-50: Cytotoxicity and resistance comparison of LT and LTbio in NHBE 3D. 57 
INDEX OF TABLES 
 
 110
10 INDEX OF TABLES 
Table 2-1: Resistant and susceptible macrophage cell lines or mouse strains. 9 
Table 2-2: Posttranslational modification of tubulin. 16 
Table 2-3: Inhibitors for lethal toxin induced cytotoxicity. 25 
Table 2-4: Symptoms of 10 Inhalational anthrax cases between October-November of 2001. 27 
Table 4-1: Antibody List. 33 
Table 4-2: Primer list. 34 
Table 4-3: Non-cleavable MKK mutants. 44 
Table 12-1: Lung cell markers 57 
INDEX OF MOVIES 
 
 111
11 INDEX OF MOVIES 
Movie 1:  Untreated cells imaged every minute for 2 hours.  
 
Movie 2:  Lethal toxin treated cells imaged every minute for 2 hours. 
 
Movie 3:  Untreated cells imaged every 30 seconds for 40 minutes. 
 
Movie 4:  Lethal toxin treated cells imaged every 30 seconds for 40 minutes. 
 
Movie 5:  Three MAPK inhibitor combination imaged every 30 seconds for 40min. 
 
Movie 6:  MKK1/2 inhibitor imaged every 30 seconds for 40min. 
 
Movie 7:  p38 inhibitor imaged every 30 seconds for 40min. 
 
Movie 8:  JNK II inhibitor imaged every 30 seconds for 40min. 
 
Movie 9:  Infection of VECTOR EGFP CONTROL imaged every 30 seconds for 40min.  
 
Movie 10:  Infection of VECTOR EGFP CONTROL and 24hr LT treatement imaged every 30 
seconds for 40min. 
 
Movie 11:  Infection of non-cleavable mkk1 and 2 MUTANTS imaged every 30 seconds for 
40min. 
 
Movie 12:  Infection of non-cleavable mkk3 and 6 MUTANTS imaged every 30 seconds for 
40min. 
 
Movie 13:  Infection of non-cleavable mkk1 and 2 MUTANTS and 24 HR LT TREATMENT 
imaged every 30 seconds for 40min. 
 
Movie 14:  Infection of non-cleavable mkk3 and 6 MUTANTS and 24 HR LT TREATMENT 
imaged every 30 seconds for 40min. 
 
Movie 15:  Infection of non-cleavable mkk4 and 7 MUTANTS imaged every 30 seconds for 
40min. 
 
Movie 16:  Infection of non-cleavable mkk4 and 7 MUTANTS and 24 HR LT TREATMENT 
imaged every 30 seconds for 40min. 
 
Movie 17:  Biotinylated lethal Toxin imaged every 30 seconds for 40min.  
 
 
 
 
 
 
 
 
APPENDIX 
 
 112
12 APPENDIX  
12.1  Summary of Characteristically Marker of Lung Cells 
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Table 12-1: Lung cell markers  
(adapted from [199]) 
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12.2  Abbreviations 
 
2D   two dimensional 
3D    three dimensional  
3H   tritium 
%   percent 
Å   angstrom 
aa   amino acids 
ADF   actin depolymerization factor 
ADP   adenosine diphosphate 
AKT   V-akt murine thymoma viral oncogene homolog 
Ala   alanine (A) 
ALI   airway surface liquide 
APS   ammonium persulfate 
Arp2/3  actin related protein 2/3 
ASC   apoptosis-associated speck-like protein 
ATP   adenosine triphosphate 
ATR   anthrax eeceptor 
AVA   anthrax-vaccine absorbed 
BCA   bicinchoninic acid 
BD-1   beta-defensin-1  
BD-2   beta-defensin-2 
BEGM  bronchial epithelial growth media 
bp   base pairs  
BSA   bovine serum albumin 
Ca   calcium 
Ca2+   calcium ion 
cAMP   cyclic adenosine monophosphate 
CapZ   capping protein from the Z-disc of muscle 
CARD   caspase recruiting domain 
CCCP   carbonyl cyanide 3-chlorophenylhydrazone 
cDNA   coding DNA 
CHO   chinese hamster ovary cell line 
CMG2   capillary morphogenesis gene 2  
CO2   carbon dioxide  
Cortactin  cortical cortex binding protein 
CRK   v-crk sarcoma virus CT10 oncogene homolog  
Da   dalton 
DAPI   4’,6-diamidino-2-phenylindole dihydrochloride  
dH2O   deionized water 
DIC   differential interference contrast 
DMSO  dimethyl sulfoxide 
DNA   deoxyribonucleic acid 
e.g.    exampli gratia, latin; for example 
ECL   enhanced chemiluminescent 
ECM   extracellular matrix 
EDTA   ethylenediaminetetraacetic acid 
EF   edema factor 
EGCG  epigallocatechin gallate 
EGF   epithelial growth factor 
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EGTA   ethylenebis (oxyethylenenitrilo) tetraacetic acid 
EM   electronmicroscope  
ERK   extracellular signal-regulated kinases 
ET   edema toxin 
EtBr   ethidium bromide 
EVOM  epithelial voltohmmeter 
F-actin  filamentous actin 
FAK   focal adhesion kinase 
FBS   fetal bovine serum 
Fc   fragment, crystallizable 
Fig   figure 
FITC   fluorescein isothiocyanate 
for   forward 
FSC    forward scattering 
g   gram 
G-actin  globular actin 
GDP   guanosine diphosphate 
Glu   glutamic acid (E) 
GM130  cis-golgi matrix protein 130kDa 
GTP   guanosine triphosphate 
HBSS   hank´s balanced salt solution 
hr   hour 
HRP   horseradish peroxidase 
hrs   hours 
Hsp   heat shock protein 
HUVEC  human umbilical vein endothelial cells 
IF   immunofluorescence     
IL   interleukin  
IP   immunoprecipitation  
JNK   Jun N-terminal kinase 
kb   kilo base pairs 
kDa   kilo dalton 
KGF   keratinocyte growth factor  
Kif1c    kinesin family member 1c 
LDH   lactate dehydrogenase 
LF   lethal factor 
LFIR   lethal factor interacting region 
LPS   lipopolysaccharide 
LRP2   low-density lipoprotein receptor-related protein 2  
LRR   leucine-rich repeats 
LT   lethal toxin 
mA   milliampere  
MAP   mitogen-activated protein 
MAPK   MAP kinase 
MAPKAPK 2/3 MAPK-activating protein kinase 2/3 
MAPKK  MAP kinase kinases 
MAPKKK  MAP kinase kinase kinases 
MAPs   microtubule-associated proteins  
MDCK  Madin-Darby Canine Kidney Epithelial Cells 
MEK   MAP ERK kinase 
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mg   milligram 
MIDAS  metal ion-dependent adhesion site 
min   minutes 
ml   milliliter 
MLCK   myosin light chain kinase 
MMP   matrix metalloproteinase 
mRNA  messenger RNA 
MT   microtubules  
MTOC microtubules organizing center  
MTT 3-(4, 5-Dimethyl-2-thiazolyl)-2, 5-diphenyl-2H-tetrazolium 
bromide 
MUC5AC  mucin 5AC 
NaCl   sodium chloride 
NADPH  nicotinamide adenine dinucleotide phosphate oxidase 
Nalp1   NACHT, leucine rich repeat and PYD (pyrin domain) containing1 
NaN3   sodium azide 
nano-LC-MS-MS  nano-liquid chromatography-mass spec-mass spec 
NaOH   sodiumhydroxide 
NCBI   national center for biotechnology information  
ng   nanogram 
NHBE   normal human bronchial epithelial cells 
NIH   national institute of health 
NLR     NOD-like receptor protein 
nm   nanometer 
nmol   nanomolar 
NOD   nucleotide-binding oligomerization domain 
NP-40   nonidet P-40 
PA   protective antigen 
PAGE   polyacrylamide gel electrophoresis  
PAK   p21-activated kinase 
PARP   poly (ADP-ribose) polymerase-1 
PBS   phosphate buffered saline 
PCR   polymerase chain reaction  
PET   polyester 
PFA   paraformaldehyde 
PI   propidium iodide 
PI3K   Phosphoinositide-3 kinase 
PIP2   phosphatidylinositol bisphosphate 
PIX   PAK-interacting exchange factor 
PLC   phosphorlipase C 
PMSF   phenylmethylsulphonylfluoride  
Pro   proline (P) 
RA   retinoic acid 
RCC   renal cell carcinoma 
Rev   reverse 
RIPA   radioimmuno-precipitation assay buffer 
RNA   ribonucleic acid 
ROCK   Rho-associated coiled-coil protein kinase 1 
ROS   reactive oxygen species 
rpm   rounds per minute  
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RT   room temperature 
SAEC   small airway epithelial cells 
SAGM  small airway growth media 
Scar   suppressor of cAMP receptor  
SDS   sodium dodecyl sulfate 
sec   seconds 
SP-A   surfactant A 
SP-B   surfactant B 
SSC    side scattering 
T   thymidine  
TAE   tris acetate EDTA 
TBS   tris buffered saline 
TBST   tris-buffered saline with tween 
TE   tris EDTA buffer 
TEER   trans epithelial electric resistance 
TEM   transmission electron microscopy 
TEM8   tumor endothelial marker 8  
TEMED  N,N,N`,N’,tetramethylethylene diamine 
THP-1   human acute monocytic leukemia cell line 
Thr   threonine (T) 
TMRM  tetramethyl rhodamine methyl ester 
TNFα   tumor necrosis factor α 
TNS   trypsin neutralizing solution 
TSRI The Scripps Research Institute 
TUNEL  terminal deoxynucleotidyl transferase biotin-dUTP nick end 
labeling 
Tyr   tyrosine (Y) 
V   volts 
VCAM-1  vascular cell adhesion molecule 1 
VIP2   vegetative insecticidal protein 2 
VWA/I   von Willebrand Factor type A domain/integrin inserted domain 
WASP  wiskott aldrich syndrome protein 
µg   microgram 
µl   microliter 
µM   micromolar 
 
12.3  Alphabetical List of Companies 
Aaper Alcohol Co     Shelbyville, KY 
Abgene     United Kingdom 
Airgas West     San Diego, CA 
Alpha Innotech     San Leandro, CA 
Amersham Bioscience   Uppsala, Sweden 
Applied Biosystems    Foster City, CA 
BD Biosciences    San Jose, CA 
Beckman Coulter     Fullerton, CA 
Bellco Glass INC     Vineland, NJ  
BioRad Laboratories   Hercules,CA 
Brinkman Instuments Inc.   Westbury, NY 
Lonza      Walkersville, MD 
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Cell Sciences    Canton, MA 
EG + G Berthold     Bad Wildbach, Germany 
Electron Microscopy Sciences  Hatfield, PA 
EMD Biosciences    San Diego, CA 
Eppendorf AG     Hamburg, Germany 
Fisher Scientific     Hampton, NH 
GE Healthcare    Piscataway, NJ 
Genesee Scientific    San Diego, CA 
Gibco Invitrogen     Carlsbad, CA 
Integrated DNA Technology (IDT)  Coralville, IA 
Invitrogen     Carlsbad, CA 
J.T. Baker     Phillipsburg, NJ 
Konica Minolta    Wayne, NJ  
Labnet International Inc   Edison, NJ 
Leica      Wetzlar, Germany 
Perkin Elmer Instruments   Wellesley, MA 
List Biological Laboratories  Campbell, CA 
Mettler      Toledo, Switzerland 
Millipore      Temecula, CA 
Molecular Devices    Sunnyvale, CA 
MP Biomedical    Solon, OH  
NanoDrop Technologies   Wilmington, DE 
Nikon      Melville, NY 
NUAIRE     Plymouth, MN 
Olympus     Center Valley, PA 
Perkin Elmer     Wellesley, MA  
Pharmacia Biotech     Cambrige, UK 
Philips     New York, NY   
Pierce      Rockford, IL 
Promega     Madison, WI 
Qiagen     Valencia, CA 
Reichert     Depew, NY 
Roche      Basel, Switzerland 
Santa Cruz     Santa Cruz, CA. 
Sigma-Aldrich Co    St. Louis, MO 
Southern Biotech    Birmingham, AL 
STERIS Corporation   Mentor, Ohio 
Stratagene     La Jolla, CA 
Thermo Forma Scientific   Waltham, MA 
ThermoHybaid    Heidelberg, Germany 
VWR      West Chester, PA 
World Precision Instruments   Sarasota, FL  
Zeiss      Goettingen, Germany 
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